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‘Nothing in life is to be feared, it is only to be understood. Now is the time to 
understand more, so that we may fear less.’ 
Marie Skłodowska-Curie (1867 - 1934) chemist & physicist, Nobel Prize for 
Physics in 1903, in Our Precarious Habitat (1973) by Melvin A. Benarde. 
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Abstract 
This thesis investigates the use of Volatile Organic Compounds (VOCs) in disease diagnosis 
and monitoring. VOCs may be found in the human body, in exhaled breath, faecal matter, 
urine, and skin. Analysis of the volatile profile produced in the human body can provide 
an indicator of metabolic status, allowing the screening and monitoring of different 
diseases and conditions, non-invasively and painlessly.  
In this thesis a range of highly sensitive analytical techniques have been adopted to 
measure such VOCs and demonstrate that such monitoring may be used as a disease 
diagnostic. For example breath samples may be analysed and calibrated against gas-phase 
standards prepared under physiologically representative concentrations as a tool for 
non-invasive disease monitoring, e.g. type 2 diabetes.  
Detailed faecal headspace analyses of two different mouse models of type 2 diabetes 
(Cushing´s mice and Afmid) were made. The mouse model of Cushing’s syndrome develop 
excessive circulating glucocorticoid concentrations, which are associated with obesity, 
hyperglycaemia and insulin resistance. The Afmid knockout mice suffer inactivation of 
Afmid genes, which in part regulates many functions including pancreatic secretion. These 
mice show impaired glucose tolerance. The gut microbiota of diabetic mice appear to 
have a different composition when compared to wild-type littermates, i.e. significantly 
increased levels of short-chain fatty acids (SCFAs), ketones, alcohols and aldehydes were 
found in the faecal headspace of diabetic mice, and a possible link between gut 
microbiota and type 2 diabetes is demonstrated. 
The use of VOCs as a screening tool of colorectal cancer was also explored. The current 
screening tools show lack of sensitivity and specificity for the screening of the disease. 
The volatile faecal profile of patients with colorectal cancer was investigated, and 
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sulphide compounds, including hydrogen sulphide (H2S) are shown to have potential as 
biomarkers for screening of colorectal cancer. 
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1. 1 Introduction 
The contemporaneous technological advance in analytical techniques allows the 
measurement of volatile organic compounds (VOCs) emitted from clinical samples such as 
exhaled breath, urine, blood, serum, sputum and faeces. However, in spite of its 
advantages, diagnostics based on VOCs profiling is not yet widely used in clinical practice. 
Volatile organic compounds (VOCs) are carbon-based molecules that are volatile at 
ambient temperature (Pysanenko et al., 2009). VOC analysis, particularly breath analysis, 
appears as a promising non-invasive method when compared to the traditional blood 
analysis, and may potentially be used for the screening of several conditions, such as 
cancer.  
During the last decades, Selected Ion Flow Tube Mass Spectrometry (SIFT-MS), Proton 
Transfer Reaction Mass Spectrometry (PTR-MS) and Gas Chromatography-Mass 
Spectrometry (GC-MS) with thermal desorption or solid-phase micro extraction (SPME) 
have been widely used for medical research. SIFT-MS and PTR-MS analytical techniques 
have been developed for potential medical applications, by using breath analysis, urine 
analysis, faecal analysis, in vivo human skin studies, and in vitro cell cultures. SIFT-MS and 
PTR-MS have been developed for real-time, on-line detection and quantification of trace 
gases in air with a high sensitivity and wide dynamic range. 
VOCs as disease indicators is being explored in both human/patient studies and in 
animal/mouse models. This thesis reports the results of new studies in the use of VOCs as 
markers of disease. This thesis is composed on 7 chapters. Chapter 1 introduces VOCs in 
disease diagnosis and monitoring; parameters that affect the VOC levels detected in the 
human body; the methods available for collection and storage of volatile samples; and 
some of the applications of VOC analysis in disease diagnosis and monitoring. Chapter 2 
presents the current methods for analysing VOCs and its gas-phase ion chemistry. 
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Chapter 3 gathers the analytical methods used in the sampling and analysis of VOCs. 
Experimental studies are presented in chapters 4, 5, 6, and explore three different 
aspects of current research. 
 
 Fundamental chemistry studies. The lack of standardization between different 
analytical techniques is still a major challenge in monitoring VOCs in breath analysis. 
Therefore, chapter 4 discusses a potential method for comparing instrumental 
analysis of breath gas volatile organic compounds found in breath using standards 
calibrated in the gas-phase, where theoretical prediction of reaction rate coefficients 
were determined and quantitative determination of VOC concentrations via Selected 
Ion Flow Tube Mass Spectrometry (SIFT-MS), Proton Transfer Reaction Mass 
Spectrometry (PTR-MS) and Gas Chromatography-Mass Spectrometry (GC-MS) 
combined with thermal desorption was achieved. 
 
 In the future VOC analysis may be potentially used to monitor progress of disease in 
humans with type 2 diabetes. 
In chapter 5 the use of mouse models to identify potential indicators in VOCs emitted 
from faeces related to changes in blood glucose in type 2 diabetes (T2D) and impaired 
glucose tolerance is discussed. Mouse models can provide large datasets for 
metabolic profiling in a short period of time and under controlled conditions.  
 
 VOCs emitted from human body are potentially biomarkers of disease.  
In chapter 6 a pilot study is presented on the use of the volatile faecal metabolome in 
screening for colorectal cancer. Screening for colorectal cancer is extremely invasive, 
and not very effective, requiring many ultimately unnecessary invasive and 
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unpleasant diagnostic colonoscopies thus analysis of VOCs in faecal headspace can be 
potentially used to screen for colorectal cancer, non-invasively and painlessly, and 
thus reduce the number of unnecessary colonoscopies. 
 
In the final chapter 7 the results obtained in the present work are summarised and 
some suggestion for future research directions presented. 
 
1. 2 The use of VOCs as disease biomarkers 
The VOCs are generated within the body, travel around the body via the blood and then 
they can cross the alveolar interface and appear in exhaled breath, being measured at 
trace concentrations in the parts-per-million by volume (ppmv) and parts-per-billion by 
volume (ppbv) levels or lower (Smith and Španěl, 2007). A detailed review on breath 
analysis in disease diagnosis has been written by myself and published in Metabolites 
open access journal (Lourenço and Turner, 2014) and it may be find in Appendix B. 
Analysis of the relative differences of VOCs can, therefore, provide an indicator of 
metabolic status, allowing a distinction between healthy and diseased state of the body. 
Thus, these techniques have the potential to detect diseases in their early stages, non-
invasively and painlessly.  
Michael Phillips has been a pioneering breath researcher for more than 30 years. Anton 
Amann organized the International Association of Breath Research (IABR), and created 
the Journal of Breath Research followed by the annual international meetings on Breath 
Analysis starting in 2004. They have set the research community the challenge of 
diagnosis of diseases based upon VOCs not only in exhaled breath, as well as urine, faeces 
and skin. The scientific community is willing and eager to study all the parameters but this 
presents several difficulties that need to be investigated before such a technique can be 
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brought into clinical practice, these includes defining the methodology for sampling, 
storage and analysis of VOCs. Diagnostics based upon VOCs requires a reliable instrument 
ready for real-time analysis. Data acquisition of the measurements is managed by the 
software installed in the instrument, namely, specific software for PTR-MS, SIFT-MS, and 
GC-MS. Normalization and scaling is required prior to statistical analysis, followed by the 
use of unsupervised [e.g. Principal Component Analysis (PCA)] or supervised (e.g. 
classification) multivariate statistical methods with further method cross-validation. The 
process continues with identification of relevant VOCs and VOCs profiles combining a 
biochemical explanation of the data. The screening test should be able to distinguish 
between healthy and diseased patients with high sensitivity and specificity (Figure 1.1). 
 
 
Figure 1. 1 – Schematic representations of the steps involved in the identification of VOC as disease biomarker. 
 
 
Before exploring further how we may detect VOCs and explore their role as a biomarker 
for disease it is necessary to understand how and where VOCs are produced in the body. 
 
1. 3 VOC production in the human body and their use as biomarkers 
 
Volatile organic compounds (VOCs) are a diverse group of organic molecules that are 
volatile at ambient temperature (Pysanenko et al., 2009). At a given temperature, a 
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substance with higher vapour pressure vaporizes more readily than a substance with a 
lower vapour pressure. Many of these compounds occur naturally in the environment. 
Most people encounter VOCs in their day-to-day lives in the form of solvents, 
constituents of petroleum fuels, etc. In addition, they may be emitted from bodily fluids 
and as a result, VOCs emitted from urine, faeces, breath, and even skin can provide 
insight into various biochemical pathways within the body and in the assessment of 
diseases or drugs monitoring.   
 
The normal range of VOC concentrations largely depends on several factors, such as age; 
gender; ethnicity; ovulation; environmental contaminants – “exposome” – such as 
radiation, life-style, pollution, diet, and stress; physiological parameters and physical 
activity. In addition, the type of breath sampling (end-tidal or mixed air) and analysis 
strongly contribute to the VOC profile obtained.   
 
 
1.3.1 VOC detection in human breath 
VOCs are produced by metabolic processes in various places in the body, e.g. by bacteria 
in the gut and in the oral cavity by bacterial infections. However, is likely that many of the 
VOCs which may be detected from the body are not biochemically produced in the body 
and predominantly come from environmental exposure – so called exogenous VOCs. 
VOCs from metabolic processes in the human body may be detected in breath as well as 
urine and faeces. VOC analysis from the human body started in the 1970s when Linus 
Pauling and co-workers detected over 200 different VOCs in human exhaled air and in 
urine headspace by gas chromatography (Pauling et al., 1971). However, many of the 
VOCs found as major components of breath, such as acetone, isoprene, etc. are not of 
endogenous origin (Miekisch et al., 2004, Smith et al., 2007). A large variety of trace gases 
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exist in ambient air and these can be taken up via inhalation and skin absorption; the 
source of others is through ingestion. Hence, some of the trace compounds in exhaled 
breath, perhaps the majority of them, will be exogenous, and these need to be 
distinguished from the truly endogenous compounds (Smith et al., 2007, Buszewski et al., 
2007).  
 
The endogenous compounds found in human breath, such as inorganic gases (e.g., NO 
and CO), and VOCs (e.g., isoprene, ethane, pentane, acetone) can be measured directly; 
other typically non-volatile substances, such as isoprostanes, peroxynitrite, or cytokines, 
can be measured in breath condensate (Miekisch et al., 2004). These non-volatile 
substances (isoprostanes, peroxynitrite, or cytokines) are supposed to be present in 
exhaled breath as aerosol particles. 
 
Background air VOC concentrations are an issue. The concept of alveolar gradient 
proposed by Michael Phillips (Phillips et al., 1994), defined as the abundance in breath 
minus the abundance in room air, for substances having higher inspired than expired 
concentrations has been proposed to deal with this, however it, does not properly 
account for the background air a subject breathes. This has been demonstrated by the 
work of many researchers, including Schubert (Schubert et al., 2005) and Španěl (Španěl 
et al., 2013). Indeed, it has been shown (Schubert et al., 2005) that the previous 
assumption does not lead to quantitative results; instead they suggested that when 
inhaled (ambient) concentrations of compounds are greater than 5% of the exhaled 
concentrations, exhaled concentrations cannot be correlated with blood levels with 
confidence. The levels detected in breath will depend on many factors, including the 
concentration in ambient air, the duration of exposure, the solubility and partition co-
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efficient into tissues, the mass and fat content of the individual, as well as the underlying 
endogenous concentration. Sample procedures for breath analysis have many advantages 
over traditional blood analysis of compounds suspended in or dissolved in blood: they are 
painless and non-invasive, easy to perform, inexpensive, and the results are available 
immediately for therapeutic assessments (Amann and Smith, 2013). The exhaled air 
matrix is less complex than that of blood or other body fluids (Buszewski et al., 2007). 
However, storage of blood is generally easier than breath. Traditional blood analysis 
typically involves measuring the concentrations of specific salts, proteins or other non-
volatile components. However, sampling procedures for blood analysis are stressful for 
patients and a non-invasive sample, such as breath, is, therefore, preferable. 
 
 
Mouth- vs. Nose-Exhaled Breath 
 
The challenge of breath analysis for clinical diagnosis and therapeutic monitoring lies in 
the identification of endogenous volatile compounds present in mouth-exhaled breath 
which are potential markers of diseases and which reflect levels in the systemic 
circulation. Many of these trace volatile compounds may be produced in the airways, the 
oral cavity by bacterial infections, by bacteria in the gut, and also emitted from mucus, 
saliva and aerosols created in the respiratory tract. Phillips and co-workers performed a 
pilot study by GC–MS for detecting VOCs in breath associated with oral malodour (Phillips 
et al., 2005). However, this technique has some limitations since the lower molecular 
weight VOCs may not be detected due to the sorbent trap selectivity for two carbon 
atoms or more. 
 
A sampling device of breath exhaled via the mouth, nose, and air in the mouth cavity was 
developed by Smith and co-workers (Wang et al., 2008). Studies were performed using 
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SIFT-MS to evaluate the concentration of mouth- and nose-exhaled breath, in order to 
understand the biological origin of several compounds (Wang et al., 2008, Smith et al., 
2008, Pysanenko et al., 2008). Ammonia in the exhaled breath is largely generated in the 
mouth (Smith et al., 2008) as is ethanol (Wang et al., 2008) and hydrogen cyanide (Wang 
et al., 2008). This has been demonstrated through showing that the levels measured in 
the nose exhalations are much lower than those observed in the mouth exhalations. Very 
low concentrations of propanol and acetaldehyde in exhaled breath appear to be partially 
systemic and partially mouth generated (Wang et al., 2008). Blood-borne acetaldehyde 
levels in exhaled breath result from endogenous ethanol metabolism (Lourenço and 
Turner, 2014). Acetone, methanol, and isoprene showed similar profiles for mouth- or 
nose-exhaled breath (Wang et al., 2008), indicating that these compounds are totally 
systemic. However, methanol may be ingested by food intake or drink; hence methanol 
concentration in breath may not be totally produced through the human biochemistry. 
The decarboxylation of acetoacetate and the dehydrogenation of isopropanol are the two 
sources of acetone production in the human body (Kalapos, 2003). The simplicity of the 
ion chemistry of acetone with H3O
+ was established in the 90’s (Španěl et al., 1997). Thus 
to avoid the possibility of contamination of the endogenous VOCs through mouth flora, 
taking breath from the nose is recommended by Smith and co-workers.  
Furthermore, a recent study using solid-phase micro-extraction (SPME) of bacterial 
cultures demonstrated that several compounds detected in mouth-exhaled breath are 
produced by anaerobic bacteria in tongue biofilms (Khalid et al., 2013b). In addition, poor 
oral hygiene can be a confounding factor leading to production of ammonia from urea or 
ethanol from sugars, thus, increasing VOCs concentration in mouth-exhaled breath 
(Španěl et al., 2006). Ethanol may arise in exhaled breath as an anaerobic fermentation 
product by gut bacteria. Most breath ethanol, however, appears to be due to mouth 
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fermentation of sugars (unless the subject has been consuming alcoholic drinks) (Smith et 
al., 2002). 
Additionally, volatile compounds may be produced by bacteria in the gut, transported to 
and excreted by the lungs (Amann et al., 2010). Helicobacter pylori living in the hostile 
acidic environment of the human stomach release compounds that can be detected in 
mouth-exhaled air, i.e. converts urea into ammonia, allowing it to survive and grow in 
gastric acid (Ulanowska et al., 2011). Bacteria present in the gut produce alcohols, 
including 1-propanol and 2-propanol; structural isomers that exists in the human body 
(Enderby et al., 2009). 
The analysis of mouth- and nose-exhaled breath following ingestion of different doses of 
alcohol (Smith et al., 2010a) at different concentrations in water was carried out using 
SIFT-MS by Smith and co-workers. They determined how the volume of ingested liquid 
influenced the gastric retention and degradation of ethanol. This showed the fraction of 
ethanol ingested and, consequently, the fraction which enters the blood stream, which in 
turn is diluted in exhaled breath. The decay of breath ethanol has been followed and 
measured in mouth- and nose-exhaled breath. Smith and co-workers suggested that 
saturation of the liver enzymes have an important role in managing the decay of breath 
ethanol. Additionally, has been shown that gastric retention clearly results in a slower 
release of ethanol into the gut. 
 
End-tidal and Alveolar breath 
The VOCs in breath are at trace levels (ppmv, pptv or lower) and that coupled with the 
high humidity, means that storage, transport and analysis of samples is challenging due to 
the possibility of having condensation effects and hydrated hydronium ions acting as 
precursor ions during analysis. Concentrations of volatile compounds in blood are 
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reflected by their concentrations in the exhaled air, depending on their blood-gas 
partition coefficient or solubility. Alveolar breath is the part of exhaled air in equilibrium 
with systemic blood, whereas end-tidal air is the last fraction of expired air, whose 
composition resembles alveolar air. Generally, the term end-exhaled breath is applied 
because it does not imply that the composition of expired air is always identical to the 
equilibrated air inside the alveoli. It has long been acknowledged that alveolar gas 
exchange is dependent on ventilation, pulmonary perfusion, and the blood:air partition 
coefficient (Anderson et al., 2003), thus, there are non-homogeneities in the composition 
of alveolar air among different lung regions over different blood:air solubilities of VOCs 
(Levitt et al., 1998). There is evidence that the gas exchange of highly soluble volatile 
compounds occurs in the airways rather than alveoli (Anderson and Hlastala, 2007), 
meaning that VOCs measured from the mouth depend on expiratory flow. Generally, the 
term alveolar breath may be applied for low blood soluble VOCs, whereas for highly 
soluble volatiles such as acetone, the term end-exhaled breath should be used due to the 
evidence that gas exchange occurs in the airways rather than alveoli. Such evidence was 
quantified for the first time by Španěl and co-workers, who demonstrated the 
discrepancy between the concentration in the alveolar region to that in exhaled air (a 
factor of 3 for isoprene) (Španěl et al., 2013). Exhaled air is a mixture of dead space and 
alveolar air (Fowler, 1948). Dead space was previously defined as the volume of expired 
air, which acts as a conducting airway (nose, pharynx, larynx, trachea), whereas alveolar 
air is the expired air fraction that has been exchanged in the alveoli. Initial approaches 
have been taken, such as discarding the first 500 mL of exhaled breath to avoid dilution of 
the sample by dead space. However, it incorrectly assumes that all subjects have the 
same volume of dead space (Dubowski, 1974).  
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Monitoring of expired CO2 has been used to identify alveolar gas. Thus, Schubert and 
co-workers measured CO2 (Schubert et al., 2001, Birken et al., 2006) in the exhaled air of 
mechanically ventilated patients by means of a capnograph, using a CO2-triggered 
alveolar sampling valve (Figure 1.2). They reported this as a reliable and reproducible 
method for alveolar sampling through CO2 concentration measures. Later on, Di 
Francesco and co-workers designed a CO2-triggered breath sampler suitable for multiple 
breaths (Di Francesco et al., 2008). 
 
 
Figure 1. 2 – (a) Schematic drawing of a normal capnogram and typical modes of sampling: Phase I is the end of 
inspiration and beginning of expiration. Gas sampled during this phase represents anatomical dead space air and would 
typically not contain CO2 and endogenous VOCs. Phase II reflects the appearance of CO2 and a steep upstroke of CO2 
tension in the normal capnogram. Gas sampled during this phase typically contains a mixture of alveolar and dead space 
air. Phase III reflects the alveolar or expiratory plateau. As the result of alveolar emptying, PetCO2 represents the end-
tidal concentration. (b) Alveolar breath sampling at the bed-side. Alveolar gas samples are withdrawn from the circuit 
under visual control of expired CO2 (Miekisch and Schubert, 2006). 
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More recently, Filipiak and co-workers (Filipiak et al., 2012) applied the same on-line 
monitoring of expired CO2 in order to collect alveolar air by needle traps used in GC-MS 
analysis. 
 
The on-line breath sampling so-called buffered end-tidal (BET) (Herbig et al., 2008) breath 
sampling method has been developed to extend the analysis time of the end-tidal fraction 
of a single exhalation. This sampling system was designed to buffer only the end-tidal 
fraction of the breath. The patient is asked to exhale through a tailored tube in which the 
end-tidal fraction of breath is buffered. 
 
Dilution of VOCs 
Hydrophilic exhaled trace gases, such as acetone, interact with the water-like mucus 
membrane lining the conductive airways, an effect known as wash-in/wash-out behaviour 
(Anderson et al., 2006). The exhaled breath concentrations of water soluble substances 
appear to dilute on their way up from the deeper respiratory track to the airway opening, 
leading to discrepancies between the true alveolar breath and the measured 
concentrations, demonstrating a dilution effect. It means that highly soluble gases are 
present in large concentrations in the airway tissue and mucus as compared to less 
blood-soluble gases for a given partial pressure. 
 
Single or multiple breaths 
Breath sampling may be performed for a single breath or for multiple breath cycles 
(O’Hara et al., 2008). However, the composition of a single breath may not be a 
representative alveolar gas sample for the reason that breaths may considerably vary 
from each other due to different modes and depth of breathing. Multiple breaths may be 
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preferable in order to get reproducible breath samples. However, it may be that exact 
quantification is less important when characterizing breath profiles. 
Comparison of rebreathing and on-line single exhalations of the highly soluble 
compounds acetone and methanol, and the low soluble isoprene, has been reported 
previously (O’Hara et al., 2008, King et al., 2012). For highly soluble compounds, such as 
acetone, exchange occurs in the airways rather than alveoli (Anderson and Hlastala, 
2007), thus, breath sampling becomes much more complicated because acetone 
concentration in end-exhaled breath may not be in equilibrium with the systemic blood. 
For that reason, an isothermal rebreathing model has been proposed for estimating the 
alveolar levels of highly soluble exhaled endogenous volatiles (King et al., 2012). 
 
1.3.2 Influence of age/ gender and ovulation on VOC concentrations in human breath 
The age and gender of the patient is an important factor in VOCs analysis. PTR-MS was 
used for determination of isoprene concentrations in the exhaled breath of children by 
Taucher and co-workers, and was found to be significantly lower than in adults (Taucher 
et al., 1997). Lechner and co-workers measured the VOCs in the breath of 126 volunteers, 
using the same technique, reporting an increase in isoprene concentration of exhaled air 
of male subjects with age (Lechner et al., 2006). SIFT-MS was also used to determine the 
concentrations of some metabolites in the breath of healthy children aged between 7–18 
years old (Enderby et al., 2009); where the median concentration of pentanol (15 ppbv) 
was also determined. The exhaled breath of several volunteers within the age range 4–83 
years was measured and reported a trend of increasing breath ammonia concentration 
with age (Španěl et al., 2007a). Isoprene is apparently elevated in breath during 
adolescence, as reported by Smith and co-workers, probably due to the onset of puberty, 
as stated by the authors (Smith et al., 2010b). 
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During analysis of the headspace of urine from a number of female volunteers, Smith and 
co-workers observed acetone and ammonia levels occasionally higher than the normal, 
i.e. 3- to 12-fold increase in the level of acetone in the urine headspace, and similar 
increase in the ammonia levels although these were a day out of phase. The urine 
samples were collected before any food intake. Such findings suggested that it may be 
caused by metabolic changes occurring during ovulation and related to menstrual cycle 
length (Diskin et al., 2003, Smith et al., 2006). Studies applied to VOCs present in exhaled 
breath correlated with ovulation have not yet been reported. 
 
1.3.3 Influence of diet on VOC concentrations in human breath 
The levels of breath metabolites are influenced by food intake (Smith and Španěl, 2005, 
Španěl and Smith, 1999). The breath metabolites ammonia, methanol, ethanol, propanol, 
formaldehyde, acetaldehyde, isoprene, and acetone were quantified by SIFT-MS for a 
group of five volunteers, before and after ingesting 75 g of glucose in the fasting state 
(Turner et al., 2008). Increased levels in the blood/exhaled breath after the consumption 
of alcohol were also observed, as reported by Smith and co-workers, using SIFT-MS (Smith 
et al., 2002). Similarly, studies on ethanol metabolism were recently reported by Winkler 
and co-workers (Winkler et al., 2013). Metabolic degradation of ethanol was tracked by 
the ingestion of isotope-labelled ethanol using real-time breath gas analysis with PTR-MS. 
The findings indicated that in part, ethanol was metabolized to acetone and isoprene via 
acetyl-CoA, as deuterated acetone and isoprene were observed in the mass spectra. 
Usually, ethanol is metabolized into acetaldehyde in the liver, however, signals from the 
deuterium-labelled acetaldehyde were not observed, suggesting that this intermediate 
product was rapidly further metabolized. The VOCs emitted by mouth-exhaled breath 
after garlic ingestion was assessed by PTR-MS, and the main constituents of garlic were 
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reported (Taucher et al., 1996). Other products, such as carrots, potatoes, onion, mint, 
banana and coffee, are also known to emit volatiles at trace concentrations (Sánchez-
López et al., 2014, Wang et al., 2016, Alasalvar et al., 2001, Hui, 2010). 
 
1.3.4 Influence of smoking and background contaminants of breath analysis 
measurements 
It has been shown that the composition of exhaled breath is considerably influenced by 
exposure to pollution and indoor-air contaminants, for instance, smoking-enhanced 
acetonitrile concentrations were found in the breath and urine of smokers (Jordan et al., 
1995, Španěl et al., 1996, Abbott et al., 2003). Compounds present in cigarette smoke, 
such as 2,5-dimethylfuran, acetonitrile, benzene, toluene, and styrene, can also be 
identified in smokers and passive smokers’ breath (Buszewski et al., 2009, Prazeller et al., 
1998). Acetonitrile in breath is a good indicator of whether a given subject is indeed a 
smoker or not because the concentration of acetonitrile in breath takes nearly a week 
after cessation of smoking to decrease to that of non-smokers (Jordan et al., 1995). Such 
findings were reported in an early study using PTR-MS. Smoking increased exhaled ethane 
and pentane levels in breath. This may be caused by high concentrations of hydrocarbons 
in cigarette smoke, as well as oxidative damage caused by smoking (Habib et al., 1995). 
Hydrogen cyanide (HCN), along with acetonitrile and benzene, are known to be present in 
exhaled breath (Kushch et al., 2008), after analysing the exhaled breath of smokers 
compared with non-smokers. Measuring carbon monoxide (CO) in exhaled breath is a 
well-established method used to differentiate between smokers and non-smokers 
(Sandberg et al., 2011). As a constituent of cigarette smoke, carbon monoxide enters the 
blood circulation during smoking and forms carboxyhaemoglobin (COHb). The elimination 
of CO is primarily by respiration, thus, there is a strong correlation between CO in breath 
and COHb (Sandberg et al., 2011).  
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Aside from smoking, there are other ways of VOCs entering the body. Breath contains a 
diverse range of VOCs that can be taken up by the body through inhalation or skin, and, 
depending on distribution kinetics, may be present in exhaled breath for different periods 
after exposure. For instance, limonene is found in most air fresheners and cleaning 
products and is emitted by wooden furniture and floorings and is known to be soluble in 
blood and adipose tissue and, therefore, has the potential to be taken up by the body 
during inhalation (Beauchamp, 2011). 
Background contaminants (Schubert et al., 2005, Španěl et al., 2013) are an important 
issue, particularly, when a compound is present in both alveolar breath and inspired air. 
One approach is to provide a source of purified air (Steerenberg et al., 2000) to inspire 
during the breath collection and, in this way, it is possible to determine which of the VOCs 
have originated endogenously. However, different compounds have different wash-out 
periods from the human breath (Pleil and Lindstrom, 1998), hence, the use of purified air 
for removal of exogenous compounds does not work consistently for all compounds.  
 
 
1.3.5 Influence of physiological parameters, physical activity, and stress on VOC 
concentrations in human breath 
Gas exchange (Greger and Windhorst, 1996) during respiration occurs primarily through 
diffusion. It takes place between the air within the alveoli and the pulmonary capillaries. 
Nowadays, it is known that exhalation of breath biomarkers may well depend on 
physiological parameters, such as blood pressure, heartbeat rate and alveolar ventilation 
(Schubert et al., 2012). Understanding the influence of these factors is an essential 
requisite for the development of a reliable methodology based on breath volatiles.  
Breath gas concentration can then be related to blood concentrations via mathematical 
modelling. The simplest model relating breath gas concentration to blood concentrations 
40 
 
was developed by Farhi (King et al., 2011). The Farhi equation (equation 1.1), shows that 
alveolar air concentration, CA, is proportional to the concentration of VOCs in mixed 
venous blood (CV) and depends on the blood:air partition coefficient, b:air, which 
describes the diffusion equilibrium between capillaries and alveoli, and ventilation-
perfusion ratio, VA/QC. Such a ratio ensures that the ideal amount of blood and gas is 
received by the alveoli for efficient gas exchange. It depends on the alveolar ventilation 
(VA) controlling the transport of the VOC through the respiratory track, and cardiac output 
(Qc) controlling the rate at which the VOC is delivered to the lungs. The blood:air partition 
coefficient, b:air, is strongly dependent on temperature ranging from 23 °C in the mouth 
to 37 °C in the alveoli, affecting soluble gas exchange (Anderson et al., 2003). This 
coefficient represents the ratio of the concentration in blood to the concentration in the 
gas phase. 
 
Equation 1.1 
𝐶𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 = 𝐶𝐴 =
𝐶𝑉
𝜆𝑏:𝑎𝑖𝑟 +
𝑉𝐴
𝑄𝐶
 
 
For low blood soluble gases (b:air ≤ 10) (Anderson et al., 2003) the measured 
concentration is dependent on the rates at which blood is pumped through the lungs and 
ventilation, specifically the ventilation-perfusion ratio, VA/QC, where Cmeasured = CA, 
meaning that low blood soluble VOCs must exchange completely in the alveoli. 
 
Highly soluble VOCs (b:air > 10) (Anderson et al., 2003) tend to be less affected by 
changes in ventilation and perfusion, however, hydrophilic exhaled trace gases, such as 
acetone, interact with the water-like mucus membrane lining the conductive airways. The 
exhaled breath concentrations of these volatiles appear to dilute on their way up from 
the deeper respiratory track to the airway opening (dilution effect), consequently for 
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these highly soluble volatiles the concentration measured in exhaled breath is different 
from the alveolar air concentration, Cmeasured ≠ CA. There is also evidence that, with highly 
soluble volatile compounds, gas exchange occurs in the airways rather than alveoli 
(Anderson and Hlastala, 2007).  
Some studies have been performed assessing the concentration profiles during exercise 
(King et al., 2010, Schubert et al., 2012, King et al., 2009, Karl et al., 2001, Smith et al., 
2013). Recently, the influence of exercise on mouth-exhaled and nose-exhaled breath was 
further investigated (Smith et al., 2013). Smith and co-workers reported a significant 
increase of isoprene breath levels after exercise above the respective inactive levels by a 
factor of 2 or 3 times, which is in agreement with previous findings (King et al., 2010). 
 
An isoprene gas exchange model has been developed and shows a good fit to breath-
isoprene levels measured during exercise. The influence of heartbeat rate and breath rate 
on isoprene breath concentrations have been assessed, where isoprene levels were 
measured during exercise (Schubert et al., 2012, Karl et al., 2001). Isoprene 
concentrations showed drastic increase within the initial seconds of exercise, followed by 
a decline when the heartbeat rate reached the maximum value and respiration rate 
increased, and lastly at the end of the exercise isoprene concentrations reached similar 
levels seen at the beginning. This means that the degree of blood-to-air partitioning of 
isoprene is very sensitive to heart rate. Such measurements demonstrate a relationship 
between breath rate volume (Vbr), heartbeat volume (HBV), Henry’s law constant (H) and 
temperature (T), seen in Equation 1.2 (Karl et al., 2001). 
 
Equation 1.2 𝐶𝐴0 = 𝐶𝑉0 ∙ 𝑒𝑥𝑝 (−
1
𝐻𝑅𝑇
∙
𝑉𝑏𝑟
𝐻𝐵𝑉
) 
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For VOCs such as isoprene, with low solubility in blood and high volatility (when the 
Henry’s law constant is extremely low) a concentration gradient within the lungs is 
created and governed by the velocity of the bloodstream pumped through the lungs 
(proportional to heartbeat frequency) and the breathing rate. Namely, with increases in 
both heart rate and breathing rate, more efficient partitioning of isoprene to breath air is 
restored. This means that isoprene evaporates efficiently through the transport via the 
bloodstream to the lungs, hence, CA0 ≠ CV0, and meaning that isoprene venous blood 
concentration entering the lungs, CV0, is different from isoprene arterial blood 
concentration leaving the lungs, CA0. 
Moreover, measurements taken during sleep showed enhanced blood isoprene 
concentration due to lower heartbeat rate achieved during the night (Karl et al., 2001). 
 
The influence of stress (Lima et al., 2013) has been acknowledged as an important factor 
in changing VOC concentrations and may therefore act as confounding factor in the 
definition of VOCs as disease biomarkers. Additionally, women have demonstrated higher 
stress-induced levels of cortisol compared to men (Dickerson and Kemeny, 2004).  
Stress plays an important role particularly in VOC sampling from mice, since mice become 
easily stressed under unfamiliar conditions.  
 
1. 4 Collection and storage of volatile samples 
 
The first guidelines concerning sample collection for breath analysis was released in 1999 
by the American Thoracic Society for nitric oxide (NO) monitoring in breath (Society, 
1999). Updated guidelines were published in 2005 for measurement of NO in mouth- or 
nose-exhaled breath (Society, 2005). In 2005, recommendations were also published for 
exhaled breath condensate sampling and analysis (Horváth et al., 2005). Hence, 
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reproducibility and reliability of sampling methods and analytical measurement 
procedures continue to be of critical importance. 
 
Collection of VOCs samples may be accomplished through the use of polymer sampling 
bags, metal canisters, sorbent tubes, and glass vials used in SPME. The stability of 
selected breath constituents in polymer sampling bags have been previously investigated 
and assessed by PTR-MS and GC-MS (Mochalski et al., 2013, Beauchamp et al., 2008, 
Mochalski et al., 2009). Smaller samples are more vulnerable to VOCs losses by 
permeation. Additionally, the volume of the sample collected affects the stability of the 
sample, thus, Mochalski and co-workers recommended sample collections as large as 
possible to prevent background emissions of contaminants (Mochalski et al., 2013).  
 
Lately, needle trap micro-extraction (NTME) (Trefz et al., 2013) combined with GC has 
been assessed for sample preparation in VOCs analysis. This is a technique similar to 
SPME but with the advantage of allowing automatic alveolar sampling. The analysis is 
quite similar to that used in thermal desorption traps. VOCs are thermally desorbed from 
the needle trap device and separated, identified and quantified by means of two-
dimensional gas chromatography combined with MS detector, GC × GC-MS, which has 
been applied to solve complex problems of separation. Needle traps have offered 
increased robustness in comparison to SPME, due to the existence of an extraction 
sorbent packed inside a hypodermic needle rather than supported on a fragile silica fibre 
that is exposed to the breath matrix during extraction. The influence of humidity, sample 
volume, and sampling flow has to be thoroughly evaluated in order to be used for pre-
concentration of breath volatiles.  
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Biological intra- and inter-variability among subjects has been introduced as an issue in 
VOC sampling, particularly exhaled breath. Therefore, breath analysis methods based on 
monitoring subjects over time may be desirable because they can serve as their own 
controls (Beauchamp and Pleil, 2013). 
 
Further aspects related to sampling continue to be debated in the scientific community, 
such as body posture of the subject when providing the breath sample; hyperventilation; 
breath holding; control of the flow or volume of breath during collection; sampling via 
nose or mouth; the number of breath samples to be taken to reduce variability (single or 
multiple breaths); dilution and contamination of the sample; physiological parameters, 
such as respiratory rate or heart beat rate; alveolar breath or end-tidal volume and dead 
space; the number of subjects per study to avoid “over-modelling”; and direct analysis or 
sampling for storage (Beauchamp and Pleil, 2013). 
 
Direct/active sampling is preferable to storage for later analysis since, in this way the 
decomposition of samples or possible loss of compounds by diffusion is avoided. When 
direct analysis is not possible, the appropriate storage of VOCs is an important issue to 
consider. This is an important difficulty with breath analysis, there is a frequent need to 
store samples, because most of the times the patient cannot get near the instrument, and 
then the subsequent problems of analysis of stored breath samples. In contrast, sampling 
and storage (prior to analysis) of urine and other body fluids is much easier than breath. 
Background emission of pollutants, losses by diffusion through the bag or adsorption to 
the inner bag, and interactions between sample constituents, namely oxidation artefacts 
of the sample if stored for too long, may irreversibly modify the original sample 
composition and consequently, mislead the results and assumptions.  
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In the studies presented in this thesis, direct sampling and further analysis of samples was 
not possible to perform, therefore VOCs were tested inside Nalophan® bags. Nalophan® 
bags are made from PET-polyethylene terephthalate, are also popular due to its low 
price, inertness, and relatively high durability. Nalophan® bags are much cheaper than the 
Tedlar® bags and they can be discarded after a single use, removing the need for bag 
cleaning or infection control measures. 
Previous studies reported the testing of Nalophan® bags for storing tobacco samples, and 
investigated the factors contributing to decay of gas samples during storage, between 4 
and 40 hours  after collection (van Harreveld, 2003). Samples remained relatively stable 
between 4 and 12 hours after sampling. Nalophan® is slightly porous and volatiles are 
gradually lost over time by diffusion. 
Emissions from Nalophan® bags, were assessed 48 hours after filling for storage of 
volatile sulphur compounds, and none showed emissions of contaminants, thus, all 
proving to be excellent materials for VOC collection (Mochalski et al., 2009). Nalophan® 
bags have proven to be much better materials for VOC collection than Tedlar® bags, in 
terms of contaminants released during storage, sample stability and cost (Ghimenti et al., 
2015a).  
A study performed by Gilchrist and co-workers investigated the collection and storage of 
breath samples containing hydrogen cyanide (Gilchrist et al., 2012). Breath was collected 
into 25 μm thick Nalophan, 70 μm Nalophan and Tedlar bags, at 20 C or 37 C. Results 
showed better correlation between on-line and off-line concentrations for all bag types at 
37 C. Correlation of hydrogen cyanide concentrations in breath samples stored at 37 C 
was good up to 24 hours for the 70 μm Nalophan® and Tedlar® bags. Such findings 
suggested that either would be appropriate to use for collection of breath containing 
hydrogen cyanide. 
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Tedlar® (PTFE-polytetrafluoroethylene) bags are the most common materials for breath 
collection (Mochalski et al., 2013) and are available in a range of sizes. Background 
contaminants released from the bags must be taken into account. Tedlar® bags showed 
significant emissions of COS and CS2, especially for black Tedlar bags with COS and CS2 
emissions being seen at up to 7 ppb after three days of storage (Mochalski et al., 2009). 
Temperature dependence strongly influences the composition of breath samples in off-
line measurements. As the temperature of breath sample falls below body temperature 
(37 °C), water vapour condenses on the inside of the bag and takes down water soluble 
compounds. Warming the sample to body temperature will avoid condensation issues 
and compound losses due to negative temperature gradients (Gilchrist et al., 2012).  
The loss of volatile compounds to condensed water in Tedlar bags used for breath 
sampling has been previously evaluated (Groves and Zellers, 1996), showing differences 
between dry and wet matrices smaller than 10%. For VOCs with molecular mass above 
110 amu, higher losses were detectable (20%–40%) (Mochalski et al., 2013). Thus, as 
general rule is recommended storing breath samples in pre-conditioned Tedlar® bags up 
to 6 hours at the maximum possible filling volume.  
 
Metal canisters are essentially stainless-steel vessels where the internal surface has been 
electro polished, as a result the internal surface of the canisters is chemically inert (Pleil 
and Lindstrom, 1995). The canisters are extremely robust and samples can be kept in the 
canisters for a considerable length of time without degradation. However, these canisters 
are quite expensive and they are not practical when many samples are analysed. 
 
Sorbent tubes are generally made of glass or stainless-steel and contain the desired 
sorbent suited for the trapping of VOCs at a specific flow rate. It is common practice to 
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use multi-bed sorbent tubes, up to three sorbents is generally recommended, allowing 
the broadest volatility range to be analysed with a single tube. The choice of sorbent 
principally depends upon the volatility (specifically the vapour pressure) of the particular 
analyte(s). The adsorption material used must have a high thermal stability and must not 
contribute to the background of the analysis, therefore it should be inert. The expected 
adsorption and stability properties should not change for a large number of analyses, 
even on repeated use. The most common materials used in thermal desorption of VOCs, 
illustrated in Figure 1.3, include porous polymers (e.g. Tenax), graphitised carbon black 
sorbents (e.g. carbotrap), carbonised molecular sieves (e.g. sulficarb), and zeolite 
molecular sieves (e.g. carbosieve III) (MARKES, 2013/2014).   
 
Figure 1. 3 – Surface model for common adsorbents. (A) Carbotrap surface area ca. 100 m
2
/g, uniform charge 
distribution over all carbon atom centres; (B) Tenax (2,6-diphenyl-p-phenylene oxide), surface area ca. 35 m
2
/g, non-
uniform charge distribution, the charge is essentially localised on the oxygen atoms; (C) Amberlite XAD-2, surface area 
ca. 300 m
2
/g, non-uniform charge distribution, less polar than Tenax (Hübschmann, 2009). 
 
In Table 1.1 the main sorbents currently used for the collection and storage of VOCs are 
shown. Tenax TA is the worldwide favourite thermal desorption (TD) sorbent due to its 
specific features, i.e., it is inert and therefore suitable for labile compounds and may be 
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used for humid atmospheres; the most thermally stable of the porous polymers it also 
allows efficient desorption at the lowest practical temperature. Carbotrap picks up more 
volatile compounds and those may be desorbed at higher temperatures. Carbonised 
molecular sieves such as sulficarb, are the strongest sorbents and are used to trap the 
most volatile compounds. These sorbents are not very hydrophobic and therefore, may 
require dry purging prior to desorption to remove excess water. Zeolite molecular sieves 
are very selective hydrophilic sorbents, thus they provide significant water retention, and 
are used for specific applications, e.g. occupational hygiene monitoring of nitrous oxide 
(MARKES, 2013/2014).     
 
Table 1. 1 – Types of sorbents and its application  
Sorbent 
Compound 
range 
Temperature limits Main features 
Tenax TA C6/7 to C30 
280– 320 C for 
analysis; 330C for 
conditioning 
Weak strength; inert and hydrophobic; very 
efficient desorption of VOCs. 
Carbotrap C3/4 to C6/7 
Up to 360 C for 
analysis; 380 C for 
conditioning 
Weak/medium strength; some activity (e.g. 
with monoterpenes); hydrophobic; low 
background. 
SulfiCarb C3 to C6 
Up to 360 C for 
analysis; up to 380 C 
during conditioning 
 
Very strong strength; moderate water 
retention; inert; very volatile compounds and 
sterically large molecules, e.g. SF6 
Carbosieve III C2 to C5 
Up to 360 C for 
analysis; up to 380 C 
during conditioning 
Very strong strength; significant water 
retention. 
 
 
 Stainless-steel TD tubes are suited for passive or active pumping of a VOC mixture and 
this is typically performed at flow rates of around 20–100 mL min-1 (MARKES, 2013/2014). 
The VOC mixture is pumped through multiple sorbent beds allowing the trapping of 
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compounds of different volatilities in a single tube. The initial bed comprises the sorbent 
of weak strength and at the end the stronger sorbent (Figure 1.4).  
 
 
Figure 1. 4 – An example of a stainless-steel TD tube (Perkin-Elmer) and the active sampling direction (Adapted from 
Hübschmann, 2009). 
 
 
TD sorbent tubes have been widely used in medical research for the trapping of the 
headspace of cell cultures (Filipiak et al., 2010); collection of faecal (Proudman et al., 
2015) and urine (Thalhamer et al., 2011) headspace; and collection of exhaled breath for 
exposure (Ghimenti et al., 2015b) and disease (Khalid et al., 2013a) assessment.   
 
 
Breath analysis was the original way of analysing VOCs from the body and how they differ 
as a result of disease.  However, other samples have also been used in VOC analysis, for 
example urine and faecal headspace, and VOCs emanating from skin (Batty et al., 2015, 
Huang et al., 2013, Mochalski et al., 2014a). Some of the applications of VOC analysis in 
disease monitoring and diagnosis now follow. 
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1. 5 Diabetes mellitus 
Diabetes is a group of metabolic diseases characterized by hyperglycaemia resulting from 
deficiencies in insulin secretion, insulin action, or both. The chronic hyperglycaemia of 
diabetes is associated with long-term damage, dysfunction, and failure of different 
organs, especially the eyes, kidneys, nerves, heart, and blood vessels. According to the 
World Health Organization (WHO) guidelines there are three variations of Diabetes 
mellitus: Type 1 diabetes mellitus (T1DM) (insulin-dependent); Type 2 diabetes mellitus 
(T2DM) (non-insulin dependent); and gestational diabetes mellitus (GDM). The WHO 
criteria for diabetes and intermediate hyperglycaemia are given in Table 1.2. 
 
Table 1. 2 – WHO diagnostic criteria for diabetes and intermediate hyperglycaemia 
 Normal Impaired fasting glycaemia 
(IFG) 
Impaired glucose tolerance 
(IGT) 
Diabetes mellitus 
(DB) 
Venous 
plasma 
Fasting 2 h Fasting 2 h Fasting 2 h Fasting 2 h 
Glucose  
(mmol L
−1
) 
<6.1 <7.8 6.1 &<7.0 <7.8 <7.0 7.8 7.0 11.1 
Glucose  
(mg dL
−1
) 
<110 <140 110 &<126 <140 <126 140 126 200 
 
During fasting, the normal levels for a healthy individual are lower than 110 mg dL-1. 
Impaired fasting glycaemia (IFG), more commonly known as pre-diabetes refers to a 
condition in which the fasting blood glucose level is consistently elevated above what is 
considered normal levels. For this condition the levels range between ≥ 110 & 
< 126 mg dL-1 during fasting. IFG can progress to type 2 diabetes mellitus if life-style 
changes are not made. Impaired glucose tolerance (IGT) is a pre-diabetic state of 
hyperglycaemia that is associated with insulin resistance and increased risk of 
cardiovascular pathology. IGT might precede type 2 diabetes mellitus by many years. For 
impaired glucose tolerance the levels are inferior to 126 mg dL-1 during fasting. A person 
is diagnosed with diabetes mellitus for venous plasma levels equal or higher than 
126 mg dL-1 for the fasting state.  
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1.5.1 Type 1 Diabetes 
Type 1 diabetes (insulin-dependent) develops when the insulin-producing cells in the 
body have been destroyed and the body is unable to produce any insulin. The 
pathogenesis of T1DM remains poorly understood, but the most likely scenario is that an 
environmental factor triggers a selective autoimmune destruction of the β-cells in the 
pancreas of a genetically predisposed individual, decreasing the amount of insulin that is 
produced and resulting in hyperglycaemia. The destruction is irreversible and can take 
place over a period of several years; this is known as the pre-diabetic phase (Holt and 
Hanley, 2012). Treatment of T1DM involves exogenous injections of insulin which cannot 
be taken orally due to insulin degradation in the gastrointestinal tract (Holt and Hanley, 
2012). 
 
1.5.2 Type 2 Diabetes 
Type 2 diabetes is a heterogeneous disorder creating insulin resistance and insulin 
deficiency. Type 2 diabetes develops when the body can still make some insulin, but not 
enough, or when insulin that is produced does not work properly, known as insulin 
resistance. The World Health Organization states that T2DM comprises 90% of people 
with diabetes around the world.   
The two main pathological components of T2DM are insulin resistance, and β-cell 
dysfunction and failure. The risk of developing T2DM increases with age, obesity, 
cardiovascular disease (hypertension) and lack of physical activity (Srinivasan and 
Ramarao, 2007). Type 2 diabetes is a combination of environmental factors such as diet 
and lack of exercise, as well as genetic predisposition. It has an onset after the age of 40 
years, however due to the increasing prevalence of obesity, it is also being observed in 
younger people (Song and Hardisty, 2008). 
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1.5.3 Regulation of blood glucose levels 
Insulin is secreted by -cells of the pancreas, and is crucial to regulating carbohydrate and 
fat metabolism in the body. Under normal physiological condition, insulin is the principal 
controller of glucose metabolism, and is triggered by high blood glucose levels. On the 
other hand, glucagon hormone produced in the pancreas, is triggered by low glucose 
levels (Holt and Hanley, 2012).  
Insulin resistance creates increasingly high levels of hepatic glucose output due to the 
inability of insulin to produce its usual biological effects, and therefore the build-up of 
glucose in the blood stream. As a consequence, glucose uptake in adipose tissue 
decreases. A summary diagram is presented in Figure 1.5. In a vasculature point of view, 
the consequences of insulin resistance are increased stiffness of arteries and increased 
coagulability (Holt and Hanley, 2012).  
 
 
Figure 1. 5 – Diagram showing insulin action on adipose tissue and the liver to regulate blood glucose levels. 
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The mechanisms leading to the development of insulin resistance are not fully 
understood. However, there are potential mechanisms of insulin resistance, namely 
absent or a reduced number of insulin receptors; abnormal insulin receptors; deficiencies 
in post-receptor signalling.  
 
1.5.4 Methods of glucose determination and monitoring 
A key to controlling diabetes is monitoring and controlling blood glucose concentrations.  
Glucose concentration may be determined in whole blood, plasma, or serum samples. 
Concentrations in blood are lower than those measured in plasma or serum. This is due to 
the greater water content of the cellular fraction (Walker et al., 1990). Under usual 
circumstances, the concentration of glucose in whole blood is about 15% lower than in 
plasma or serum. 
Self-monitoring of blood glucose (SMBG) has been established as a valuable tool for the 
management of diabetes, assisting in the detection of any incidence of hyperglycaemia or 
hypoglycaemia, providing real-time information for adjusting medications and dietary 
regimens. Electrochemical glucose biosensors are mainly preferred for SMBG among the 
others, optical, thermometric, piezoelectric, and magnetic, due to their better sensitivity, 
reproducibility, and easy maintenance as well as their low cost (Yoo and Lee, 2010). 
Enzymatic amperometric glucose biosensors are the most common devices commercially 
available for self-monitoring of blood glucose. Amperometric sensors monitor currents 
generated when electrons are exchanged either directly or indirectly between a biological 
system and an electrode (Heller, 1996, Turner et al., 1999). Glucose biosensors for SMBG 
are usually based on the two enzyme families, glucose oxidase (GOx) and 
glucose-1-dehydrogenase (GDH) (Yoo and Lee, 2010). Glucose oxidase is the standard for 
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SMBG due to its higher selectivity for glucose. Glucose biosensors are reliable, rapid, and 
accurate.  
 
In vivo glucose monitoring was proposed in 1982 (Shichiri et al., 1982). The first 
continuous glucose-monitoring device to be approved by the US Food and Drug 
Administration (FDA) was the Continuous Glucose Monitoring System (CGMS™) 
(Medtronic MiniMed, Northridge, CA, USA), which consists of a glucose sensor implanted 
into the subcutaneous tissues and connected to a pager-like monitor worn by the user. 
The device detects glucose levels in blood every five minutes or automatically overnight 
(Poscia et al., 2003). However, these devices require calibration against a regular blood 
glucose meter. 
 
Many diabetics do not test their blood glucose levels periodically because it is unpleasant 
and inconvenient. Hence it’s worth exploring alternative, non-invasive methods of 
monitoring blood glucose. Other non-invasive alternatives have been studied, namely, 
saliva (Agrawal et al., 2013), tears and urine (Srinivasan et al., 2003). Just recently, VOCs 
in breath or skin has been proposed as a potential way to provide information about the 
glycaemic levels in blood (Righettoni et al., 2013, Turner et al., 2009, Turner et al., 2008).  
 
1.5.5 Volatile metabolites as monitor of diabetes 
Centuries ago, John Gallo reported a compound in human breath that had the smell of 
decaying apples (Crofford et al., 1977). Nowadays, it is well known that the compound 
was principally acetone (Reichard et al., 1986). Acetone is produced by decarboxylation of 
acetoacetate and through dehydrogenation of isopropanol (Kalapos, 2003). Diabetic 
patients exhibit increased concentrations in blood and urine of ketone bodies, acetone, 
55 
 
acetoacetic acid, and beta-hydroxybutyric acid. Ketone bodies are produced by the liver 
during fatty acid metabolism, and are used as an energy source, instead of glucose, when 
glucose is not readily available (Smith et al., 2011).  
 
Acetone is a highly soluble compound present as a major common breath metabolite in 
everyone. This VOC has been identified and quantified previously (Smith et al., 2007, 
Turner et al., 2006a). Elevated breath acetone levels associated with diabetes mellitus 
have been reported for more than a decade (Kalapos, 2003, Manolis, 1983, Deng et al., 
2004). A few studies have been carried out, involving cohorts of patients with diabetes 
and healthy controls, in whom parallel with blood glucose analysis. Biochemical changes 
that occur in the diabetic state may be reflected in changes in the profile of VOCs in 
exhaled breath, however, the high inter-individual variability in breath acetone 
concentration is not well understood with effects arising from diurnal variability, fasting 
status, diet, age, and gender. 
Acetone levels were previously quantified for healthy volunteers, before and after 
ingesting 75 g of glucose in the fasting state (Turner et al., 2008). The intake diet seems to 
significantly influence the levels in breath acetone. Measurements were taken following a 
ketogenic diet (Musa-Veloso et al., 2002, Španěl et al., 2011) in the exhaled breath of 
healthy individuals, and for a small group of individuals suffering from diabetes. Results 
have shown that breath acetone concentrations increased after ingestion of a ketogenic 
meal, or either following a low carbohydrate diet (Španěl et al., 2011). Smith and 
co-workers reported that breath acetone increases substantially during fasting when a 
change takes place from carbohydrate to fat metabolism (Smith et al., 2011). PTR-MS has 
been used to report a variation on breath acetone with age and fasting state, but no 
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statistically significant differences between gender or body-mass index (BMI) were found 
(Schwarz et al., 2009). 
Glycaemic control is essential for management of diabetes. At the moment, blood 
analysis is the faster way to provide information/monitoring of glucose levels in patients 
with diabetes. However, studies amongst adults and children showed discomfort 
associated to blood sampling and needle phobia (Simmons et al., 2007, Hamilton, 1995). 
Only recently, breath analysis appears as a potential non-invasive method for monitoring 
glucose concentrations in blood (Turner et al., 2009, Guo et al., 2010, Minh et al., 2011). 
Turner and co-workers have monitored the breath of eight patients with T1DM using a 
glucose clamp technique. In all patients, the breath acetone declined linearly with blood 
glucose concentration. Hence, this study indicates that breath acetone does vary as 
glycaemia and/or metabolic status changes in T1DM. In contrast little is currently known 
for T2DM, some measurements of breath acetone were taken, nevertheless, with no 
significant results (Storer et al., 2011). Monitoring and reliable quantification of VOC 
concentrations within the body of a diabetic patient is not that easy as VOC fluctuate over 
the day.  
Although the findings have pointed to acetone as a potential biomarker of diabetes, there 
is no simple association of breath acetone concentration and blood glucose 
concentration. The issue lies in the fact that acetone generation is linked to lipolysis and 
blood glucose changes (Kalapos, 2003). 
 
Isoprene has also been proposed as a potential indicator of diabetes (Salerno-Kennedy 
and Cashman, 2005). However, several studies reported no apparent correlation between 
blood glucose and breath isoprene (Turner et al., 2006b, O’Hara et al., 2009). Methyl 
nitrate is also suggested to be correlated with blood glucose in insulin dependent 
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diabetics, though the levels are reported to be lower than acetone or isoprene. 
Therefore, this might not be a useful compound for monitoring purposes (Smith et al., 
2011). 
Gas sensors (Righettoni et al., 2013) have been used to assess the relationship between 
blood glucose of healthy volunteers and breath components. It should also be noted that 
dogs (Wells et al., 2008) have been shown to be able to detect hypoglycaemic episodes in 
their diabetic owners through detecting breath or skin odour. 
 
1. 6 Mouse models of Type 2 Diabetes  
Animal models allow identification of genes and how alterations to these genes can 
impact on the pathways of the disease. Thus, mice are used to investigate the function of 
genes and develop reproducible models in which the phenotype of the animal can be 
tested. Mouse mutants are important in understanding biological processes and 
biochemical or cellular pathways in diseases such as T2DM. The physiology shared 
between mice and humans makes the mouse ideal for modelling complex human 
diseases and for drug efficacy testing. This is not just because they are extremely similar 
to humans at the genomic level, but also because the pathophysiology of disease in mice 
is similar to that of humans.  
The Home Office annual statistics 2012 in Great Britain states that the “mouse” is the 
available model most used in scientific research because mice are quite small which 
allows low maintenance and costs; they have a fairly short gestation; and they have a 
short life span allowing investigation of aging phenotypes. Consequently, mouse models 
can provide large datasets for metabolic profiling in a short period of time and at 
controlled conditions. Thus, animal models are an important tool to decipher the various 
sources of VOCs in a controlled environment. 
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Similar to humans, the phenotype of a mouse model also depends on the genetic 
background, gender, and age; this means that some mice are more susceptible to obesity 
and diabetes than others, and insulin resistance manifested at different time points (Ueda 
et al., 2000, Cheverud et al., 2004).  
In order to understand the complex genetics of insulin resistance and β-cell dysfunction, 
investigators have generated transgenic and knockout mice bearing mutations in genes 
required for insulin action/or insulin secretion.  
Animal models of T2DM include insulin resistance, β-cell dysfunction and impaired 
glucose homeostasis, and insulin secretion. Animal models develop diabetes either 
spontaneously or by using chemical, surgical, genetic or other techniques (McMurray and 
Cox, 2011). 
 
 
1.6.1 Mouse model of Cushing´s Syndrome 
The mouse model of Cushing´s syndrome is a chemically induced T2DM model. The 
animals are chemically induced by N-ethyl-N-nitrosourea (ENU) (Hitotsumachi et al., 
1985), a highly efficient mutagen used to induce random point mutations triggering a 
diabetic phenotype. N-ethyl-N-nitrosourea (ENU) (Figure 1.6) is a powerful and efficient 
mutagen, i.e. toxic and carcinogenic, and has been found to induce random point 
mutations in mouse spermatogonial stem cells (Hitotsumachi et al., 1985), meaning that 
observed phenotypes will be a consequence of single gene effects. The mutagenic effects 
of ENU depend on the dosage and strain of the animal used (Noveroske et al., 2000).  
 
Figure 1. 6 – Chemical formula of N-ethyl-N-nitrosourea (ENU). Ethyl group is highlighted in red.  
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The mutation is generated by nucleotide substitution. ENU is an alkylating agent and acts 
by transferring its ethyl group to any of a number of identified nucleophilic nitrogen or 
oxygen sites on each of the four nucleotides (adenine, thymine, guanine and cytosine) 
(Noveroske et al., 2000). However, 82% of nucleotide substitutions occur at A-T 
(adenine-thymine) base pairs to T-A (thymine-adenine), and A-T (adenine-thymine) base 
pairs to G-C (guanine-cytosine) (Takahasi et al., 2007, Noveroske et al., 2000) (Figure 1.7).  
 
 
Figure 1. 7 – Alkylation of thymine results in the formation of O4-Ethylthymine which is recognised as cytosine and 
mispairs with guanine (Adapted from Noveroske et al., 2000) 
 
 
ENU treatment: A detailed protocol for mouse mutagenesis using ENU is described 
elsewhere (Salinger and Justice, 2008). ENU is usually administered by a sequence of 
intraperitoneal injections to adult male mice, followed by a period of infertility due to the 
depletion of spermatogonia caused by the ENU treatment.  
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Cushing´s mice develop excessive circulating glucocorticoid concentrations in the body 
potentially due to adrenocorticotrophic hormone (ACTH) alterations by the anterior 
pituitary gland, and directly affecting the production and release of cortisol hormone by 
the cortex of the adrenal gland (Bentley et al., 2014). When a pituitary tumour is the 
cause of elevated ACTH this is known as Cushing's disease and the symptoms of the 
excess cortisol is known as Cushing's syndrome. Glucocorticoid is involved in the 
metabolism of carbohydrates, proteins and fats (Kufe et al., 2003). As a consequence, 
mice are prone to develop obesity, hyperglycaemia, and insulin resistance, along with hair 
loss, thin skin and low bone mineral density (Bentley et al., 2014).  
 
1.6.2 Afmid mice 
The enzyme arylformamidase (AFMID), also known as kynurenine formamidase 
participates in tryptophan metabolism (O’Mahony et al., 2015) which in turn regulates 
many functions including pancreatic secretion, among others. Figure 1.8 illustrates the 
brain-gut dependence, and brief description of serotonin synthesis from tryptophan.   
 
Figure 1. 8 – A schematic representation of brain-gut dependence, and brief description of serotonin synthesis from 
tryptophan (O’Mahony et al., 2015) 
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The Afmid knockout mice suffer inactivation of Afmid genes in order to further investigate 
possible links between abnormal tryptophan metabolism and diabetes and to examine 
the effect of single Afmid knockout. These mice show impaired glucose tolerance, 
although their insulin sensitivity is unchanged when compared to wild-type animals. This 
phenotype results from a defect in glucose stimulated insulin secretion and these mice 
show reduced islet mass with age (Hugill et al., 2015). Kidney failure has been reported in 
double (Afmid and thymidine kinase (Tk) genes) knockout mice (Dobrovolsky et al., 2005), 
however no evidence was found for a single Afmid knockout, suggesting that this specific 
phenotype of kidney failure resulted from loss of Tk expression in the double knockout. 
 
The gene knockout was achieved by using Cre-Lox recombination giving deletion of tm1b 
allele. Cre-Lox recombination is a site-specific recombinase technology, used to carry out 
deletions, insertions, translocations and inversions at specific sites in the DNA of cells. The 
system consists of a single enzyme, Cre recombinase, that recombines a pair of short 
target sequences called the Lox sequences (Liu et al., 2003). 
 
1.6.3 VOC analysis in rodent models 
 
The biochemical origin of VOC in breath, faeces, urine or even skin in rodent models is far 
from being well understood, furthermore, published literature is scarce. Breath analysis in 
rodent models has been the preferred method used by researchers to assess the VOC 
composition within the body. Breath analysis in mice is complex, the sampling is 
challenging, and the detection of VOC at trace concentration with enough sensitivity is 
difficult, not to mention the confounding factors needed to be taken into account, i.e. 
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VOCs arising from other sources, faeces, urine, stress (Lima et al., 2013), and physical 
activity/movement (King et al., 2009).   
Breath acetone has been measured in a rat model to assess the feasibility of using it as an 
indicator of ketosis induced by high fat, low-carbohydrate ketogenic diet (Likhodii et al., 
2002). This ketogenic diet is used primarily to treat difficult-to-control (drug-resistant) 
epilepsy in children (Lefevre and Aronson, 2000), and it requires testing for its efficacy 
fairly regularly. Breath acetone was measured and analysed over a thirty three days 
period and compared against blood glucose and plasma -hydroxybutyrate (-HBA), the 
most commonly measured ketone body. They found a good correlation between breath 
acetone and plasma -HBA.  
The analysis of exhaled breath in an induced mouse asthma model via ion mobility 
spectrometry (IMS), anaesthetised prior to breath analysis present many challenges 
(Vautz et al., 2010). Effects to take into account include contaminants from the 
background air; contaminants coming from the plastic sampling system; ovulation effects 
on the measured VOC profile; the influence of anaesthesia on the measured VOC profile.  
The online breath gas analysis in real-time in unrestrained mice was established using a 
setup consisting of a respiratory chamber directly connected to PTR-MS (Szymczak et al., 
2014). Later on, a study on the changes of breath VOC profile in diet-induced obese mice 
was reported (Kistler et al., 2014). More recently, the same research group analysed the 
breath of unrestrained mice in real-time of two different obese mouse models (Kistler et 
al., 2016). High fat diet (HFD) induced obese and mono-genetic obese mice, and have 
looked for alterations in the volatile profile which might be due to either metabolic 
deregulations, according to the degree of obesity, but could also be due to changes in diet 
composition. 
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Other studies have been carried out in other animals, specifically in a caprine animal 
model (Fischer et al., 2015), where the physiological variability in VOCs in exhaled breath 
and released from faeces have been evaluated, and the study assessed the effects of feed 
composition and somatic growth on VOC patterns. 
 
1. 7 Colorectal cancer 
Colorectal cancer (CRC) has been attributed to individual genetic predisposition and 
environmental factors, including life-style and diet. Within life-style factors, elevated 
body mass index (BMI), obesity, and low physical activity are related to increased risk of 
colorectal cancer. It has been shown that diet can significantly influence and promote the 
growth of malignant colon cells, particularly, red meat intake, where protein is the major 
constituent leading to protein fermentation metabolites (e.g. sulphur compounds, 
N-nitroso compounds, and phenolic and indolic compounds) potentially carcinogenic and 
possible linked to colon cancer (Cummings and Bingham, 1987, Van Munster and 
Nagengast, 1993, Windey et al., 2012, Larsson and Wolk, 2006, Nyangale et al., 2012). 
Sulphate reducing bacteria in the gut produce sulphur compounds, including H2S, 
potentially linked to colon cancer. N-nitroso compounds are known to be carcinogenic 
and formed via nitrosation of amines. Phenolic (phenol and p-Cresol) and indolic (indole 
and skatole) compounds are products of catabolism of aromatic amino acids and these 
have been shown to be toxic to cells (Nyangale et al., 2012). 
There is also evidence of a relationship between infective agents and some human 
cancers. Certain intestinal microbiota play an important role in the pathogenesis of 
colorectal cancer (Marchesi et al., 2011). Carbohydrate fermentation by bacteria in the 
gut results in production of hydrogen, methane, carbon dioxide, and short-chain fatty 
acids (SCFAs) mainly acetate, propionate and butyrate (Lourenço and Turner, 2014). 
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Significant changes in faecal microbiota, elevated faecal pH, and significant decreases in 
faecal SCFAs concentrations, have been described in patients with colorectal cancer 
(Ohigashi et al., 2013). In addition, bacteria have an important role on the generation of 
the majority of some compounds present in breath, such as hydrogen, hydrogen cyanide, 
aldehydes, and alkanes (Ajibola et al., 2013). 
 
1.7.1 Screening Programmes and Strategies 
Given that colorectal cancer is the second leading cause of cancer-related death in 
Europe, one  of  the  essential  necessities  for  CRC  screening  is detection  of  the  
disease  at  earlier  stages  with  high  sensitivity and specificity. 
In the UK and USA the screening programmes are quite similar and the initial screening 
stage includes stool/faecal based tests, and then secondary structural based tests. The 
current chosen faecal based test in the UK’s NHS s is the faecal occult blood test (FOBT) 
and then the more invasive structural test is the colonoscopy/sigmoidoscopy (UK 
colorectal cancer screening pilot group, 2004). 
The FOBT is the most commonly used non-invasive CRC screening method and is designed 
to detect occult (i.e. not accompanied by discernible symptoms or signs) blood in the 
stool, considering that large polyps and the actual colorectal cancers in the colon and 
rectum tend to bleed. The test requires the sampler to smear a card with faeces twice 
after a bowel movement, then repeat this for a further two bowel movements, making a 
total of six windows covered on the card. The test is then sent in a hygienically sealed 
envelope back to the relevant clinic and is tested. A positive result is given when any of 
the windows return as ‘positive’. The FOBT has a high false positive rate (2–13%) (Allison 
et al., 1996) due to the existence of other sources of blood which such test does not take 
into account, i.e. haemorrhoids and peptic ulcers. The sensitivity ( 40%) and specificity of 
65 
 
the FOBT are low with respect to detecting early-stage CRC (Niv and Sperber, 1995, 
Towler et al., 1998). Therefore, most patients who test positive will require an invasive 
and expensive confirmatory diagnostic procedure such as colonoscopy, which has 
demonstrated to be a relatively accurate and reliable method for detecting CRC with a 
sensitivity of approximately 90% (Bretthauer, 2011). Hence, there is a need for a more 
accurate screening test for colorectal cancer to reduce the number of unnecessary 
colonoscopies.  Being able to screen for colorectal cancer by detecting VOCs present in 
the headspace of faeces may be a suitable alternative. 
 
1.7.2 Use of volatile biomarkers in screening for colorectal cancer 
Normal metabolism generates VOCs that may emanate from faecal matter. Human faecal 
flora comprises bacteria involved in colonic fermentation producing sulphur containing 
compounds, such as hydrogen sulphide, dimethyl disulphide, methyl disulphide, and 
dimethyl trisulphide, and these compounds are responsible for the specific odour of 
faecal matter (Moore et al., 1987). In the last decade, very little work has been published 
on the volatiles from stool and their potential in the screening of colorectal cancer. The 
analysis of VOCs in faecal headspace of neonates showed a large discrepancy in volatiles 
from premature neonates compared to healthy adults (De Lacy Costello et al., 2008). 
Indeed, this finding reflects the simplicity of neonatal flora compared to the microbiota of 
adult gut indicating that most of these VOCs are produced by fermentation of dietary 
substrates by gut microbes. This study indicates that analysis of VOCs in faecal headspace 
has the potential for the diagnosis of a range of gastro intestinal diseases, non-invasively 
and painlessly. However, further studies are necessary to support this experiment and to 
determine whether analysis of VOCs in faecal headspace can be used to screen for 
colorectal cancer. 
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Not only faecal headspace analysis provides insight into the disease but also breath 
analysis, in which Altomare and co-workers used GC-MS to analyse breath samples from 
patients with colorectal cancer. The authors established that the pattern of VOCs in 
patients suffering from colorectal cancer were different from that in healthy controls, 
particularly levels of some specific VOCs such as 1,3-dimethylbenzene, 1,2-pentadiene, 
cyclohexene and methylcyclohexene (Altomare et al., 2013), although the confidence of 
the results is questioned since these VOCs might arise from environmental exposure and 
the biochemical pathways within the body are unknown.  
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Chapter 2 
 
Analytical methods for analysing VOCs 
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The use of VOCs has been discussed previously in disease diagnosis and monitoring and 
some applications. Detailed information on theory and practice of the instrumental 
methods for analysing VOCs is now explained below. 
 
2. 1 Gas-phase ion chemistry 
 
Gas-phase ion chemistry is a broad field that has many applications and which embraces 
several branches of chemistry and physics. It is the science that studies ions and 
molecules in the gas-phase, most often enabled by some mass spectrometry technique. 
Gas-phase reactions mainly provide thermochemical and kinetic data which contribute to 
the fundamental understanding of the reaction mechanisms of a wide range of species 
from simple inorganic ions to highly reactive organic ions.  
Ion-molecule reactions in the gas-phase were first studied under equilibrium conditions in 
a high-pressure mass spectrometer in 1963 by Kebarle and Godbole for an ion clustering 
reaction comprising the gas-phase solvation of H3O
+ (Kebarle and Godbole, 1963). 
Ion-molecule reactions in the gas-phase proceed via proton transfer, charge transfer, 
hydride ion transfer, adduct formation, association, oxidation and hydrogen atom 
transfer (Hoffman and Stroobant, 2007). 
 
A number of instruments and experimental methods have been developed to study these 
reactions in more detail under highly controlled conditions, such as Selected Ion Flow 
Tube Mass Spectrometry (SIFT-MS) and Proton Transfer Reaction Mass Spectrometry 
(PTR-MS), Fourier Transform Mass Spectrometry (FT-MS) and Quadrupole Ion Trap Mass 
Spectrometry (QIT-MS). Advances in these detection techniques have coincided with the 
development of new ionization methods such as chemical ionization (CI), fast atom 
bombardment (FAB) and electrospray (ESI). Together these tools have allowed gas-phase 
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ion chemistry to be exploited as an analytical tool to monitor chemical species directly, 
e.g. VOCs in breath. 
 
2. 2 Techniques for VOC measurements  
VOC research relies on analytical methods (Table 2.1) that offer high sensitivity, precision 
and resolution. The on-line, real-time mass spectrometric (MS) techniques SIFT-MS and 
PTR-MS have been developed with limits of detection ranging from ppbv to pptv, making 
them ideally suited to VOC analysis (Smith, 2014). Proton transfer reactions occur in both 
techniques in a chemical ionization process that allows efficient ionization for many 
organic compounds in the gas phase. Product ion generation in SIFT-MS and PTR-MS is 
managed using chemical ionization, arising from ion-molecule reactions rather than 
electron impact or photoionization, leading to much less fragmentation of the molecules. 
Thus, these techniques are called soft ionisation techniques.  
 
SIFT-MS and PTR-MS are well suited to direct, real-time MS profiling without pre-
concentration. The MS data sets are produced by either technique are quite simple, easy 
to handle, including numerous variables perfectly suited for multivariate statistics. Hence 
both SIFT-MS and PTR-MS are well suited to the work presented in this thesis enabling 
unequivocal real-time quantification of VOCs, with high sensitivity, precision and 
resolution. 
 
Gas Chromatography-Mass Spectrometry (GC-MS) combined with thermal desorption 
(TD) or solid-phase micro extraction (SPME) is also widely used in the analysis of volatile 
samples. In contrast to SIFT-MS and PTR-MS a major advantage of chromatographic 
methods are their very high sensitivity due to sample concentration via thermal 
70 
 
desorption (TD) or solid-phase micro extraction (SPME). In addition, the existence of 
extensive compounds libraries makes compound identification much easier than in 
SIFT-MS and PTR-MS. In addition, the chromatography component allows compound 
separation so compound identification of spectra is easier. In this thesis, all the samples 
were analysed using a GC-MS combined with a thermal desorption unit (TD-GC-MS). 
 
Table 2. 1 – A comparison of the characteristics of the available research techniques in VOC measurements (Adapted 
from Lourenço and Turner, 2014) 
Analytical Method Mode of operation Limit of detection (LOD) Sensitivity Specificity 
SIFT-MS Direct/Real time ppbv High High 
PTR-MS Direct/Real time pptv High Medium-High 
IMS Real-time ppbv Medium Medium 
Sensor arrays Reference to a database ppbv Medium Medium 
TD-GC-MS Pre-concentration pptv-ppbv Very-high Very-high 
GC-FID Direct ppbv-ppmv High High 
LAS Real-time ppbv High High 
 
Other analytical techniques that may be used, include laser absorption spectroscopy 
(LAS), ion mobility spectrometry (IMS), and a variety of gas sensors and semiconductor-
based sensor arrays. Many applications have combined various sensors and materials into 
a single array, leading to the development of an “electronic nose” (Shurmer et al., 1987). 
 
For the LAS technique, the amount of light absorbed by a sample is related to the 
concentration of the target specie in the sample. The LAS technique enables 
quantification of volatiles in exhaled breath down to below ppbv levels. It is particularly 
useful for monitoring purposes, and, recently, the exhaled breath of healthy volunteers 
was assessed by LAS-based technique cavity ringdown spectroscopy (CRDS) (Vaittinen et 
al., 2013). 
 
In the IMS technique, the ions are generated by any of a number of methods (e.g.  
radioactive strip, electrospray) and they are separated according to their mobilities 
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through the gas, which is usually air at atmospheric pressure (Borsdorf and Eiceman, 
2006) in an applied electric field. During the last ten years the IMS technique has been 
applied in medical research, such as detection of skin volatiles (Ruzsanyi et al., 2012), 
detection of volatiles in exhaled breath of patients with lung cancer (Westhoff et al., 
2009), and determination of anaesthetics concentration in exhaled breath (Perl et al., 
2009).  
 
Sensor technology has been used for many years in clinical testing. However gas sensors 
are often much less sensitive, usually lack specificity, and are prone to drift. The 
combination of specificity, selectivity, robustness in operation, reproducible 
manufacturing uniformity, and long-life stability is not yet offered by current sensors at 
an acceptable cost level. There are also difficulties in inter-device reproducibility. 
 
2. 3 Mass Spectrometry and Gas-phase ion chemistry 
Gas-phase ions are generated and separated according to their mass-to-charge ratio 
(m/z) using electric fields/ magnetic fields. Figure 2.1 shows a schematic representation of 
how a mass spectrometer works.  
 
Figure 2. 1 – Components of a mass spectrometer 
 
Overall a mass spectrometer consists of an inlet, an ion source, a mass analyzer, a 
detector, a high-vacuum system and an acquisition system. The procedure for sample 
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injection will strongly depend on the physical properties of the sample and it may be 
accomplished by direct insertion, liquid-chromatography or gas chromatography. The ions 
are generated in the ion source by many different ways, e.g. electron ionization (EI) or 
chemical ionization (CI). Current mass analyzers include quadrupole (Q), time-of-flight 
(TOF), ion trap (IT), magnetic sector field (B), electric sector (E), fourier transform ion 
cyclotron resonance (FT-ICR), fourier transform orbitrap (FT-OT), in addition to tandem 
mass spectrometry commonly known as MS/MS, consisting of two mass spectrometers in 
series connected by a chamber known as collision cell. The ions are recorded by the 
detector, e.g. electron multiplier, Faraday cup, among others, and the data generated 
being acquired in the form of a mass spectrum.    
 
2.3.1 Ionization methods 
Chemical ionization (CI) uses a molecular ion to transfer charge onto the target analyte 
(i.e. charge transfer) or through formation and/or the breaking of chemical bonds, such as 
proton transfer, hydride ion transfer, or ion-molecule adduct formation (Ellis and 
Mayhew, 2014). Ion-molecule reactions such as proton transfer are often very fast and 
occur on every collision, which makes them useful for efficient ionization of target 
molecules in mass spectrometry. Chemical ionization is called a soft ionization technique, 
transferring less energy to the analyte, resulting in less fragmentation of the parent ions.  
 
 
Electron ionization (EI) can be used for analysing a wide range of VOCs up to 1000 Da 
molecular weight including hydrocarbons, oils, alkaloids, steroids, pesticides, dioxins, 
flavours, fragrances, etc. EI is often used in conjunction with gas chromatography. In 
principle, direct analysis of VOCs can be achieved by simply introducing a sample into a 
commonly used EI ion source of a conventional mass spectrometer. However, the 
resulting mass spectra obtained by this procedure are extremely complex, making it 
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difficult to identify a peak that can be attributed to the molecular parent ion. This is due 
to the high energies employed (70 eV) which largely exceed the first ionization energies 
of all chemical compounds. Thus, this excess of energy available generally leads to 
fragmentation of the molecular ion (Ellis and Mayhew, 2014). 
Figure 2.2 shows an EI source. Within the heated ion source operated under high vacuum 
(10-5 to 10-6 mbar), electrons emitted by a heated tungsten filament are accelerated to 
the ionization chamber by a potential difference, usually set to 70 eV. In addition, the 
electron beam is collimated by a moderate magnetic field generated by two small 
magnets. The ionization is achieved after collision of the gas sample with the electron 
beam followed by the removal of an electron from the analyte molecule producing a 
positively charged ion respectively (Ashcroft and Barnett, 1997). 
    
Equation 2.1 𝑒− +𝑀 → 𝑀+ + 2𝑒− 
 
 
Figure 2. 2 – Electron ionization (EI) source showing the generation of positively charged ions towards the mass analyzer 
(Sparkman et al., 2011) 
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Since the internal covalent bonds in the molecule are susceptible to cleavage, most 
molecular ions tend to fragment due to an excess of energy available, and these fragment 
ions can in turn fragment leading to a complex product ion pattern. Thus, data analysis 
becomes complex and difficult to interpret, which delays biomarker discovery accurately. 
 
2.3.2 Gas-phase ion-molecule reactions 
Gas-phase ion-molecule reactions yields information on the reactivity of cations or anions 
in the absence of solvation and counter ion effects. As an illustrative example, Figure 2.3 
correlates the energy characteristics of both gas-phase and aqueous solution phase 
required for the substitution reaction below (Hoffman and Stroobant, 2007). 
 
Equation 2.2 𝐶𝑙− + 𝐶𝐻3𝐵𝑟 →  𝐶𝐻3𝐶𝑙 + 𝐵𝑟
− 
 
 
Figure 2. 3 – Potential energy diagram for a substitution reaction in the gas-phase and in solution in water (Hoffman and 
Stroobant, 2007) 
 
Ion chemistry in the condensed phase is often dominated by ion pairing and solvation 
interactions which can mask the intrinsic reactivity of the reaction partners. The 
molecules are strongly solvated, which in turn requires more energy to overcome such a 
strong activation barrier to form the activated complex. In contrast, chemical reactions in 
the gas-phase are exothermic, and the activated complex is generated without a 
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pronounced activation barrier to supress. However, some activation energy is necessary 
to transform the Cl-.CH3Br complex into the activated complex and finally into Br
-.CH3Cl, 
and the energy produced in the second step is generally lower than the energy produced 
by the first step. Overall, the actual activation energy in the gas-phase is negative and due 
to the inexistence of solvation interactions, gas-phase rate coefficients are rather faster 
than the respective rates coefficients in solution (Hoffman and Stroobant, 2007).   
 
2.3.3 Types of ion-molecule reactions 
Ion-molecule reactions in the gas-phase such as those in Table 2.2 are often very fast, 
which means that they often occur at each collision considering an exergonic reaction 
where the change in the free energy is negative, indicating a spontaneous reaction (Ellis 
and Mayhew, 2014).  
  
Table 2. 2 – Ion-molecule reactions in the gas phase. 
Ion-molecule reaction Designation 
X
+ 
+ M  →  M
+ 
+ X Charge transfer 
XH
+ 
+
 
M  →  MH
+ 
+ X Proton transfer 
X
+ 
+ MH  →  M
+ 
+ HX Hydride ion transfer (H
-
) 
X
+
 + M + Z  →  (M+X)
+ 
+ Z Adduct formation 
X
+
 + M  →  MX
+
 Association or clustering 
X
+
 + MO → XO
+ 
+ M Oxidation reaction 
X
+
 + MH → XH
+ 
+ M Hydrogen atom transfer 
 
The most abundant types of ion-molecule reactions (Hoffman and Stroobant, 2007) are 
charge transfer reactions. In this process the transfer of charge from the ion to the 
neutral species occurs. In the case of proton transfer, the proton affinity of the proton 
acceptor (neutral or anion) has to be higher than the proton affinity of the donor (cation 
or neutral). An adduct is formed by direct combination of a neutral species and an 
“ionizing” ion other than the proton. Hydride (H-) ion transfer occurs every time the H- ion 
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is extracted from the carbon group of the neutral molecule to form a different neutral 
species. In association or clustering reactions, clusters or aggregates (nM+H)+ are 
generally observed and result from the combination via noncovalent forces of two or 
more atoms or molecules of one or more chemical species with an ion. Generally, the 
proton can be replaced by another cation. The formation of such aggregates is 
exothermic and its stability is enhanced whether the partners of the aggregate have 
similar basicities or affinities for the cation, i.e. two or more identical molecules. 
Commonly, the abundance of the aggregates drops with the increase of the number of 
associated molecules. Oxidation corresponds to the loss of electrons or an increase in 
oxidation state by a molecule, atom or ion, and usually followed by chemical reduction. 
Hydrogen atom transfer occurs every time a hydrogen free radical is abstracted from the 
neutral species into the ion.      
 
 
 
2.3.4 Proton transfer 
 
Proton transfer ion-molecule reactions in the gas-phase are the basis of both SIFT-MS and 
PTR-MS and have been used to study the reaction mechanisms of many VOCs. Exothermic 
proton transfer reactions in the gas-phase tend to be fast (k ≥ 10-9 cm3 s-1) and usually 
proceed at the collisional rate (Blake et al., 2009, Bohme et al., 1980). 
Precursor ion formation 
H3O
+, NO+ and O2
+ are the most suitable reagent ions used in SIFT-MS analyses of air and 
breath, because they do not react rapidly with the major components of air and breath, 
N2, O2, H2O, CO2 and Ar, but they do react rapidly with most VOCs to produce product 
ions characteristic of the various neutral molecules, M, in a gas sample being analysed 
(Smith and Španěl, 1996b). The great majority of PTR-MS experiments carried out to date 
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have employed H3O
+ as precursor ion generated by a hollow cathode discharge ion 
source. The latest instruments use a switchable reagent ion capability, alternating 
between the three precursor ions, H3O
+, NO+, and O2
+ (Jordan et al., 2009a).  
 
The reaction with water molecules yields the H2O
+ ions, which in turn are readily 
converted into H3O
+ by the fast reaction of direct dissociative ionisation below. 
 
Equation 2.3 𝑂𝐻+ + 𝐻2𝑂 → 𝐻3𝑂
+ + 𝑂    
Equation 2.4 
 
𝑒− +  𝐻2𝑂 → 𝐻2𝑂
+ + 2𝑒− 
Equation 2.5 𝐻2𝑂
+ + 𝐻2𝑂 → 𝐻3𝑂
+ + 𝑂𝐻 
 
In highly humid conditions, the H3O
+ water cluster ions, H3O
+(H2O)n, n = 1,2,3, appear in 
the product ion mass spectrum (Španěl and Smith, 2000a). Similarly, either for NO+ or O2
+, 
the hydrated cluster ions are produced respectively, NO+ (H2O)n, n = 1,2 and O2
+(H2O)n, n = 
1,2 (Španěl and Smith, 2009). These cluster ions can also act as precursor ions and lead to 
hydrated product ions MH+(H2O)n, n = 1, 2, 3.  
NO+ ions formed in the discharge ion source are due to the reactions of O+ and N+ atomic 
ions generated in the ion source from N2 and O2 molecules (Španěl et al., 2007b).   
 
Equation 2.6 𝑁+ + 𝐻2𝑂 → 𝐻2𝑂
+ + 𝑁   
Equation 2.7 𝑂
+ + 𝐻2𝑂 → 𝐻2𝑂
+ + 𝑂 
Equation 2.8 𝑂+ + 𝑁2 →  𝑁𝑂
+ + 𝑁 
Equation 2.9 𝑁+ + 𝑂2 →  𝑁𝑂
+ + 𝑂 
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O2
+ ions are formed via direct ionisation of O2 molecules and via the reaction of O
+ and 
H2O
+ ions with O2 molecules (Španěl et al., 2007b). 
 
Equation 2.10 𝑂+ + 𝑂2 → 𝑂2
+ + 𝑂 
Equation 2.11 𝐻2𝑂
+ + 𝑂2 → 𝑂2
+ + 𝐻2𝑂 
The humidity of the air source gas and the total pressure, determines the total ion 
currents and the relative signals of the three precursor ion species. 
 
H3O
+ reactions 
 
Reactions of H3O
+ ions with VOCs proceed via exothermic proton transfer. Chemical 
ionization is managed by the proton affinity of the volatile, thus VOCs with proton 
affinities (PA) higher than proton affinity of water, PA(VOC) > PA(H2O) = 691 kJ mol
-1 
(Hunter and Lias, 1998), will react and protonated ions (MH+) will be detected. If this 
condition is fulfilled, then a reaction occurs in every ion-molecule collision. Reactions of 
H3O
+ ions with VOCs occur either in the flow tube of SIFT-MS or drift tube of PTR-MS. 
 
Equation 2.12 𝐻3𝑂
+ +𝑀 → 𝑀𝐻+ + 𝐻2𝑂 
 
Depending on the type of organic molecule under study (i.e. alcohols, aldehydes, ketones, 
amines, carboxylic acids, etc.), MH+ product ions may dissociate to form ions resulting 
from the elimination of H2O molecules.  
 
Equation 2.13 𝐻3𝑂
+ + 𝑅𝑂𝐻 → 𝑅+ +  𝐻2𝑂 + 𝐻2𝑂 
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This usually occurs following the protonation of alcohols, aldehydes and carboxylic acids 
because of the OH group present in these molecules (Španěl and Smith, 1997, Španěl et 
al., 1997, Španěl and Smith, 1998c). 
The ether reactions are quite complex. In this situation, following the protonation of the 
ether, MH+ ions are usually generated from the elimination of alcohol and hydrocarbon 
molecules (Španěl and Smith, 1998d). Elimination of alcohol is also common in the esters 
reactions (Španěl and Smith, 1998c). The equations below illustrate the process in ethers, 
R being a radical such as CH3. 
 
Equation 2.14 𝐻3𝑂
+ + 𝑅𝑥𝑂𝑅𝑦 → 𝑅𝑥𝑂𝑅𝑦𝐻
+ + 𝐻2𝑂 
Equation 2.15 𝐻3𝑂
+ + 𝑅𝑥𝑂𝑅𝑦 → 𝑅𝑥
+ + 𝑅𝑦𝑂𝐻 + 𝐻2𝑂 
Equation 2.16 𝐻3𝑂
+ + 𝑅𝑥𝑂𝑅𝑦 → 𝑅𝑦𝑂𝐻2
+ +  𝑅 + 𝐻2𝑂 
 
Previous studies in amines reactions showed that they are efficiently protonated by H3O
+ 
due to its high proton affinity (Španěl and Smith, 1998a). In the reactions of the 
secondary amines with H3O
+ another reaction process is observed, the loss of an H2 
molecule from the excited protonated parent molecule (Španěl and Smith, 1998a).  
 
Equation 2.17 𝐻3𝑂
+ + 𝑅2𝑁𝐻 →  𝑅2𝑁
+ + 𝐻2 +𝐻2𝑂 
 
Remarkably, the reactions of some aliphatic hydrocarbons and halocarbons with H3O
+ 
proceed via ion-molecule association (Španěl and Smith, 1998a). 
80 
 
Equation 2.18 𝐻3𝑂
+ +𝑀 +𝐻𝑒 → 𝐻3𝑂
+𝑀+𝐻𝑒 
This unusual reaction apparently occurs when the proton affinity of the VOC is less than 
the proton affinity of water, PA(VOC) < PA(H2O) = 691 kJ mol
-1. However, the study of 
lower order hydrocarbons is impossible to carry out, because its proton affinity is 
excessively smaller than PA(H2O), thus neither proton transfer nor association occurs 
(Španěl and Smith, 1998a).  
 
NO+ reactions  
The reactions of NO+ ions with VOCs usually procced via charge transfer. However, it can 
be followed by one or two of these processes in parallel, hydride ion transfer, hydroxide 
ion transfer, alkoxide ion transfer, and ion-molecule association. Most amines proceed via 
charge transfer with NO+, and sometimes the process is observed in parallel with hydride 
(H-) ion transfer (Španěl and Smith, 1998a). The ionization energy of NO is 9.26 eV (Lias et 
al., 1988), so it ionizes fewer compounds via the charge transfer mechanism than does 
O2
+. For organic molecules satisfying the following conditions, IE(VOC) < IE(NO+) = 9.26 eV, 
a reaction via charge transfer is guaranteed.  
 
Equation 2.19 𝑁𝑂+ +𝑀 →  𝑀+ + 𝑁𝑂 
Hydride (H-) ion transfer and hydroxide (OH-) ion transfer are the most common reactions 
occurring in primary and secondary alcohols with NO+. However, the reactions of tertiary 
alcohols proceed only via hydroxide (OH-) ion transfer (Španěl and Smith, 1997). In ethers 
and saturated aldehydes, hydride (H-) ion transfer is the only process that occurs in the 
reactions with NO+ (Španěl and Smith, 1998d, Španěl et al., 1997). In hydride ion transfer 
the H- ion is extracted from the –CH3 carbon group of either alcohol, ether, or aldehyde. 
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Equation 2.20 𝑁𝑂+ + 𝑅𝑂𝐻 →  [𝑅𝑂𝐻 − 𝐻]+ + 𝐻𝑁𝑂 
Equation 2.21 𝑁𝑂+ + 𝑅𝑂𝐻 →  [𝑅𝑂𝐻 − 𝑂𝐻]+ + 𝐻𝑁𝑂2 
Ion-molecule association is common in the reactions between NO+ and carboxylic acids 
and esters (Španěl and Smith, 1998c), and ketones (Španěl et al., 1997). Association 
reaction is indicated below. 
Equation 2.22 𝑁𝑂+ +𝑀 → 𝑀𝑁𝑂+ 
In NO+ reactions with carboxylic acids, association is seen in parallel with hydroxide (OH-) 
ion transfer. In the case of ester reactions with NO+, association often occurs in parallel 
with alkoxide (OR-) ion transfer. Alkoxide ion transfer is indicated below.  
 
Equation 2.23 𝑁𝑂+ + 𝑅𝐶𝑂2𝑅 →  𝑁𝑂
+𝑅𝐶𝑂2𝑅 + 𝐻𝑒 
Equation 2.24 𝑁𝑂+ + 𝑅𝐶𝑂2𝑅 →  𝑅𝐶𝑂
+ + 𝑅𝑁𝑂2 + 𝐻𝑒 
Alkenes proceed via charge transfer due to its small IE < IE(NO+) = 9.26 eV (Španěl and 
Smith, 1998a). 
 
O2
+ reactions  
The reactions of O2
+ ions with VOCs mostly proceed either by charge transfer, where 
IE(VOC) < IE(O2
+) = 12.07 eV (Lias et al., 1988), or dissociative charge transfer yielding two 
or several fragment ions. Such reactions are defined below. 
 
Equation 2.25 𝑂2
+ +𝑀 → 𝑀+ + 𝑂2 
Equation 2.26 𝑂2
+ +𝑀 → 𝐹𝑟𝑎𝑔𝑚𝑒𝑛𝑡+ +  𝑛𝑒𝑢𝑡𝑟𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑠 
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The efficiency of the charge transfer process is often less than 100%. The reactions of O2
+ 
ions are most used for the quantification of small molecules that do not react with either 
H3O
+ or NO+ ions, such as small hydrocarbons. Reactions of O2
+ ions are less useful 
because their reactions with polyatomic ions usually result in multiple ion fragments 
(Smith and Španěl, 2005). 
 
 
2.3.5 Theoretical prediction of proton transfer rate coefficients 
 
Quantification of VOC concentrations may be accomplished if proton transfer rate 
coefficients are known. Proton transfer reactions occur efficiently if the proton affinity of 
the acceptor molecule exceeds the proton affinity of the donor (H2O), thus such reactions 
are exothermic, fast (k ≥ 10-9 cm3 s-1) and usually proceed at the collisional rate (Blake et 
al., 2009, Bohme et al., 1980). 
 
The simplest theory to determine rate coefficients of exothermic ion-molecule reactions 
is given by the calculations using the Langevin (Langevin, 1905) theory. The Langevin 
theory provides rate coefficients, kL, between a point of charge (ion) and a non-polar 
neutral molecule; assuming there is no permanent dipole; and interaction occurs through 
an induced dipole. 
 
 
Equation 2.27 
𝑘𝐿 = √
𝜋𝛼𝑞2
𝜇𝜀0
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where, q represents the charge of the ion (1.60 × 10-19 C); α is the polarizability of the 
neutral molecule (m3); 0 represents the permittivity of free space (8.85 × 10
-12 J-1 C2 m-1); 
µ stands for the reduced mass of colliding partners (µ = m1 × m2/(m1 + m2), where m1 and 
m2 are the masses of the ion and the neutral molecule respectively.  
 
In polar molecules, such as many VOCs, it is necessary to account for the ion-induced 
dipole interaction between the ion and the permanent dipole of the neutral molecule. 
This interaction is accounted for in the second term of the following equation developed 
by Su and Bowers (Su and Bowers, 1973), and known as The Average Dipole Orientation 
(ADO) theory: 
 
Equation 2.28 𝑘𝐴𝐷𝑂 = √
𝜋𝛼𝑞2
𝜇𝜀0
 +
𝐶𝜇𝐷𝑞
𝜀0
+√
1
2𝜋𝜇𝑘𝐵𝑇
 
 
 
where, kB represents the Boltzmann constant (1.38 × 10
-23 m2 kg s-2 K-1); T is the 
temperature of 300 K; µD is the dipole moment expressed in Debye (D); C accounts for the 
average orientation of the permanent dipole moment of the molecule, and is a function 
of dipole moment (µD) and polarizability (α) which can be determined elsewhere (Ellis and 
Mayhew, 2014). 
 
Su and Chesnavich  parameterised trajectory calculations (Su and Chesnavich, 1982) to 
model the reaction process of thermal ion-polar molecule capture collisions to derive 
capture rate coefficients, kcap, which in turn have been widely determined and then used 
in the determination of VOC concentration via SIFT-MS. The rate coefficient, kcap, is given 
by: 
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Equation 2.29 𝑘𝑐𝑎𝑝 = 𝑘𝐿 × 𝐾𝑐𝑎𝑝(𝑇𝑅 , 𝐼
∗) 
 
 
 
where, kL is the Langevin rate coefficient. Kcap (TR, I*) is a parameterised quantity 
dependent on two reduced parameters TR and I*. Where, TR = 40 × (2αkBT/µ
2
D); x = 
√(1/TR); and I* = µDI/αqµ (Ellis and Mayhew, 2014). 
 
 
Considering that Kcap is insensitive to the value of I*, thus: 
 
 
Equation 2.30 𝐾𝑐𝑎𝑝 =
{
 
 
 
 
 
 
(𝑥 + 0.5090)2
10.526
+ 0.9754 ,                     𝑥 ≤ 2
0.4767𝑥 + 0.6200 ,                       2 ≤ 𝑥 ≤ 3
0.5781𝑥 + 0.3165 ,                     3 ≤ 𝑥 ≤ 35
0.6201𝑥 − 1.153 ,                     35 ≤ 𝑥 ≤ 60
0.6347𝑥 − 2.029 ,                                𝑥 ≥ 60
 
 
 
 
The theories discussed so far do not consider the effect of a homogenous electric field on 
the rate coefficients. Ion-molecule reactions in the drift tube of PTR-MS proceed with 
energies larger than thermal. This means that ions travel with an additional energy 
provided by the applied electric field. Thus, it is necessary to consider the centre-of-mass 
kinetic energy, KEcm, (Lindinger et al., 1998) for a collision between an ion and the neutral 
molecule: 
 
Equation 2.31 𝐾𝐸𝑐𝑚 =  
𝑚𝑛
𝑚𝑖𝑜𝑛 +  𝑚𝑛
(𝐾𝐸𝑖𝑜𝑛 −  
3
2
 𝑘𝐵𝑇) +  
3
2
𝑘𝐵𝑇 
 
where, mion is the mass of the ion, and the mass of the neutral molecule, mn. The mean 
kinetic energy of the ions, KEion, is expressed by the Wannier expression (Wannier, 1953): 
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Equation 2.32 𝐾𝐸𝑖𝑜𝑛 =
3
2
𝑘𝐵𝑇 +  
1
2
𝑚𝑖𝑜𝑛𝑣𝑑
2 +  
1
2
𝑚𝑏𝑣𝑑
2 
 
where, mb is the buffer gas molecules (air) and the velocity of the drift tube, vd, is given by 
the following equation: 
 
Equation 2.33 𝑣𝑑 = 𝜇0 ×𝑁0 ×
𝐸
𝑁
 
 
µ0 represents the reduced ion mobility for H3O
+ in air and this can be experimentally 
determined as a function of E/N. This can be achieved by sending a short pulse of ions 
along the drift tube and measuring the time of arrival at the end. These values are 
reported elsewhere (Ellis and Mayhew, 2014) and in this work an average value of 2.8 cm2 
s-1 V-1 has been used; N0 stands for the gas number density under standard conditions of 
temperature and pressure (273.15 K and 760 Torr = 1.01325 × 105 Pa); E/N ratio, where E 
is the electric field strength and N is gas number density in the reaction chamber. The 
drift velocity increases either by increasing the electric field strength on PTR-MS, or by 
decreasing the pressure or temperature of the drift tube.  
 
The effective temperature, Teff, describes the internal energy of ion-neutral molecule 
collisions and depends only on the ratio E/N (Viggiano and Morris, 1996). The following 
expression can be used to estimate the effective ion translational temperature and may 
be derived from the equation 2.31 by imposing KEcm = 3/2kBTeff, thus getting: 
 
Equation 2.34 
𝑇𝑒𝑓𝑓 = 𝑇 +
𝑣𝑑
2
3𝑘𝐵
[
𝑚𝑛(𝑚𝑖𝑜𝑛 +  𝑚𝑏)
𝑚𝑖𝑜𝑛 +  𝑚𝑛
] 
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Su published a method to calculate collisional rate coefficients, kcap (Trot, KEcm), and 
parameterising kcap explicitly as a function of the centre-of-mass kinetic energy, KEcm, and 
not just of the temperature (Su, 1994). Based on trajectory calculated results relating the 
rate coefficient given by the Langevin theory (kL) to the capture rate constant (kcap) by a 
factor, Kc, parameterised by KEcm and rotational temperature, Trot. 
Equation 2.35 𝑘𝑐𝑎𝑝 (𝑇𝑟𝑜𝑡, 𝐾𝐸𝑐𝑚) = 𝑘𝐿 ×  𝐾𝑐 
 
 
Kc is given by the following equation, where  and  are given respectively.  
 
 
Equation 2.36 
𝐾𝑐 =  1 + (0.727143 × 𝜏
0.4 × 𝜀2 × 𝑆) + [3.71823 × (1 − 𝑆)] × [sin(0.58692 × (4.97894 + ln 𝜏)) × 𝜏0.6 × (𝜀 − 0.5)0.5] 
 
 
Depending on two reduced parameters, namely,  = µD /√(αTrot) and  = µD/ √(αKEcm). 
 
 
2. 4 SIFT-MS 
 
Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) was conceived and developed by 
Adams and Smith in 1976 (Adams and Smith, 1976), for the study of ion-neutral reactions 
at thermal interaction energies (Smith and Adams, 1987). Initially it was developed to 
satisfy the need of kinetic data on gas-phase ion-neutral reactions observed in cold 
interstellar clouds (Smith, 1992 ). In 1996, it became a method focused on real-time, 
on-line analysis of volatile trace gases of biological origin with medical applications 
(Španěl et al., 1996, Španěl and Smith, 1996, Smith and Španěl, 1996a, Smith and Španěl, 
1996b), such as clinical diagnosis, therapeutic monitoring and physiological studies (Smith 
and Španěl, 2007, Smith and Španěl, 2005, Španěl et al., 1996, Španěl and Smith, 2007). 
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SIFT studies are carried out under well-controlled thermalised conditions at 300 K, 
allowing the determination of kinetic data (i.e. rate coefficients) and these are used to 
derive the analyte concentrations. Thus, quantification of VOCs in air is achieved by using 
an in-built kinetics library, although it is good practice to periodically check the 
quantification using known standards.  
 
With this real-time device (Figure 2.4) the patient may breathe directly into the 
equipment through a heated capillary in order to avoid condensation in the capillary. 
Alternatively, headspace samples may also be analysed, i.e. those produced in Nalophan 
bags containing the VOC or other material suited for this type of experiment, which 
ideally does not emit background contaminants. 
 
 
Figure 2. 4 – A schematic of the selected ion ﬂow tube apparatus, SIFT (Smith and Španěl, 2015). 
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With the SIFT-MS technique, it is possible to identify and differentiate isomers by using 
the different precursor ions (H3O
+, NO+, O2
+) and by applying two different modes of 
analysis. The full scan mode (FS) produces a complete mass spectrum, and a multiple ion 
mode (MIM) monitors the count rates of the selected precursor ion and selected product 
ions in real-time. A complete mass spectrum is obtained by sweeping the downstream 
quadrupole mass analyzer over a selected mass-to-charge ratio (m/z) range for a selected 
period of time. The count rates of the ions are then calculated from the numbers of 
counts and the total sampling time for each ion. In the MIM mode the downstream 
quadrupole mass analyzer is rapidly switched between the masses of all of the precursor 
ions and the selected products ions, briefly pausing on each of these masses for a short 
time period. The partial pressures of the trace gases are calculated as a function of time 
(Smith and Španěl, 2005). 
 
The precursor ions are produced in an ion source – microwave discharge ion source. 
These microwave discharges are established in a glass tube separated from the upstream 
quadrupole mass filter by a disc in which there is a central orifice that is small enough to 
allow pressures approaching 1 Torr to be established in the ion source whilst ensuring 
that the pressure in the mass filter is maintained at about 10−4 Torr by a turbomolecular 
pump.  
The ions are selected in the upstream quadrupole mass filter according to their 
mass-to-charge ratio, and injected into a fast-flowing carrier gas (usually pure helium at a 
pressure of approximately 1 Torr) through a Venturi inlet, in order to minimize backflow 
of the carrier gas into the mass filter. Both quadrupoles of the instrument require a 
pressure of ≤ 10-4 Torr for effective operation, while the flow tube is set at pressures near 
0.6 Torr. An excess of carrier gas is used to certify that the reactant ions are formed well 
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upstream of the point where the neutral reagent gas is added, ensuring ion-molecule 
reactions at thermal energies.  
 
The chemical reaction takes place in the flow tube, where the selected precursor ion 
rapidly reacts with the sample gas, a process achieved by soft chemical ionization of the 
sample. Reactions of H3O
+ ions with organic compounds proceed via exothermic proton 
transfer. The reactions of NO+ ions with organic molecules proceed via charge transfer, 
hydride transfer, hydroxide transfer, alkoxide transfer, and ion-molecule association. For 
O2
+ precursor ions, the ionization process mostly proceed either by charge transfer 
reaction or dissociative charge transfer (Smith and Španěl, 2005).  
 
In the downstream quadrupole mass analyzer, different count rates of product ions are 
selected and further detection is achieved in an electron multiplier, for example a 
channeltron.     
 
Satisfactory pressure regimes are obtained throughout the instrument by a two-step 
vacuum. A vacuum pump delivers the preliminary vacuum necessary for the start-up of 
the mass filter, followed by the action of a high-speed pump at the downstream end of 
the flow tube. 
 
Compared to PTR-MS, SIFT-MS is less sensitive due to the existence of a mass filter, which 
selects the precursor ion to be used according to its mass-to-charge ratio, however, 
recent developments have led to improved sensitivity in SIFT-MS (Spesyvyi et al., 2015). A 
uniform electric field has been incorporated along the flow-drift tube to supress ion 
diffusive loss, thus increasing analytical sensitivity, and to allow a smaller, lower speed 
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carrier gas drive pump to be used. The kinetic and internal energies of the ions can be 
altered by changing the E/N value.  
 
2.4.1 Quantitative determination of VOC concentration in SIFT-MS 
Quantitative determination of VOC via SIFT-MS is achieved by means of using an in-built 
kinetics library, where k is determined through Su and Chesnavich (Su and Chesnavich, 
1982) trajectory calculations. Quantification depends on reaction rate coefficient; 
reaction time; temperature; sample flow rate; flow tube pressure; reagent and product 
ion intensity; and mass discrimination (diffusion loss). 
 
 
Equation 2.37 [𝑀] =  
1
𝑡
𝐼𝑝1
𝐷𝑒𝑝1
⁄ +
𝐼𝑝2
𝐷𝑒𝑝2
⁄ +⋯
𝐼𝑖1𝑘1 +
𝐼𝑖2
𝑘1 + 𝑘2
2
𝐷𝑒𝑖2
⁄ +⋯
 
 
k is the rate coefficient for the reaction and t is the reaction time. De is a differential 
diffusion enhancement coefficient that accounts for the fact that the reagent ions and the 
product ions diffuse through the helium carrier gas to the walls of the SIFT-MS flow tube 
at different rates. Mass discrimination occurring in the quadrupole mass analyzer, is 
accounted for to obtain accurate quantitative analyses. Ip1, Ip2, etc. are the count rates 
(corrected for mass discrimination in the quadrupole mass analyzer) for all the product 
ions; Ii1, Ii2, etc. are the count rates (also corrected for mass discrimination) of the 
precursor ions; k1 are the rate coefficients for the reactions of the precursor ions with 
each molecule (M). The rate coefficients k2, etc. are the rate coefficients for the reactions 
of the hydrated precursor ions with each M; Dep1, Dep2, etc. are the respective differential 
diffusion enhancement correction factors (Smith and Španěl, 2005).  
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2. 5 PTR-MS 
 
Proton transfer reaction mass spectrometry (PTR-MS) was developed in the mid-90s by 
Lindinger and co-workers (Lindinger et al., 1998). This technique allows real-time, on-line 
determination of concentrations of VOCs, with detection sensitivity greater than SIFT-MS. 
The first PTR-MS instruments developed only used H3O
+ as precursor ion, a disadvantage 
compared to SIFT-MS. However, the latest instruments use a switchable reagent ion 
capability like SIFT-MS (Jordan et al., 2009a). There are usually overlapping ions in clinical 
sample headspace and the use of PTR-MS equipped with a time-of-flight (TOF) mass 
analyser improves mass resolution to assist ion identification (Herbig et al., 2009, Jordan 
et al., 2009b). 
 
PTR-MS employs an electric field, E, along the drift tube axis to increase the velocities of 
the ions. The change of the ratio E/N, where N is the number density of the drift tube 
buffer gas molecules, will affect the reagent ion hydration and product ion fragmentation. 
Under normal operating conditions E/N is in the range 120–130 Td, representing a 
compromise between reagent ion hydration on the one hand, and molecular (product) 
ion fragmentation on the other. The electric field also prevents the formation of 
substantial quantities of cluster ions. In contrast to SIFT-MS, PTR-MS operates at higher 
effective temperatures and thus the underlying ion chemistry is often not known 
(Beauchamp et al., 2013, Hewitt et al., 2003). The recent advances in PTR-MS technology 
have demonstrated a diverse range of applications, especially for breath gas analysis 
(Herbig and Amann, 2009). 
 
A PTR-MS instrument is often much shorter than a SIFT-MS, due to its shorter drift tube, 
has a typical length being 10 – 20 cm, and, consequently, the pumping system is reduced 
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in size, making PTR-MS suitable for transport and field studies. However, the latest 
advances in SIFT-MS have surpassed this issue, in which the instrument has become much 
smaller and suitable for transport (Španěl and Smith, 2013).  
 
 
 
The measurements discussed in chapter 4 were acquired with a commercial Series I 
PTR-TOF-MS (Kore Technology Ltd.) (Figure 2.5) equipped with an ion funnel, although for 
this study the ion funnel facility was not used. Note that in the schematic representation 
indicated in Figure 2.5 the drift tube is not equipped with an ion funnel, which has been 
added later on. The instrument delivers: mass resolution ≈ 2000-2500 (FWHM), and 
sensitivity for benzene > 200 cps/ppbv. This instrument uses a reflectron TOF-MS, another 
way to improve mass resolution, in which the trajectories of all of the ions are 
deliberately reversed part way along their journey to the detector, as illustrated in Figure 
2.5. The hollow cathode discharge ion source (Figure 2.6) used in PTR-MS is maintained at 
about 1 mbar and consists of two planar electrodes able to produce an electrical 
discharge in a gas. A high voltage is established between the two electrodes, cathode 
negatively charged and anode positively charged. Neutral molecules are ionised by 
collisions with high energy electrons to produce primary ions (Ellis and Mayhew, 2014). 
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Figure 2. 5 – A schematic of the Series I KORE PTR-MS used for this work equipped with a reflectron TOF-MS. Note that in 
this schematic the drift tube is not equipped with an ion funnel (Adapted from Kore Technology). 
 
 
 
 
Figure 2. 6 – A schematic of the Series I KORE PTR-TOF-MS used for this work. Features of the PTR ion source adapted 
with a hollow cathode discharge ion source containing two electrodes, one cathode negatively charged and anode 
positively charged (Adapted from Kore Technology). 
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Other mass analyzers such as quadrupoles create spectra by scanning the allowed mass 
through the mass-range of interest. This is the fundamental reason why a TOF-MS can 
have a very high overall sensitivity compared to other mass analyzers. Not having to scan 
in the conventional sense also means that TOF mass analyzers have no difficulties with 
high mass ions; it is just a matter of waiting for them to arrive.  
 
 
The growing need for analytical methods with great sensitivity in the analysis of VOCs led 
to the development of the PTR-QiTOF (Sulzer et al., 2014), whereas “Qi” stands for 
“Quadrupole interface”. In contrast to commercially available PTR-TOF-MS devices so far, 
which utilize a transfer lens system, the novel prototype is equipped with a quadrupole 
ion guide for the highly effective transfer of ions from the drift tube to the mass 
spectrometer. This innovation in the PTR-MS system greatly improves the TOF mass 
resolution, approximately 10400, because of the encouraging injection conditions.  
Like all chemical ionisation techniques, PTR-MS cannot separate isomers, which usually 
creates difficulties in the qualitative analysis of VOCs. To overcome this downside of PTR-
MS, gas chromatography has been coupled with PTR-MS, but this will greatly reduce the 
time resolution due to the relatively slow transit times of compounds through a GC 
column (Fall et al., 2001, Lindinger et al., 2005). Recent development of fast gas 
chromatography (fastGC) coupled with PTR-MS promises much faster separation 
(Romano et al., 2014, Materić et al., 2015). The capability of fast temperature ramps and 
short/ thin-film capillary columns combined with a fast and sensitive detector may 
provide resolution times of less than 5 minutes. 
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2.5.1 Theoretical determination of VOC concentration in PTR-MS 
In contrast to SIFT-MS in PTR-MS the underlying ion chemistry is often not known, 
specifically, the kinetics of the ion-molecule reactions and reaction time are not well 
established and can be very sensitive to changes in E/N. Thus, careful calibration of the 
instrument is usually carried out for each VOC. Nevertheless, quantification of VOC 
concentrations may be accomplished if the reaction time and proton transfer rate 
coefficients are known (Beauchamp et al., 2013). As PTR-MS is a real time soft ionisation 
technique, such protonated parent ions usually are the main product ions making 
identification much easier than with other analytical techniques. Quantification is directly 
dependent on the proton transfer rate coefficient, therefore it is essential to stress the 
importance of the gas-phase ion chemistry studies on ion-molecule reactions. Theoretical 
determination of VOC concentration via PTR-MS is discussed in chapter 4, where 
standards calibrated for the gas-phase were generated according to Henry´s law and 
theoretical prediction of reaction rate coefficients were determined, and further 
calculation of VOC concentrations derived. 
 
VOC concentration in ppbv is determined according to the following expression: 
 
Equation 2.38 [𝑅] =
[𝑅𝑝𝑝𝑏]
[𝑎𝑖𝑟]
 
where, R is VOC concentration in ppb by volume of air, i.e. ppbv, and the density of air in 
the reaction chamber is given by: 
Equation 2.39 [𝑎𝑖𝑟] =
273.15
𝑇𝑑  [𝐾]
∙
𝑁𝐴
22400
∙
𝑝𝑑 [𝑚𝑏𝑎𝑟]
1013 [𝑚𝑏𝑎𝑟]
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where, pd represents the pressure and Td the temperature in the drift tube, in mbar and K 
respectively. 22400 indicates conversion from mole-volume using Avogadro’s number 
NA = 6.022 × 10
23 cm-3. 
 
Gas-phase ion-molecule reactions occur in the drift tube, according to:  
Equation 2.40 𝐻3𝑂
+ + 𝑅 
𝑘
→  𝑅𝐻+ + 𝐻2𝑂 
A first approximation to determine [R] was given by Lindinger, considering [RH+] << [H3O
+] 
 [H3O
+]0 = constant (Lindinger et al., 1998): 
Equation 2.41 [𝑅𝐻+] = [𝐻3𝑂
+]0(1 − 𝑒
−𝑘[𝑅]𝑡) ≈ [𝐻3𝑂
+]0[𝑅]𝑘𝑡 
 
Theoretical determinations of R expressed in ppbv (Beauchamp et al., 2013), i.e. the VOC 
concentration in PTR-MS, may be accomplished via the following equation (equation 
2.42): 
Equation 2.42 [𝑅] =
1
𝑘𝑡
∙
𝑖(𝑅𝐻+)𝑐𝑝𝑠
𝑖(𝐻3𝑂+)𝑐𝑝𝑠
∙
𝑇𝑑
𝑇0
∙
22400
𝑁𝐴
∙
𝑝0
𝑝𝑑
∙
𝑇𝑟𝐻3𝑂+
𝑇𝑟𝑅𝐻+
 
 
 
 
where, k represents the proton transfer rate coefficient expressed in cm3 s-1 between the 
hydronium ion (H3O
+) and R; t expressed in seconds is the reaction time of the ions in the 
drift tube and is usually fast, typically 100 s, where t = L2/µU and µ0 =  pd T0/Td p0. L is 
the drift tube length in cm; U is the electric potential applied to the drift tube in Volts; µ 
expressed in cm2 s-1 V-1 is the mobility of the H3O
+ in the drift tube which depend on the 
working conditions (pressure and temperature). µ0 represents the reduced ion mobility 
for H3O
+ in air and for this work it has been considered an average value of 2.8 cm2 s-1 V-1. 
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i(RH+)cps stands for the counts per second of detected protonated parent ion and its 
fragments; i(H3O
+)cps is the counts per second of hydronium ion. For highly humid 
samples, a better approximation would consider the presence of H3O
+ water clusters 
[H3O(H2O)n]
+ ions, with  n  = 0, 1, 2 , 3 (the extension of which depends upon reduced 
electric applied). Td and T0 represent the temperature (K) of the drift tube and standard 
temperature (273.15 K), respectively; 22400 indicates conversion from mole-volume 
using Avogadro’s number NA = 6.022 × 10
23 cm-3; p0 and pd represent the standard 
pressure (1013.25 mbar) and the pressure in the drift tube in mbar respectively. Tr terms 
indicate the mass-dependent transmission efficiency of ions into the PTR-TOF-MS 
detection system, where TrH3O+= √ (m/z)H3O+ and TrRH+ = √ (m/z)RH+ (Cappellin et al., 2012).   
 
Depending on the working conditions, the protonated parent ion might undergo 
fragmentation and the contribution of all fragment ions must be taken into account 
(equation 2.43):   
 
Equation 2.43 [𝑅]𝑡𝑜𝑡𝑎𝑙 = [𝑅] +∑
1
𝑘𝑡
𝑖
 ∙
𝑖(𝑅𝐻𝑖
+)𝑐𝑝𝑠
𝑖(𝐻3𝑂+)𝑐𝑝𝑠
∙
𝑇𝑑
𝑇0
∙
22400
𝑁𝐴
∙
𝑝0
𝑝𝑑
∙
𝑇𝑟𝐻3𝑂+
𝑇𝑟𝑅𝐻𝑖
+
 
 
 
 
2. 6 Gas chromatography-mass spectrometry combined with thermal desorption  
 
Gas chromatography coupled with a mass spectrometer allows qualitative and 
quantitative analysis of complex mixtures of VOCs at trace concentration. This 
hyphenated technique uses a mass spectrometer as the GC detector to identify and 
quantify unknown samples. Isomers are therefore easier to identify due to the separation 
of compounds achieved in the column, an advantage compared to the common mass 
spectrometric techniques which usually deliver overlapping peaks in clinical samples. 
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Usually, the concentration of the VOC of interest is too low for the direct measurement of 
an air sample, and therefore enrichment on suitable adsorbents is necessary.  
 
Gas chromatography-mass spectrometry (GC-MS) combined with thermal desorption (TD) 
(Figure 2.7), or solid-phase micro extraction (SPME) has been widely used for trace gas 
analysis though it has some limitations. For example, pre-concentration of the sample is 
required prior to analysis through pumping significant volumes of trace gases samples 
onto adsorption traps; VOCs with low molecular weight can be difficult to accurately 
quantify; it is time consuming; it is not a real-time monitoring technique; GC-MS requires 
calibration for each trace gas; and some compounds are separated better than others. 
Thermal desorption (TD) relies on the use of heat, up to 350 °C, to directly extract 
analytes from sample and swept onto GC column, with no chemical bonds broken. 
Nevertheless, TD-GC-MS was used to test all the volatile samples analysed in this thesis. 
 
 
Figure 2. 7 – A schematic representation of a thermal desorption GC-MS system (Adapted from Poole, 2012). 
 
Electron ionization is often used in a GC-MS system, producing positively charged ions, in 
conjunction with a mass analyzer (e.g. quadrupole or TOF) allowing separation of 
compounds according to their mass-to-charge (m/z) ratio and further detected. If 
electron ionization is being used, a spectrum of the analyte can usually be found in the 
NIST Mass Spectral Database.  
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2.6.1 Calibration with internal standards 
Thermal desorption procedures are generally calibrated using internal standard methods, 
such as internal standard addition using deuterated toluene or bromofluorobenzene. 
Calibration is accomplished by loading standards onto sample tubes and desorbing them 
through the two-stage thermal desorption process. Standard solutions are prepared and 
small volumes (typically 0.2 - 2 µL) loaded into each TD tube individually (Poole, 2012). 
Markes’ Calibration Solution Loading Rig (CSLR™) (Figure 2.8) was specifically designed for 
this purpose.  
 
Figure 2. 8 – Calibration Solution Loading Rig (CSLR™), Markes International Ltd (MARKES, 2014). 
 
 
The CSLR™ setup consists of an injection port with a controlled carrier gas supply and a 
sorbent tube connection. The sampling end (grooved end) of the sorbent tube is 
connected to the back side of the port. The carrier gas flow (typically 99.999% purity 
nitrogen or helium) is set with a needle valve to 50 – 100 mL min-1 (MARKES, 2014). The 
standard solution or gas standard is introduced through the injector septum using an 
appropriate precision syringe. Liquid standards of VOCs vaporise in the flow of gas, 
allowing the solvent (methanol) and analytes to reach the sorbent bed in the vapour 
phase.  
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2.6.2 Desorption of VOCs from TD tubes 
The VOC mixture initially adsorbed onto the sorbent surface is then heated and back 
flushed with the carrier gas (helium); the compounds are released from the sorbent into 
the cold trap, which is usually maintained at -7 C; the sample is transferred to the GC 
column by rapidly heating the cold trap and back flushed with helium; following trap 
desorption the trap is cooled down prior to the next desorption. Thermal desorption is 
usually carried out automatically by means of using a TD autosampler (Figure 2.9) 
connected to a thermal desorption unity.  
 
 
 
Figure 2. 9 – ULTRA™ thermal desorption autosampler, MARKES International. 
 
 
Split/splitless injections may be used, particularly for highly concentrated samples which 
the split injection is recommended. However, split injection is not useful for trace gas 
analysis. 
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2.6.3 Chromatographic separation 
Chromatography is a physical separation process, where VOCs undergo separation along 
the GC column according to their relative affinity for the stationary phase of the column. 
The strength of the analyte-stationary phase; the vapour pressure, and the relative 
polarity of the analyte determine the order of elution of the VOCs. The lower the boiling 
point is, the higher the vapour pressure of the compound and the shorter retention time 
usually is, i.e. VOCs with higher vapour pressure, elute faster. If the polarity of the 
stationary phase and compound are similar, the retention time increases because the 
compounds are more strongly adsorbed and take longer to migrate through the column.  
 
Chromatographic analysis with GC-MS generally uses fused silica capillary columns, liquid 
phase coated with the stationary phase, called Wall Coated Open Tube (WCOT) column 
(Sparkman et al., 2011). The stationary phase of these columns is generally constituted of 
siloxane based polymers or polyethylene glycol (PEG).  
The complex chemical diversity of VOCs in clinical samples requires the use of longer GC 
columns, typically a column length of 60 metres, improving separation of analytes along 
the column. These chemical characteristics make column selectivity, thermal stability, and 
inertness critical to resolving volatiles. Rxi®-624Sil MS columns offer reliable resolution of 
VOCs and also provide lower bleed and greater inertness than other columns. Column 
specifications, such as the column internal diameter, improves the separation of analytes 
and reduces the analysis time, but on the other hand reduces the column capacity. As 
regards to film thickness, increasing the film thickness improves separation of analytes, 
however it also increases the run time. 
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The GC column is kept in a heated oven. The separation of VOCs of different volatilities 
requires the use of temperature ramps, allowing the separation of compounds at 
different retention times. Whenever possible low bleed columns should be used, 
nevertheless, high oven temperatures operated over a long period may lead to the 
thermal decomposition of the column and consequently, column bleeding products will 
be detected and possibly will stain the ion source. Typically, the column bleed 
incorporates phenyl or phenyl-type group into siloxane polymer backbone structure, and 
m/z 207 is commonly known as column bleed product.  
 
The carrier gas flow rate has a significant impact on the resolution. Apart from hydrogen, 
helium provides the best resolution for higher flow rates, improving the resolving power 
and shorter run times. 
 
2. 7 Biomarkers vs. Biomarker Profiles  
The complex relationships between a number of different compounds and the presence 
or absence of a disease or condition indicates that perhaps volatile biomarkers profiling 
with bioinformatics is a more promising approach. A specific breath marker related to a 
specific disease is the ideal. However, this is unlikely to be the case for the majority of 
diseases or conditions, where it is more probable that a range of VOCs with varying 
concentrations will have to be used. By adopting a strategy of identifying patterns, rather 
than trying to identify individual VOCs, “breath fingerprinting” could provide a suitable 
and reliable method for discriminating between healthy and diseased states. This 
approach requires elaborate methods of data analysis, pattern recognition techniques, 
such as principal component analysis (PCA) and partial least squares discriminant analysis 
(PLSDA). Principal component analysis is a mathematical algorithm that reduces the 
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dimensionality of the data. It accomplishes this reduction by identifying directions, called 
principal components, in which the variation in the data is maximal. Samples can be 
plotted, and visually assess similarities and differences between samples, and determined 
whether samples can be grouped. Other multivariate methods also exist, such as PLSDA, 
or support vector machines (SVMs). All of these methods use whole profiles, and yet it is 
possible to identify individual components (e.g., compounds or ions), which are most 
responsible for the differences observed between groups (e.g., groups of samples positive 
or negative for a disease). Thus, “biomarkers” (which are not usually unique) may be 
identified in this way. Cross validation of the models is used to predict the classification 
capabilities on unknown objects. Hence, if there is a good correlation between the 
predicted and actual values this means that the model fits.  
In clinical practice, biomarkers such as genes and proteins are identified and quantified in 
order to track the biochemistry within the body for a specific disease. However, clear 
quantification of VOCs is a harder job due to the difficulties in finding the biochemical 
pathways in the body for each metabolite. This will involve a close collaboration between 
clinicians and analytical chemists. The need to understand the relationships between 
many variables makes multivariate analysis an inherently difficult subject. It is important 
to note that when the number of variables quickly overwhelms the number of samples, 
spurious correlations may be found (Miekisch et al., 2012). Confounding variables may 
lead to wrong conclusions. Confounding variables comprise environmental compounds, 
physiological parameters and even the sampling procedures (Miekisch et al., 2012). The 
statistical technique used to control the influence of confounding variables is called 
Analysis of covariance (ANCOVA). Classification of the subjects into groups is achieved by 
discriminant analysis, cluster analysis, and propensity score analysis. Clustering attempts 
to find similarities among the subjects that were measured instead of among the 
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measures that were made. For multiple dependent variables, in which two or more 
dependent variables are included, multivariate analysis of variance (MANOVA) and 
canonical correlation analysis are applied. Recently, Halbritter and co-workers (Halbritter 
et al., 2012) used the MANOVA technique to discriminate according to whether the 
pregnant women had gestational diabetes mellitus, impaired glucose tolerance, or 
normal glucose tolerance, by means of analysing the women´s breath by PTR-MS and 
correlating it with the oral glucose tolerance test. 
The success of proper statistical analysis is to have a good statistical validation, as well as 
trustworthy biological interpretation of the results. 
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Chapter 3 
 
Materials and analytical/statistical methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
106 
 
3. 1 A potential method for comparing instrumental analysis of breath gas volatile 
organic compounds using standards calibrated for the gas phase 
 
Chapter 4 discusses a potential method for comparing instrumental analysis of breath gas 
volatile organic compounds found in breath using standards calibrated in the gas phase. 
Standards calibrated for the gas-phase were generated according to Henry´s law (see 
below), and these were analysed via Selected Ion Flow Tube Mass Spectrometry (SIFT-
MS), Proton Transfer Reaction Mass Spectrometry (PTR-MS) and Gas Chromatography-
Mass Spectrometry combined with thermal desorption (TD-GC-MS). Analysis by SIFT-MS 
and TD-GC-MS was carried out at The Open University (OU) and the solutions for PTR-MS 
headspace were transported from the OU to University of Birmingham in DURAN® glass 
bottles, so the same solution could be used for SIFT-MS and PTR-MS. 
 
3.1.1 Samples 
Accurate creation of partial pressures of volatile compounds in the headspace is an 
essential requirement for a correct determination of VOC concentration. Thus, this 
requires an understanding of liquid-phase/gas-phase equilibrium, commonly known as 
Henry’s law.  The Henry’s coefficient, kH, relates the concentration of the compound in a 
dilute aqueous solution and its headspace partial pressure so that at a constant 
temperature, the molar concentration of the compound in the liquid is directly 
proportional to its vapour pressure in the gas phase. Moreover, Henry’s constant is 
temperature dependent, typically increasing with temperature at low temperatures 
(Smith and Harvey, 2007). To calculate Henry’s law coefficients via this method the 
following equation (equation 3.1) is applied:  
Equation 3.1                                              
𝑘𝐻 = 𝑘𝐻
°  × 𝑒𝑥𝑝 (
−∆𝑣𝑎𝑝𝐻
𝑅
(
1
𝑇
 – 
1
𝑇°
)) 
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A correction can be made according to temperature (equation 3.2): 
Equation 3.2                                                 𝑑𝑙𝑛𝑘𝐻
𝑑(1 𝑇⁄ )
=  
−∆𝑣𝑎𝑝𝐻
𝑅
 
 
 
 
Here, k˚H represents the Henry's law constant for solubility in water at 298.15 K; -∆vap H/R 
is the temperature dependence parameter; T˚ is the standard temperature of 298.15 K; 
and T is the actual temperature. In this work, the values k˚H and dlnkH/d(1⁄T) are 
tabulated in Table 3.1. 
Standard aqueous solutions of six VOCs acetone, ethanol, methanol, 1-propanol, 
2-propanol and acetaldehyde (which are physiologically important and present in human 
breath), were created to produce headspaces containing known concentrations of these 
compounds in the vapour phase, as calculated using the measured temperature and 
Henry’s law coefficient (kH) (Table 3.1). Mean values were calculated for k°H and vapH/R 
and these values were empirically determined (Sander, 1999). 
 
Table 3. 1 –  Henry’s law constants at 298 K (k°H), vapH/ R values in K and the derived Henry’s law constants at 293 K 
for acetone, ethanol, methanol, 1-propanol, 2-propanol, acetaldehyde in aqueous solution. Mean values are given for 
k°H and vapH/ R. 
 k°H [(mol dm
-3
) atm
-1
] 298 K 
a
 vapH/ R [K] 
a
 kH [(mol dm
-3
) atm
-1
] 293 K 
Acetone 30.0 4600 39.0 
Ethanol 184.4 6500 267.5 
Methanol 203.8 5400 277.5 
1-propanol 138.0 7500 211.9 
2-propanol 127.0 7500 195.0 
Acetaldehyde 12.9 5371 17.5 
a
 Reference (Sander, 1999) 
 
Henry’s law coefficients (kH) at 293 K were calculated for each VOC according to 
equations 3.1 and 3.2. In general, the higher the partial pressure of a species in the 
gas-phase under equilibrium conditions, the lower the Henry’s law coefficient (kH), since 
the aqueous-phase/gas-phase equilibrium is defined as KH = Ca/pg, where Ca is 
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aqueous-phase concentration of a particular species, and pg is the partial pressure of that 
species in the gas phase (Sander, 1999).   
 
Aqueous solutions were prepared using accurate micropipettes and calibrated for the 
headspace (10 ppm) at 293 K. Individual one litre solutions (10 ppm) were prepared as 
follows: 29 µL acetone, 156 µL ethanol, 112 µL methanol, 158 µL 1-propanol and 149 µL 
2-propanol were added to individual clean glass bottles respectively, and the final volume 
(one litre) adjusted with purified (deionised) water. These solutions were used to provide 
more dilute solutions. Diluted solutions were prepared individually, the volumes 250 mL, 
50 mL and 5 mL were added to 500 mL glass bottles to provide more dilute solutions that 
were expected to give headspace concentrations of 5 ppm, 1 ppm and 0.1 ppm 
respectively. The 500 mL volume was adjusted using purified (deionised) water. A more 
concentrated solution of acetaldehyde (1000 ppm) was prepared, where 1000 µL of 
acetaldehyde were added to a clean glass bottle containing 1 litre of purified (deionised) 
water. This concentrated solution (1000 ppm) was used to provide more dilute solutions 
of acetaldehyde. Diluted solutions were prepared individually, the volumes 5000 µL, 2500 
µL, 500 µL and 50 µL were added to 500 mL glass bottles to provide more dilute solutions 
that were expected to give headspace concentrations of 10 ppm, 5 ppm, 1 ppm and 
0.1 ppm respectively.      
 
The reproducibility of standard generation was determined by preparing five solutions of 
2-propanol 10 ppm in the headspace, and these solutions were analysed via SIFT-MS. 
Thus, the standards were prepared with a coefficient of variation determined at 6%. The 
coefficient of variation is defined as the ratio of the standard deviation to the mean.  
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For the analysis by SIFT-MS, the calibration standards were placed (5 mL of each), 
individually, inside a 40 cm long Nalophan sampling bag, made up of 65 mm diameter 
Nalophan NA tubing 25 µm thick (Kalle UK). Regarding the analysis by PTR-MS, the same 
procedure was used, although, in this case the sample was placed inside a 45 cm long 
Nalophan sampling bag, made up of 135 mm diameter Nalophan NA tubing, 25 µm thick 
(Kalle UK). All the sample bags were sealed and filled with hydrocarbon free air (Air 
Products) to generate the VOC headspace, or N2 (BOC Gases, UK) for the PTR-MS 
measurements respectively. 
The headspaces were allowed to equilibrate at ambient temperature (where the 
temperature was carefully measured and recorded for applying enthalpy correction) for 
15 minutes after which the sampling bags were tested via SIFT-MS, in the case of PTR-MS 
sampling took place after 60 minutes. These differences are due to the equilibration time 
depending on the size of the bag, thus there is the need to guarantee that VOC are in 
equilibrium in the gas-phase, and will produce the accurate headspace concentration no 
matter the size of the bag. Therefore every headspace profile were tracked using the 
multiple ion monitoring (MIM) mode capability of SIFT-MS to ensure equilibrium in the 
gas phase. In the PTR-MS instrument a sample bag was tracked over time and its 
concentration reached equilibrium at 60 minutes. The reproducibility of the sampling 
procedure was evaluated by preparing five sampling bags (40 cm long Nalophan sampling 
bag, made up of 65 mm diameter Nalophan NA tubing 25 µm thick) containing 5 mL of 
the same solution (2-propanol 10 ppm in the headspace) calibrated for the headspace. 
Thus, the reproducibility of the sampling procedure was determined by determining the 
coefficient of variation which in this case was 3%.  
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For GC-MS analysis the VOCs were pumped for 5 min at a constant flow of 100 mL min-1 
into pre-conditioned stainless-steel TD sorbent tubes, according to the detailed 
description given in section 3.1.4. VOC mixtures were prepared according to Henry´s law 
in the same manner. The chemicals were mixed to give solutions of approximately 
(although accurately calculated) 0.1 ppm, 1 ppm, 5 ppm and 10 ppm. Then 5 mL of each 
was placed in 40 cm long Nalophan sampling bags. The bags were sealed and filled with 
hydrocarbon free air (Air Products) and the generated headspaces were left to equilibrate 
for 15 minutes. Aqueous liquid headspace sampling was performed using SIFT-MS, PTR-
TOF-MS and TD-GC-MS.  
All the chemicals used in this study were purchased from Sigma-Aldrich (purities ≥ 99%) 
and all were used without any further purification. 
 
 
3.1.2 SIFT-MS 
 
Data were collected using the Mk2 instrument (PDZ Europa, UK) with a flow rate 
corresponding to a pressure of 0.008 Torr. The sample bags were attached to a heated 
capillary and further analysed. Full spectra of the count rates at each m/z value in the 
range m/z 10 to m/z 140 were recorded for all the samples via the precursor ion H3O
+, 
using the full scan mode and a total sample time of 30 seconds. The liquid-phase/gas-
phase equilibrium was confirmed for each sample by means of using the multiple ion 
mode (MIM). Concentrations of the volatiles were automatically determined under 
thermal conditions using an on-line kinetics database containing reaction rate 
coefficients, developed from numerous detailed selected ion flow tube studies of various 
classes of compounds (alcohols, aldehydes, ketones, hydrocarbons, etc.) with the three 
precursor ions (Smith and Španěl, 1996b). Background laboratory air was also analysed.   
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3.1.3 PTR-MS 
 
Measurements were performed with a commercial PTR-TOF-MS (Kore Technology 
Limited) equipped with an ion funnel, although for this study the ion funnel facility was 
not used. The drift tube length is 9.04 cm. This instrument is particularly suited for 
reactions between the precursor ion H3O
+ and gas samples. The drift tube working 
conditions (pressure and reduced electric field) were set to deliver the highest signal of 
protonated product ion while the drift tube temperature (373.15 K) was kept constant 
over the experiments. The drift chamber parameter settings (voltage, pressure and E/N, 
where E is the electric field strength and N is gas number density in the reaction chamber; 
Td = Townsend, where 1 Td = 10-17 cm2 V) are listed in Table 3.2. 
 
Table 3. 2 – Ionization conditions in the drift tube of PTR-TOF-MS. 
VOC Drift voltage (V) Drift pressure (mbar) E/N (Td) 
Acetone 366 1.30 125 
Ethanol 230 1.31 99 
Methanol 380 1.37 125 
1-propanol 285 1.38 94 
2-propanol 209 1.31 90 
Acetaldehyde 370 1.31 160 
 
 
Mass spectra were typically collected in the range m/z 20 to m/z 250 with an integration 
time of 1 minute. Background laboratory air was also analysed. The concentrations of the 
volatiles were determined through the theoretical prediction of reaction rate coefficients. 
 
3.1.4 TD-GC-MS 
 
After headspace analysis by SIFT-MS, VOCs were pumped into pre-conditioned stainless-
steel TD sorbent tubes for 5 minutes at a constant flow of 100 mL min-1 (Pump TSI Inc. 
SidePak Model SP730). These tubes had dual packing comprising of 50% Tenax and 50% 
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Carbotrap (Markes International Limited).  Prior to analysis, the tubes were spiked with 
1 µL of internal standard, d8-toluene in methanol, and were then flushed with nitrogen 
for 30 seconds. The same protocol was used for the analysis of breath- and skin VOCs 
trapped in TD tubes.  All samples were analysed in random order according to the method 
described below. 
Chromatographic analyses were performed using an Agilent 6890/5973 GC-MS system 
(Figure 3.1) equipped with a Markes TD autosampler, and Markes UNITY thermal 
desorber. The tubes were submitted to a pre-purge of 1.0 minute, followed by desorption 
at 260 °C for 3.0 minutes. The trap temperature was set at -7 °C and the actual trap 
desorption occurred at 300 °C for 3.0 minutes. The volatiles of interest were separated 
using a Restek column (60 m × 0.32 mm, film thickness 1.8 µm) working in a constant flow 
mode (helium at 30.8 mL min-1). The column temperature program involved an initial 
increase from 35 °C to 60 °C at a rate of 11 °C min-1, followed by a rate of 20 °C min-1 up 
to 220 °C, and a constant temperature of 220 °C for 10 minutes. The mass spectrometer 
was operated in a SCAN mode with an associated m/z range set from 33.0 to 260.0. The 
quadrupole, ion source, and transfer line temperature were kept at 150 °C, 230 °C and 
230 °C, respectively. 
 
 
Figure 3. 1 – Mk2 instrument SIFT-MS (PDZ Europa, UK) and Agilent 6890/5973 GC-MS system equipped with a Markes 
TD autosampler, and Markes UNITY thermal desorber.   
 
113 
 
 
3.1.5 Data processing 
 
Prior to data analysis, the counts per second acquired by SIFT-MS were normalised 
against the counts per second of the H3O
+ (m/z 19) precursor ion. A high counts per 
second (≤ 107 cps) for H3O
+ at m/z 19 occurs using PTR-MS, therefore detector saturation 
follows. For this reason, the isotope of oxygen, 18O, is commonly used i.e. the, count rates 
of H3
18O+ at m/z 21 were measured to assess the counts per second of H3O
+. The natural 
abundance of 18O relative to 16O is approximately 1:500, thus count rates at m/z 21 were 
multiplied by 500 to obtain the actual count rates for H3O
+. Cluster ions [H3O
+(H2O)n, n = 
1, 2] at m/z 37 and m/z 55 were taken into account in the determination of H3O
+ count 
rates. PTR-MS counts per second have been normalised to a H3O
+ signal of one million 
counts per second, i.e. ncps = 106 × i(MH+)/i(H3O
+), where MH+ is the protonated parent 
ion.   
 
Using the internal standard approach via GC-MS, the determination of VOC concentration 
expressed in ng L-1 was achieved by means of the following equation (equation 3.3):  
 
Equation 3.3 
𝐶 =  
𝑎𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 (%)𝑉𝑂𝐶
𝑎𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒 (%)𝑑8−𝑡𝑜𝑙𝑢𝑒𝑛𝑒
 × 50 𝑛𝑔 ×
1000 𝑚𝑙
100 𝑚𝑙 𝑚𝑖𝑛−1 × 5 𝑚𝑖𝑛 × 1 𝐿
 
 
  
where, the VOC concentration (C) is expressed in ng L-1 and the concentration expressed 
in ppbv was calculated; relative abundances of VOC and d8-toluene are expressed in 
percentage (%); 50 ng represents the mass of d8-toluene used to prepare the standard; 
with representative VOCs being pumped into sorbent tubes for 5 minutes at a constant 
flow of 100 mL min-1. 
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GC-MS data analysis was performed through the aid of AMDIS (Automated Mass Spectral 
Deconvolution and Identification System) software, and followed by reliable identification 
of compounds using the NIST (National Institute of Standards and Technology) library. 
 
3.1.6 Product ions and branching ratios 
 
All of the analytes in this study have higher proton affinities than H2O (691.0 kJ mol
-1) 
(Linstrom and Mallard, December 2013), and so rapid proton transfer occurs in each case. 
The low molecular weight alcohols have a proton affinity range of 754.3–793.0 kJ mol-1 
(Linstrom and Mallard, December 2013). Acetaldehyde proton affinity is 768.5 kJ mol-1 
(Linstrom and Mallard, December 2013), while for acetone it is 812.0 kJ mol-1 (Linstrom 
and Mallard, December 2013). In this study proton transfer from H3O
+ to VOCs has been 
investigated with the product ions and their associated branching ratios being identified 
in chapter 4 (Table 4.1). The standard aqueous solutions prepared are highly humid as 
would be expected if aqueous solutions are present with a small enclosed headspace, 
such as a sample bag. Therefore, cluster  ions  [e.g., H3O
+(H2O)n, n = 1, 2, 3] can form from 
the precursor ions and these cluster ions can also act as precursor ions and lead to 
hydrated product ions RH+(H2O)n, n = 1, 2, 3 (Španěl and Smith, 2000a). These hydrated 
product ions must be taken into account when determining VOC concentrations. 
Accordingly, and as expected, the SIFT-MS instrument yielded much higher abundances of 
cluster ions compared to PTR-MS since the average kinetic energy of the ions are elevated 
above thermal in PTR-MS over the entire length of the drift tube, consequently, cluster 
ion formation is effectively prevented. Due to the absence of an electric field in SIFT-MS it 
is therefore possible to carry out ion-molecule reactions under thermal conditions, where 
the kinetic behaviour is well known, and less fragmentation of product ions occurs. The 
fragmentation patterns observed at specific E/N are further described below in chapter 4.  
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Our findings indicated that quantification via PTR-MS is sensitive to alterations in the 
reduced electric field (i.e. changes in the E/N ratio), therefore, the drift tube working 
conditions (pressure and reduced electric field) were set to deliver the highest signal of 
protonated product ion, and this was found to deliver the best approximation to the 
actual gas-phase concentration inside the Nalophan bag.  
 
Product ions and branching ratios found in literature for the VOCs in study now follows. 
 
Methanol: This common breath metabolite methanol has been thoroughly studied using 
SIFT-MS and PTR-MS (Španěl and Smith, 1997, Brown et al., 2010). Our results are in 
agreement with earlier measurements, where non-dissociative proton transfer 
predominantly occurs either for SIFT-MS and PTR-MS. The reaction by SIFT-MS yielded 
protonated methanol ROH2
+ (41%) at m/z 33 and the water-cluster ions ROH2
+(H2O)1,2. 
The reaction at an E/N of 125 Td for PTR-MS mainly yielded the protonated ion at m/z 33 
and clustering of the protonated methanol ROH2
+·H2O at m/z 51.   
 
Acetaldehyde: Saturated aldehyde reactions with H3O
+ have been previously studied by 
SIFT-MS, where only non-dissociative proton transfer is seen (m/z 45) for acetaldehyde 
reactions (Španěl et al., 1997, Mochalski et al., 2014b). Cluster ions ROH+(H2O)1,2 are also 
observed. At 300 K there is an increasing tendency to eject water molecules for C4 and 
higher species (Španěl et al., 1997). Recently, product ion distributions for the reactions 
of NO+ with twenty two aldehydes under dry and humid conditions were carried out using 
a selective reagent ionisation time-of-flight mass spectrometer (SRI-TOF-MS) at a specific 
E/N of 130 Td (Mochalski et al., 2014b). However ion chemistry studies on H3O
+–
acetaldehyde reactions by PTR-MS have not yet been exhaustively studied.  
116 
 
In this work, analysis of acetaldehyde was carried out at E/N of 160 Td, where 
non-dissociative proton transfer is seen, yielding m/z 45 as the major product ion, with 
additional clustering of the protonated ion to produce ROH+·H2O at m/z 63. In another 
research group was found that H3O
+-acetaldehyde studied at E/N of 112 Td, produces 
only the protonated ROH+ plus H2O (Jordan et al., 2009a).     
 
Ethanol: Similarly to methanol, the reaction of ethanol through SIFT-MS yielded the 
protonated ion ROH2
+ at m/z 47 and was observed an additional clustering of the 
protonated ethanol monomer species to H2O to produce ROH2
+(H2O)1,2, which is in 
agreement with earlier studies developed by Španěl et al. (Španěl and Smith, 1997). For 
our measurements with PTR-MS, an E/N of 99 Td was used and the reaction yielded 
ROH2
+ at m/z 47 as the major product ion, and additional clustering of the protonated ion 
to produce ROH2
+·H2O at m/z 65. Our findings are in agreement with the measurements 
of Brown et al. for a low E/N, where we observed traces of the fragment ion at m/z 45 
(C2H5O
+) corresponding to a loss of H2 (Brown et al., 2010).  
 
Acetone reacts by non-dissociative proton transfer to produce a single protonated 
product ion ROH+ at m/z 59 either by SIFT-MS and PTR-MS. An additional water-cluster 
ion ROH+·H2O at m/z 77 is yielded in the flow tube of SIFT-MS (Španěl et al., 1997).  
    
1-Propanol and 2-Propanol: The branching ratios for such isomers have been thoroughly 
studied by Warneke et al. who determined that the proton transfer between H3O
+ and a 
VOC is non-dissociative (Warneke et al., 1996).  
The isomeric compounds 1-propanol and 2-propanol show a similar behaviour via SIFT-
MS and PTR-MS. In earlier findings in PTR-MS, it was shown the loss of water from the 
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protonated alcohol is predominant and, consequently, breaking up to m/z 43 (C3H7
+) 
(Brown et al., 2010, Španěl and Smith, 1997). These isomers showed a similar 
fragmentation pattern for a low E/N (Brown et al., 2010). Both yield a major fragment ion 
at m/z 43 (C3H7
+), except for the fragment ion at m/z 59 (C3H7O
+) which in particular is 
observed for 2-propanol but not from 1-propanol. The fragment ion at m/z 59 originates 
through the loss of H2 from the protonated 2-propanol (Brown et al., 2010).  
 
3. 2 Analysis of VOC profile in faecal headspace, and exhaled breath and skin from 
type-2 diabetic mice  
 
This section concerns the study of volatile organic compounds (VOCs) coming from 
different mice models for type 2 diabetes. Two different studies were carried out, a 
longitudinal study of the VOC profile emitted by the faecal headspace of Cushing´s 
syndrome mouse model of type 2 diabetes, and a longitudinal study of the VOC profile 
emitted by the faecal headspace of single Afmid knockout mice exhibiting impaired 
glucose tolerance. Faecal headspace was analysed by SIFT-MS and TD-GC-MS and related 
to changes in blood glucose in type 2 diabetes (T2D) and impaired glucose tolerance 
respectively. A cohort of 65 Cushing´s mice (21 male and 44 female) were bred, and a 
cohort of 48 Afmid animals (24 male and 24 female) were bred.  
Faecal samples and breath samples were collected by myself at the Mary Lyon Centre 
(Harwell, UK) as well as blood glucose analysis was performed by myself at the Mary Lyon 
Centre. ELISA (Enzyme-Linked Immunosorbent Assay) measurements were performed 
either by Dr Liz Bentley or Dr Marianne Yon at the Mary Lyon Centre. Faecal samples were 
then transported to The Open University (OU) in dry ice and kept at -80 ˚C until further 
analysis. Data were acquired using SIFT-MS and TD-GC-MS at OU through the use of the 
protocols described in section 3.1.4 and 3.2.6.  
118 
 
All animal studies were carried out using guidelines issued by the United Kingdom (UK) 
Medical Research Council (MRC), in Responsibility in use of Animals for Medical Research 
(July 1993) and Home Office Project License number 30/3146. All animal studies were 
carried out at the Mary Lyon Centre (Harwell, UK).   
Mice (Cushing’s mice, Afmid mice and wild-type littermates) were maintained in 
controlled light (12 h light and dark cycle), temperature (21  2 ˚C) and humidity (55  
10%). Mice had free access to water (10–12 ppm chlorine) and were fed ad libitum on a 
commercial diet (5.3% fat [corn oil], 21.2% protein, 57.4% carbohydrate, 4.6% fibre; Rat 
and Mouse Diet No. 3 (RM3), Special Diet Services, Essex, UK). All mice were housed in 
groups of 2–5 mice. 
 
Data processing: Prior to statistical analysis, the intensity of m/z values (SIFT-MS) within 
the data were normalised against the intensity values of the H3O
+ (m/z 19) precursor ions. 
All m/z values were included in the statistical analysis for H3O
+ precursor ion. The known 
adduct ions, m/z values: 19, 21, 30, 32, 34, 37, 39, 48, 55, 57, 66, 73, 75, and 91, were 
included for all data sets (H3O
+, NO+ and O2
+). In this study assessing the faecal headspace 
levels, 18 animals (Cushing´s mice) have been removed from the SIFT-MS NO+ data set 
obtained at 12 weeks due to a read fault on the SIFT-MS software. Whereas, 18 animals 
(Cushing´s mice) have been removed from the SIFT-MS O2
+ data set obtained at 12 weeks 
due to the same issue. Only one animal was removed from the SIFT-MS O2
+ data set for 
Cushing´s mice at 16 weeks of age.    
GC-MS data analysis was performed according to the detailed description given in 3.1.5. 
The statistical analysis presented here was performed using the software IBM SPSS 
Statistics 21.0. 
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Three mice models were used in this study: Cushing’s mice, Afmid mice and wild-type 
littermates. Details of these are given below. 
 
3.2.1 Mouse model of Cushing´s Syndrome 
These mice were produced through the use of ENU mutagenesis described in chapter 1.  
 
Breeding strategy: Male Heterozygous Crh -120/+ mice on a B6-C3PDE F1 background were 
backcrossed to B6-C3PDE F1 female wild-type mice to produce progeny which were 
screened for phenotypes and classified as mutant (het) mice and wild-type (WT) mice. A 
cohort of 65 animals (21 male and 44 female) was used of whom 30 were genotyped as 
mutants and 35 WT littermates (Aigner et al., 2008). Mapping and sequencing (Aigner et 
al., 2008) was performed at Mary Lyon Centre.  
 
 
 
3.2.2 Single Afmid knockout mice 
These mice were produced through gene knockout described in chapter 1 (Liu et al., 
2003). 
Breeding strategy: Wild-type (Afmid+/+) and knockout (Afmidtm1b/tm1b) mice on a 
C57BL6/NTac background were generated by inter-crossing Afmidtm1b/+ mice. A cohort of 
48 animals (24 male and 24 female) were bred of whom 30 were genotyped as 
mutants (hom) and 18 WT littermates. It has been found that mice homozygous (hom) for 
the tm1b deleted allele have impaired glucose tolerance (Hugill et al., 2015). 
 
3.2.3 Metabolic cages 
 
Stool samples were collected from each mouse at various times for analysis of volatile 
organic compounds (VOCs). Animals were individually housed in metabolic cages 
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(Techniplast Kettering, UK) (Figure 3.2) for 30 minutes or until sufficient gathering of 
stool, i.e. six pellets per animal. The mice were fed ad libitum on water (10–12 ppm 
chlorine) and powdered chow (RM3, Special Diet Services Essex, UK). Autoclavable red 
transparent igloos (Datesand Ltd, Manchester, UK) were provided as environmental 
enrichment. Faecal samples were collected into Eppendorf containers, and these were 
immediately frozen at -20 °C.  
Cushing´s mice were tracked over 4 months, thus, samples were collected at 8, 12, 16 and 
20 weeks of age respectively. Afmid mice were tracked over 3 months, therefore, samples 
were collected at 8, 12 and 16 weeks of age respectively. 
 
Figure 3. 2 – Metabolic cage Techniplast Kettering, UK (Adapted from TECNIPLAST). 
 
 
3.2.4 Blood and plasma biochemistry 
Animal weight was recorded prior to analysis and over the duration of the study. Blood 
samples were taken on the same days as faecal samples and were taken from the lateral 
tail vein following application of topical local anaesthesia (EMLA cream) leaving it to work 
for 15 minutes, and while mice were restrained in a Perspex bleeding tube. Blood glucose 
levels were measured at the same period of the day, specifically between 2 pm and 4 pm, 
using an AlphaTRAK2 blood glucose meter. Cushing´s mice blood glucose was measured 
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over 4 months, i.e. at 8, 12, 16 and 20 weeks old. Afmid mice blood glucose was 
measured over 3 months, i.e. at 8, 12 and 16 weeks of age.  
In order to evaluate the insulin levels in mice, plasma concentrations in blood were 
measured after terminal bleeding of Afmid and Cushing´s mice. An ELISA kit (Cat no. 
EZRMI-13K) was used and the range of the assay set between 0 and 15 ng mL-1. ELISA 
measurements were performed either by Dr Liz Bentley or Dr Marianne Yon at the Mary 
Lyon Centre (Harwell, UK). Detailed information may be found in the Appendices.   
 
3.2.5 Offline breath- and skin analysis in unrestrained mice 
Offline breath analysis from unrestrained Cushing´s mice was also attempted and VOCs 
coming from breath/skin were trapped in TD tubes and further analysed by SIFT-MS and 
TD-GC-MS. However, the experiments did not work out as we expected and no results are 
presented in this thesis. This work has, therefore confirmed that offline breath analysis in 
unrestrained mice is challenging, and I faced many difficulties during the set-up of the 
methodology, which will be listed here. Direct sampling was not possible, thus the breath 
VOC sampling was performed directly into TD tubes, and detection of VOC at trace 
concentration with enough sensitivity was problematic. In addition, it is difficult to have 
control over the contamination of the VOC sample, i.e. mice tend to urinate and let go 
stools under unfamiliar or stressful situations, not to mention an increase in physical 
activity. Nevertheless, the suggested methodology is indicated below.   
 
A plethysmography chamber, commonly used for measuring the respiratory function in 
unrestrained mice, was used in an attempt to collect VOCs being emitted from breath- 
and skin in unrestrained Cushing´s mice. The chamber was connected to a hydrocarbon 
free air cylinder (Air Products) and the flow set to 60 mL min-1. The chamber was 
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prepared with a small orifice acting as pressure discharge. The empty chamber was 
flushed with clean air prior to the measurements for 3 minutes; a blank sample was 
taken; the mouse was placed in the chamber and this was flushed once again with clean 
air for 2 minutes; Air samples were then pumped (Gilian, GilAir Plus) into stainless-steel 
thermal desorption (TD) tubes [50% Tenax and 50% Carbotrap (Markes International 
Limited)] at 50 mL min-1 for 5 minutes. Duplicates were taken for analysis by SIFT-MS and 
TD-GC-MS. TD sorbent tubes were transported to OU and kept in the freezer at -20 °C for 
1 week until further analysis. 
 
TD tubes were analysed via SIFT-MS by means of using a prototype thermal desorber 
developed by Kore Technology Limited (Figure 3.3).  
 
 
Figure 3. 3 – Direct desorption into SIFT-MS using a prototype thermal desorber developed by Kore Technology Limited.      
 
The device (Figure 3.3) consists of a ceramic in which the tube is placed; the tube is 
gradually heated at different temperature ramps ranging from 20 °C to 200 °C and 
controlled by a simple temperature controller. The VOC are therefore desorbed from the 
stainless-steel tube into the SIFT-MS directly. The SIFT-MS was operated in MIM mode 
acquiring data for acetone, propanol, ethanol, pentanol, acetic acid and propanoic acid.     
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3.2.6 Faecal headspace analysis 
Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) technique was discussed in detail in 
chapter 2 as a technique suited for the analysis of VOCs in real-time with high sensitivity 
and specificity. The methodology used for the analysis of faecal headspace (Figure 3.4) by 
SIFT-MS is discussed below. After the faecal headspace analysis by SIFT-MS, VOCs were 
pumped into pre-conditioned stainless-steel TD sorbent tubes and analysed by TD-GC-MS 
according to the description given in 3.1.4. 
 
Figure 3. 4 – Illustrative diagram showing the methodology used for the analysis of VOCs via SIFT-MS and TD-GC-MS.    
 
Six pellets per animal were placed inside Nalophan bags (35 cm long Nalophan sampling 
bag, made up of 65 mm diameter Nalophan NA tubing 25 µm thick (Kalle UK)); sample 
bags were sealed and filled with hydrocarbon free air (Air Products); after an 1 hour of 
incubation at 37 °C, the bags were connected to the SIFT-MS via the heated sampling line 
and the faecal headspace further analysed. The normalisation of the data corrects for the 
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variation in sample weight. Samples were analysed in random order and full spectra of 
the count rates in the range m/z 10 to m/z 140 were recorded for all the samples via 
H3O
+, NO+ and O2
+, using the FS mode and a total sample time of 30 seconds. Background 
lab air was also analysed.   
 
3. 3 Analysis of the volatile faecal metabolome in screening for colorectal cancer 
 
3.3.1 Sample acquisition 
The cancer samples in this study were collected through the National NHS Bowel Cancer 
Screening Scheme. All the subjects received a FOBT kit at home. A sample was taken on 
three different days. The subjects who tested positive through FOBT screening 
subsequently underwent a colonoscopy and were invited to participate in this study. 
These patients were requested to produce a further stool sample to bring with them in a 
wide plastic sterile container provided by the hospital. The samples were kept frozen 
at -80 °C and these were then shipped to The Open University on ice. 
After the colonoscopy, the patients were classified into risk groups and the results are 
shown in Table 3.3. 
 
Table 3. 3 – Risk class applied to histological results. 
Class Detail Number of samples 
1 Normal, nothing of concern found = low risk 31 
5 
High Grade Adenoma = high risk 
31 
6 
Adenocarcinoma = high risk 
 
 
Initially, all the subjects tested positive for FOBT but this evidence was rapidly disproven 
by colonoscopy results. In this study, 31 samples were analysed from the ‘normal’ or low 
risk group (class 1) and 31 samples from the high risk groups (class 5 and 6), which 
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actually had colorectal cancer. The samples were stored at -80 °C until the moment of 
analysis by SIFT-MS. 
 
3.3.2 Ethics statement 
Samples were taken under the National NHS bowel cancer screening scheme. Favourable 
ethical opinion was obtained for subsequent inclusion of suitable subjects in this research 
by Cambridgeshire 2 REC, REF 08/H0308/13, and written informed consent obtained from 
each subject and consent form then kept securely. All samples were anonymised prior to 
analysis and only the cancer status was known to the authors (Batty et al., 2015) 
 
3.3.3 VOC sampling and analysis 
Sample preparation: Faecal samples were removed from the -80 °C freezer and defrosted 
for 1 hour; 5 g of sample was directly introduced into a Nalophan bag (40 cm long 
Nalophan sampling bag, made up of 65 mm diameter Nalophan NA tubing 25 µm thick 
(Kalle UK)); the sample bags were sealed and filled with hydrocarbon free air (Air 
Products); the samples were incubated for 45 minutes at 37 °C.  
 
SIFT-MS analysis: Data were acquired according to the detailed description given in 3.1.2. 
(PDZ Europa, UK) Full spectra of the count rates at each m/z value in the range m/z 10 to 
m/z 140 were recorded for all the samples via H3O
+, NO+ and O2
+ using the full scan mode 
and a total sample time of 30 seconds. Background lab air was also analysed.   
 
Data processing: Prior to statistical analysis, the intensity of m/z values within the data 
were normalised against the intensity values of the H3O
+ (m/z 19) precursor ions. All m/z 
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values were included in the statistical analysis including the known adduct ions, m/z 
values: 19, 21, 30, 32, 34, 37, 39, 48, 55, 57, 66, 73, 75, and 91. 
 
The statistical analysis presented in this thesis was performed using the software IBM 
SPSS Statistics 21.0 and will now be discussed.  
 
3. 4 Univariate Analysis 
In order to perform a proper statistical analysis, the identification of sources of bias 
should be carefully taken into account and identified. Therefore, identification of outliers, 
i.e. scores very different from the rest of the data, and identification of the distribution of 
scores along the data set, i.e. spotting normality.  
 
3.4.1 Kolmogorov-Smirnov statistic and Shapiro-Wilk statistic test 
The Kolmogorov-Smirnov test and Shapiro-Wilk test evaluate the normality of the 
distribution of scores along the data set (Field, 2013). These tests compare the scores in 
the sample to a normally distributed set of scores with the same mean and standard 
deviation. If the test is significant (p < 0.05), then the distribution is significantly different 
from a normal distribution, thus indicating that the data set is not normally distributed. 
Inspection of normality is supported by the analysis of the Normal Q-Q Plot, where each 
score is plotted against an expected value from the normal distribution. A straight line 
suggests a normal distribution.  
Considering a data set not normally distributed, non-parametric statistical techniques 
would have to be used from here on, or alternatively, transforming data not normally 
distributed into normally distributed might be one way of dealing with the matter.  
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3.4.2 T-test 
The use of a T-test (independent samples) assumes a normally distributed set of scores, 
and this test looks for the differences between two groups, i.e. compares the mean 
scores between two different groups of people (e.g. males and females) or condition (e.g. 
disease and healthy) on the same continuous, dependent variable (Field, 2013).  A 
significant result (p ≤ 0.05) indicates that there is a significant difference between the 
groups on that dependent variable.  
 
3.4.3 One-way repeated measures ANOVA with Bonferroni post-hoc test 
In one-way repeated measures ANOVA, each patient is exposed to two or more different 
conditions, or measured on the same continuous scale on three or more occasions. This 
statistical technique assumes a normal distributed population and tells if there is a 
significant difference somewhere among the three set of scores (Pallant, 2013). A 
significant result (p ≤ 0.05) indicates that there is a significant difference somewhere 
among the set of scores. Bonferroni post-hoc test is a correction to the statistical testing 
used to minimize the number of false discoveries that occur when conducting multiple 
tests. A Bonferroni adjusted p-value is used (p = 0.05/number of tests) accordingly 
(Pallant, 2013) 
 
3.4.4 Mann-Whitney U test 
The Mann-Whitney U test is a non-parametric technique and is used to compare 
differences between two independent groups, e.g. disease and healthy (Field, 2013). The 
non-parametric techniques assume a not normally distributed population. The 
Mann-Whitney U test is often considered the non-parametric alternative to the 
independent T-test. The Mann-Whitney U test uses the rank of each case to test whether 
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the ranks for the two groups differ significantly. A significant result (p ≤ 0.05) indicates 
that there is a significant difference between the groups. 
 
3.4.5 Spearman´s rho correlation coefficient 
The Spearman´s rho correlation coefficient is a non-parametric statistic based on ranked 
data, so it can help to minimize the effects of extreme scores. Spearman's correlation 
determines the strength and direction (positive or negative) of the relationship between 
the two variables. Small correlations are indicated by rho´s correlation coefficient 
between 0.10 to 0.29; medium correlations are indicated by a correlation coefficient 
between 0.30 to 0.49; and large correlations present a correlation coefficient between 
0.50 to 1.0 (Pallant, 2013). The rho´s correlation coefficient is strongly influenced by the 
size of the sample. Thus, in a small sample (e.g. n = 30) moderate correlations may not 
reach statistical significance at the traditional p < 0.05 level (Pallant, 2013). Spearman´s 
rho correlation was used in chapter 5 to determine the relationship between counts of 
m/z values and blood glucose levels in mouse models of diabetes.  
 
3.4.6 Friedman test (repeated measures) 
The Friedman test is the non-parametric alternative to the one-way ANOVA with 
repeated measures. This test is used when the same sample of participants are measured 
at three or more points in time, or under three different conditions. Statistically 
significant differences in the mean ranks for the three set of scores are indicated by p = 
0.000 (which really means less than 0.0005), meaning that there is a statistically 
significant difference somewhere among the three set of scores (Pallant, 2013). 
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3.4.7 Wilcoxon Signed Rank test using a Bonferroni post-hoc test 
Having established that there is a statistically significant difference somewhere among 
the three time points after using Friedman test, individual Wilcoxon Signed Rank tests 
combining a Bonferroni post-hoc test were used to determine which groups differ from 
the rest. A Bonferroni adjusted p-value is used (p = 0.05/number of Wilcoxon tests) 
accordingly (Pallant, 2013). Wilcoxon Signed Rank tests is a non-parametric technique and 
is used when the participants are measured on two occasions, or under two different 
conditions, thus it compares ranks at different time points. The effect size for this test can 
be calculated using the z value by the square root of N (Pallant, 2013).     
 
3. 5 Multivariate statistics  
Multivariate statistical analysis looks for relationships among multiple variables at the 
same time, and it looks for patterns (relative differences) rather than individual variables.  
 
3.5.1 Discriminant analysis 
Discriminant analysis was carried out between the groups (i.e. het/WT and hom/WT in 
chapter 5; Low Risk group/High Risk group in chapter 6), and a predictive model was built 
for group membership respectively. The model is based on a discriminant function based 
on linear combinations of the predictor variables that provide the best discrimination 
between the groups (Pallant, 2013). Cross-validation using the ‘leave one out 
classification’ produces more accurate and reliable outcomes, thus this was used in the 
discriminant analysis shown here.   
The assumptions of discriminant analysis implies that each predictor variable is normally 
distributed, thus all the variables, i.e. m/z values, were transformed using the square root 
transformation, which demonstrated to be the best transformation to deliver a more 
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normal distribution. Following this, the data sets were submitted to standardization in 
order to get comparable variables as described in the equation below.   
 
 
Equation 3.4 
 
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑𝑖𝑠𝑒𝑑 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒 (𝑚 𝑧⁄ ) =  
(√𝑚 𝑧⁄ −𝑀𝑒𝑑𝑖𝑎𝑛)
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛
 
 
3. 6 Sensitivity and Specificity  
 
Sensitivity and specificity are used to evaluate a clinical test. Ideally, sensitivity correctly 
identifies all patients with the disease, i.e. true positives, and similarly specificity correctly 
identifies all patients who are disease free, i.e. true negatives (Lalkhen and McCluskey, 
2008). Sensitivity and specificity are determined through the following equations given 
below (Lalkhen and McCluskey, 2008): 
 
Equation 3.4 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =  
𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝑓𝑎𝑙𝑠𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
 
 
The designation of the terms true positive, false positive, true negative and false negative 
are given below: 
 True positive: the patient has the disease and the test is positive 
 False positive: the patient does not have the disease but the test is positive 
 True negative: the patient does not have the disease and the test is negative 
 
 False negative: the patient has the disease but the test is negative 
 
 
I will now discuss results of sets of experiments performed during my PhD studies. 
Equation 3.5                                     
 𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =  
𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠
𝑡𝑟𝑢𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠 + 𝑓𝑎𝑙𝑠𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
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Chapter 4 
 
A potential method for comparing 
instrumental analysis of breath gas volatile 
organic compounds using standards 
calibrated in the gas phase 
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Considerable efforts have been undertaken to develop non-invasive diagnostic methods 
for detecting and monitoring disease through the analysis of volatile organic compounds 
(VOCs) which can potentially be used as biomarkers. These VOCs have been detected in 
exhaled breath, skin emanations, saliva, urine and faecal headspace (de Lacy Costello et 
al., 2014). Breath analysis in particular has recently become a topic of interest for its 
potential to provide a non-invasive screening tool in early disease diagnosis (Lourenço 
and Turner, 2014). However such measurements have been limited by inconsistent 
evaluations of the concentrations of such VOCs by different instruments even when they 
are collected under apparently identical conditions. This shows that the lack of 
standardization between techniques is still a major challenge due to the vast disparity in 
the analytical tools employed, the sampling technique itself and the rich chemical 
diversity of exhaled breath at varied concentrations (Herbig and Beauchamp, 2014). 
 
 
This chapter addresses a potential method for comparing the instrumental analysis of 
breath or headspace gas volatile organic compounds using three different analytical 
techniques, GC-MS coupled to thermal desorption (TD), SIFT-MS and PTR-MS through the 
use of standards calibrated for the gas-phase at physiologically representative 
concentrations. These analytical techniques have been widely used for medical research, 
particularly, within the breath analysis community in the identification and quantification 
of trace concentrations of VOCs in exhaled breath.  
This work is currently under review in Journal of Breath Research. 
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4. 1 Product ions and branching ratios 
A series of experiments were performed using standard aqueous solutions of acetone, 
ethanol, methanol, 1-propanol, 2-propanol and acetaldehyde were prepared according to 
Henry’s law and calibrated for the gas-phase at 293 K  20 ˚C as described in section 
3.1.1.  
Table 4.1 lists the ions observed and their branching ratios when these compounds were 
analysed by SIFT-MS and PTR-MS. These may be compared with earlier measurements 
discussed in chapter 3 (section 3.1.6). 
 
 
Table 4. 1 - Comparison of the product ions identified by SIFT-MS and PTR-MS and their associated ion branching ratios 
(percentage in parentheses), respectively, calibrated for 5 ppm in a highly humid headspace, for a series of saturated 
alcohols (ROH), acetone (RO) and acetaldehyde (RO) present in human breath. Errors in the branching ratios are 
estimated to be less than 10%.   
  SIFT-MS PTR-MS 
VOC 
Molecular formula 
(MW) 
Product ions m/z and ion 
branching ratios (%) 
Product ions m/z and ion 
branching ratios (%) 
Methanol CH3OH (32) 33 (41) ROH2
+
 
51 (28) ROH2
+
·H2O
 
69 (31) ROH2
+
·(H2O)2
 
33 (96) ROH2
+
 
51 (4) ROH2
+
·H2O 
 
 
Acetaldehyde 
 
C2H4O (44) 
 
45 (41) ROH
+
 
63 (47) ROH
+
·H2O 
81 (12) ROH
+
·(H2O)2 
 
45 (54) ROH
+
 
63 (46) ROH
+
·H2O 
 
 
Ethanol 
 
C2H5OH (46) 
 
47 (15) ROH2
+
 
65 (45) ROH2
+
·H2O 
83 (40) ROH2
+
·(H2O)2 
 
45 (1) [ROH-H2]H
+
 
47 (51) ROH2
+ 
65 (48) ROH2
+
·H2O 
 
Acetone 
 
C3H6O (58) 
 
59 (39) ROH
+ 
 
77 (61) ROH
+
·H2O 
 
 
59 (100) ROH
+ 
 
 
1-Propanol C3H7OH (60) 43 (70) R
+ 
 
61 (2) ROH2
+
 
79 (6) ROH2
+
·H2O 
97 (22) ROH2
+
·(H2O)2 
43 (77) R
+ 
 
61 (6) ROH2
+
 
79 (17) ROH2
+
·H2O 
 
 
2-Propanol 
 
C3H7OH (60) 
 
43 (54) R
+ 
 
61 (5) ROH2
+
 
79 (29) ROH2
+
·H2O 
97 (12) ROH2
+
·(H2O)2 
 
43 (68) R
+ 
 
59 (1) [ROH-H2]H
+
 
61 (12) ROH2
+
 
79 (19) ROH2
+
·H2O 
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4. 2 Theoretical prediction of reaction rate coefficients  
In order to compare these different methods and put the results in context, it is 
important to understand the theoretical prediction of reaction rate coefficients and thus 
determine headspace concentrations. A vast number of rate coefficients of VOCs with 
H3O
+ at thermal energy have been experimentally determined using SIFT-MS with a 
reported accuracy better than 10% (Španěl et al., 1995, Španěl et al., 1997, Španěl and 
Smith, 1997, Smith and Španěl, 2011, Španěl et al., 2002). The rate coefficients have been 
calculated using the parameterised trajectory formulation of Su and Chesnavich (Su and 
Chesnavich, 1982) within an estimated accuracy ± 10%. The rate coefficients at thermal 
conditions have been previously reported in the literature (Španěl and Smith, 1997, 
Španěl et al., 1997).  
In contrast the kinetics of ion-molecule reactions of PTR-MS are not well-defined, 
literature data on reaction rate coefficients is scarce, and can be sensitive to E/N (Tani et 
al., 2003, Warneke et al., 1996, Cappellin et al., 2010). A standard value (2  10-9 cm3 s-1) 
for the proton transfer rate coefficient (kcap) is often used to estimate trace-gas 
concentrations. Quantification is directly dependent on kcap, which means that using the 
same proton transfer rate coefficient for different ion-molecule reactions, such an 
assumption may introduce a significant uncertainty to the quantification.   
 
Proton transfer reactions between H3O
+ and VOCs in both SIFT-MS and PTR-MS occur 
efficiently if the proton affinity of the acceptor molecule exceeds the proton affinity of 
the donor (H2O), thus such reactions are exothermic. Exothermic proton transfer 
reactions in the gas-phase tend to be fast (k  10-9 cm3 s-1) and usually proceed at the 
collisional rate (Blake et al., 2009, Bohme et al., 1980).  
 
135 
 
An estimate of rate coefficients of exothermic ion-molecule reactions is possible, if the 
polarizability and the dipole moment of the reactant molecule are known. Therefore, in 
this study ion-neutral molecule collision theories have been applied, and the reaction rate 
coefficients were calculated according to the detailed description given elsewhere 
(Cappellin et al., 2010). Table 4.2  shows the theoretical prediction of proton transfer rate 
coefficients, kcap (Trot,KEcm), for the proton transfer reactions occurring in the drift tube of 
PTR-MS at 373 K, calculated via Su and Chesnavich trajectory theory (Su, 1994). For 
comparison, reaction rate coefficients were calculated via the Langevin theory (Langevin, 
1905), and Average Dipole Orientation (ADO) theory (Su and Bowers, 1973). 
 
Table 4. 2 - Proton transfer reaction rate coefficients kcap (Trot, KEcm) (10
-9
 cm
3
 s
-1
) between hydronium ion (H3O
+
) and 
selected VOCs at 373 K, Trot is taken as the drift tube temperature. For comparison, reaction rate coefficients kL, kADO, 
and kcap (Teff) are also reported and expressed in 10
-9
 cm
3
 s
-1
. Also given are their polarizabilities, , expressed in units of 
10
-30
 m
3
 and their permanent dipole moment, , in Debye, D.   
VOC 

(10
-30 
m
3
)
 a
 

(D)
 a
 
kL 
(10
-9 
cm
3 
s
-1
) 
kADO 
(10
-9 
cm
3 
s
-1
) 
kcap (Teff) 
(10
-9 
cm
3 
s
-1
) 
kcap (Trot,KEcm) 
(10
-9 
cm
3 
s
-1
) 
Acetone 6.40 2.88 1.57 3.10 2.24 3.10 
Ethanol 5.26 1.69 1.46 2.14 1.89 2.36 
Methanol 3.29 1.70 1.23 2.13 1.66 2.21 
1-propanol 6.74 1.58 1.60 2.21 1.96 2.33 
2-propanol 6.97 1.58 1.63 2.24 1.99 2.37 
Acetaldehyde 4.59 2.75 1.38 2.97 1.93 2.80 
a 
Reference (Lide, 2014).  
 
 
For VOCs with oxygen in their chemical structure, the permanent dipole moment is much 
greater than 1.0 D and thus the permanent dipole moment contributes significantly to the 
rate coefficient. Calculations via the Langevin theory give rate coefficients, kL, may be too 
low since the ion-dipole interaction is not accounted for. For instance, the Langevin 
theory rate coefficient for acetone is 1.57  10-9 cm3 s-1, while the corresponding value of 
the ADO theory is 3.10  10-9 cm3 s-1, which is greater than the Langevin theory by a factor 
of two. The rate coefficients, kADO , predicted from the ADO theory at 300 K tend to 
underestimate measured  rate coefficients by typically by 10 – 20% (Su and Bowers, 
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1973). The rate coefficients kL and kADO were calculated according to the equations 2.27 
and 2.28 described in chapter 2.  
 
Ion-molecule reactions in PTR-MS proceed with energies larger than thermal energy due 
to the existence of a homogenous electrical field. Increasing the electric field strength in 
the PTR-MS or decreasing the pressure or temperature of the drift tube in turn increases 
the drift velocity and, consequently, the kinetic energy of the ions. The temperature of 
the ions is higher than the drift-tube temperature as a result of the selective heating of 
the ions by the electric field. Therefore, this additional energy applied by the electric field 
should be taken into account. This means that is necessary to consider the centre-of-mass 
kinetic energy (KEcm) for a collision between an ion and the neutral molecule (Viggiano 
and Morris, 1996, Ellis and Mayhew, 2014). Calculation of KEcm is indicated in equation 
2.31 described in chapter 2.  
 
Trajectory calculations have been carried out by Su and Chesnavich (Su and Chesnavich, 
1982), combining variational transition theory and classical trajectory analysis of ion-polar 
molecule capture collisions to derive rate coefficients, kcap, for ion-polar molecule capture 
collisions. For a limited number of cases it has been shown that the effective 
temperature, Teff, describes the internal energy of the ion reactants and depends only on 
the ratio E/N (Viggiano and Morris, 1996) and this is used in this work to determine rate 
coefficients for ion-molecule collisions, kcap. Calculation of rate coefficients kcap and 
effective temperature Teff, are indicated in equation 2.29, equation 2.30, and equation 
2.34 described in chapter 2.  
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Ions have three separate energy distributions, translational, rotational, and vibrational. It 
has been found that the average translational energy can be calculated from the drift 
velocity using the Wannier expression given in chapter 2, equation 2.32 (Wannier, 1953). 
As regards to vibrational energies, it has been reported in literature that in many cases 
vibrations do not affect the kinetics significantly, i.e. rate constants measured as a 
function of KEcm at several temperatures do not vary significantly (Viggiano and Morris, 
1996). The dependence of the rate constants upon rotational temperature of the neutral 
molecule is obtained by comparing data at a specific centre-of-mass kinetic energy at 
several different temperatures. Initially it was assumed that the rotational energy of the 
reactant ion would have a negligible effect on the rate constants but more recently it has 
been reported that the rotational energy of the neutral sometimes appears to have a 
significant effect on rate constants, leading to the conclusion that the rotational energy of 
the ions may affect rate coefficients in the same manner (Viggiano et al., 1988). 
Theoretical and experimental results therefore indicate that rotational energy effects on 
ion-molecule rate coefficients must be considered, particularly for polyatomic ions 
(Viggiano et al., 1988, Viggiano et al., 1990, Viggiano and Morris, 1996). Su has developed 
a parameterization of the kinetic energy, giving capture rate constants, kcap (Trot,KEcm), 
within 5% error for ion-molecule systems with centre-of-mass kinetic energies ranging 
from thermal to several electron-volts (eV), and a wide range of temperatures (50-1000 
K) (Su, 1994). Determination of the rate coefficient kcap (Trot,KEcm) is indicated in equation 
2.35 described in chapter 2. Such a method is based on trajectory calculated results 
relating the Langevin rate constant to the capture rate constant by a factor, Kc, 
parameterised by KEcm and rotational temperature (Trot). The latest theory possibly 
provides the most accurate results, since the collision energy and rotational energy 
effects have been considered. In this work we have assumed the drift tube temperature 
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as rotational temperature (Trot) assuming no effect of the electric field on the rotational 
energy of the neutral. The findings shown in Table 4.2 indicate that the rate coefficients 
kcap, calculated at an effective ion temperature Teff, underestimate the proton transfer 
rate coefficients by 10-40% compared to Su’s rate coefficients kcap (Trot,KEcm), which is in 
agreement with earlier measurements by Cappellin et al. (Cappellin et al., 2010). While 
the accuracy of the model to determine the rate coefficient is improved by utilising 
kcap(Trot,KEcm), the uncertainty is also increased compared to simpler models. 
   
  
4. 3 Quantitative determination of VOC concentrations 
 
4.3.1 Individual headspaces 
Following on from the previous section, quantification of VOC concentrations may be 
accomplished if proton transfer reaction rate coefficients are known and Su’s 
parameterised kinetic energy dependence of ion-molecule reaction rate coefficients 
kcap (Trot,KEcm) have therefore been used to determine the PTR-MS VOC concentration. 
The kcap (Trot,KEcm) calculations were drawn from equations 2.35 and 2.36 described in 
chapter 2. 
 
PTR-MS VOC concentrations were derived in parts-per-billion by volume (ppbv) according 
to the detailed description given elsewhere (Cappellin et al., 2012), and by using 
equations 2.42 and 2.43 presented in chapter 2 (taking into account the density of air in 
the reaction chamber). In summary, the method consists of using the proton transfer rate 
coefficient [kcap (Trot,KEcm)] expressed in cm
3 s-1 between the hydronium ion (H3O
+) and 
VOC (R), calculated previously; determining the reaction time (t) of the ions in the drift 
tube expressed in seconds, which is dependent on the drift tube length (L), the electric 
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potential (U) applied to the drift tube, and the mobility of the H3O
+ ions in the drift tube 
which depend on the working conditions (pressure and temperature); and determining 
the counts per second (cps) of detected protonated parent ion (RH+) and its fragment 
ions, and the counts per second (cps) of H3O
+. The presence of H3O
+ water clusters 
[H3O(H2O)n]
+ ions, with  n  = 0, 1, 2 , 3 must also be considered. The mass-dependent 
transmission efficiency (Tr) of ions (H3O
+ and RH+) into the PTR-MS detection system was 
also taken into account since just a fraction of the total ion count reach the detector 
successfully.  
 
The contribution of fragment ions and hydronium water-cluster ions was taken into 
account in the determination of VOC concentration via SIFT-MS and PTR-MS. In gas 
samples with higher humidity, such as breath gas, the number of water-cluster ions is 
significantly enhanced, and these may play a role as a reagent ion. The contribution of 
fragment ions for the determination of VOC concentration by PTR-MS was calculated 
according to equation 2.43 in chapter 2. The sum of the normalised counts per second for 
each fragment ion plus the protonated parent ion was made for the data acquired via 
SIFT-MS. Determination of VOC concentration by GC-MS was performed through the use 
of the internal standard approach, and calculated according to equation 3.3 in chapter 3.    
 
Table 4.3 presents a comparison between the mass spectrometric techniques used and 
TD-GC-MS, for 5 ppm in the headspace, and this concentration was initially calculated 
according to Henry´s law at 20 ˚C. The ambient air temperature in the laboratory was 
measured simultaneously with experiments undertaken, and laboratory temperature was 
found to be higher than 20 ˚C. The temperature significantly influences VOC 
concentration in the headspace, therefore, concentrations were corrected for the 
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ambient air temperature in the laboratory at 20 ˚C. The compound-dependent sensitivity 
of SIFT-MS and PTR-MS is expressed in ncps/ppbv and is listed in Table 4.3.  
 
 
Table 4. 3 - Determination of VOC concentrations calibrated to 5 ppm in the headspace at 20 ˚C and a comparison 
between the mass spectrometric techniques used and TD-GC-MS; SIFT-MS and PTR-MS sensitivity in ncps/ppbv within 
the range 10
1
-10
3
 ppbv.  
VOC 
Concentration (ppbv) Retention Sensitivity (ncps/ppbv) 
SIFT-MS 
a
 PTR-MS 
b
 TD-GC-MS 
c
 time (min) SIFT-MS 
a
 PTR-MS 
b
 
Acetone 4027 5089 5230 6.6 3.4 13.1 
Ethanol 6167 3700 -- 6.1 2.4 15.8 
Methanol 6347 7203 -- 4.2 2.0 7.8 
1-propanol 4760 11816 3638 9.2 1.7 14.7 
2-propanol 3189 10294 3848 7.1 1.9 12.4 
Acetaldehyde 2600 1030 -- 4.1 3.3 11.5 
a 
Errors of ±20%, 
b
 ±50%, and 
c
 ±20% are assigned to the quantification via SIFT-MS, PTR-MS and TD-GC-MS, 
respectively. These were determined using the concentrations obtained via SIFT-MS, PTR-MS and TD-GC-
MS.      
 
 
 
 
Calibration curves for the six VOCs typically found in human breath are given within the 
range 101-103 ppbv and are represented in Figure 4.1 and Figure 4.2. The linearity of the 
response was verified for all compounds. Figure 4.1 indicates the calibration curves for 
the alcohols studied here and data acquired either using SIFT-MS (a) or PTR-MS (b). 
Figure 4.2 (a) indicates the calibration curve for acetone and Figure 4.2 (b) the calibration 
curve for acetaldehyde, either acquired via SIFT-MS or PTR-MS. 
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Figure 4. 1 - Calibration curves for 1-propanol, 2-propanol, ethanol and methanol at physiologically representative 
concentrations; data acquired using SIFT-MS (a) and PTR-MS (b). 
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Figure 4. 2 - Calibration plot for acetone (a) and acetaldehyde (b) at physiologically representative concentrations; data 
acquired using SIFT-MS and PTR-MS.  
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Under standard operating conditions E/N should be in the range 120–130 Td – with the 
exception of the explosive 2,4,6 trinitrotoluene (TNT) (Sulzer et al., 2012) whose 
sensitivity of detection is enhanced at higher E/N values – representing a compromise 
between reagent ion hydration on the one hand, and product ion fragmentation on the 
other (Lindinger et al., 1998). This E/N range has therefore become the guideline for 
numerous experiments. Nevertheless, the effects on the underlying ion-chemistry must 
be carefully considered depending on the E/N ratio. The purpose of this study was not to 
analyse product ion distributions over E/N but our findings indicated that quantification 
via PTR-MS is sensitive to alterations in the reduced electric field (i.e. changes in the E/N 
ratio) and significantly influences the quantification of compounds in the gas-phase, as 
shown in Figure 4.3. 
 
 
For most of the molecules used in this study product ion distributions as a function of E/N 
have been widely described in literature (Brown et al., 2010). For instance, in 
acetaldehyde  an increasing E/N leads to a significant fall in the signal (ncps) along with 
the decrease of the reaction time (s), followed by the decrease of the reaction rate 
coefficient kcap(Trot, KEcm). These dynamics are illustrated in Figure 4.3 presented below. 
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Figure 4. 3 - (a) Concentration of acetaldehyde in ppbv and (b) 2-propanol in ppbv, calibrated to 5 ppm in the gas-phase, 
and normalised counts per second (ncps) as a function of reduced electric field strength (E/N = 90, 125, 160); (c) 
Acetaldehyde-H3O
+
 reaction time and reaction rate coefficient as a function of E/N = 90, 125, 160.  
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4.3.2 TD-GC-MS results 
The VOCs were trapped in stainless-steel TD sorbent tubes and further desorbed into the 
GC column. The MS detector was setup to scan from m/z 33.0 to m/z 260.0, therefore, 
methanol (m/z = 32) was not detected through this specific GC-MS method. In addition, 
the TD sorbent used is suited to the trapping of volatiles with at least three carbons in 
their molecular structure, which is why acetaldehyde and ethanol were difficult to trap in 
our apparatus. Calibration functions using the internal standard procedure for 1-
propanol, 2-propanol and acetone at physiologically representative concentrations are 
represented in Figure 4.4. 
 
Figure 4. 4 - Calibration functions using the internal standard procedure for 1-propanol, 2-propanol (a) and acetone (b); 
data acquired using TD-GC-MS.  
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The internal standard calibration curves plots the area of the analytes relative to the area 
of the internal standard (d8-toluene) against the concentration in the sample. The 
parameter determined relative to the internal standard is thus independent of deviations 
in the injection volume and possible variations in the performance of the detector 
(Hübschmann, 2009). These calibrations functions are specific for a sampling flow of 
100 mL min-1 for 5 minutes, and 50 ng of internal standard d8-toluene was used. 
 
Classic calibration in GC-MS systems frequently uses a calibration standard or a standard 
mixture at different concentrations (Hübschmann, 2009, Poole, 2012), however this 
method does not correct for any variation in the recovery of analytes by thermal 
desorption sampling techniques. The use of an internal standard improves accuracy and 
corrects for any variation in the recovery of analytes. In general, the internal standard 
approach is used to determine the concentration of an unknown sample investigated by 
GC-MS. The standard itself must not be present in the original sample and must be rapidly 
cleaned up from the column. Therefore, isotopically labelled standards should ideally be 
used (Hübschmann, 2009). For unknown VOC mixtures, the use of deuterated compounds 
enables rapid identification of the peak area which otherwise would be difficult to 
confirm the origin of the peak, either from the sample itself or the internal standard, 
avoiding misleading results. Thermal desorption procedures are generally calibrated using 
internal standard addition using deuterated toluene (Poole, 2012), where standard 
solutions are prepared and small volumes (typically 0.2 - 2 L) loaded into each thermal 
desorption tube individually. 
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4.3.3 VOC mixtures 
 
Since exhaled breath is a mixture of VOCs at different concentrations, which may respond 
differently once combined, the stability in the gas-phase of VOCs mixtures has been 
evaluated by using TD-GC-MS. VOC mixtures were prepared according to Henry´s law in 
the same manner as described in chapter 3 to give solutions of acetone, 1-propanol, 
2-propanol, ethanol, acetaldehyde and methanol to give headspace concentrations of 
0.1 ppm, 1 ppm, 5 ppm and 10 ppm.  Internal standard calibration curves for the mixtures 
are given in Figure 4.5, where a sampling flow of 100 mL min-1 for 5 minutes was used and 
50 ng of internal standard d8-toluene. 
 
 
Figure 4. 5 - Calibration functions using the internal standard procedure for 1-propanol and 2-propanol within a mixture 
of VOCs (a) and acetone (b); data acquired using TD-GC-MS.  
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Peaks elute along the GC column according to their affinity for the stationary phase of the 
column. Polar compounds interact weakly with low polarity stationary phases, as 
commonly used in VOCs analysis, and consequently, short retention times follow. It 
should be noted that competitive binding may occur and the significance of this for an 
accurate quantification is not yet fully understood. At a specific gas-phase concentration 
(i.e. 0.1 ppm, 1 ppm, 5ppm, and 10 ppm), the peak areas observed for the mixtures are 
significantly lower than for the individual solutions (Figure 4.6 (a), (b), (c)). This could 
possibly be due to competitive binding within the column. Among all the VOCs separated 
in the column, 2-propanol binds most strongly to the stationary phase due to its highest 
relative polarity and eluting later on at 7.1 minutes (Figure 4.6 (d)).  
 
Figure 4. 6 - Comparison of the peaks areas observed in chromatograms acquired using TD-GC-MS for individual 
calibration solutions, and peak areas acquired for a VOC mixture containing the six VOCs analysed (a) acetone, (b) 1-
propanol, and (c) 2-propanol; (d) comparison of peak areas within the VOC mixtures at gas-phase concentrations of 0.1 
ppm, 1 ppm, 5ppm, and 10 ppm. 
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Gas chromatography–mass spectrometry has been recognised as the gold standard of 
analytical methodologies for many scientific tests. Its fundamental ability to effectively 
perform a qualitative analysis enables the identification of isomers within the sample 
which would be hard or nearly impossible to detect using a mass spectrometer only, 
particularly without separation of compounds present. However, issues remain as to the 
suitability of gas chromatography as a quantitative method of VOCs analysis, particularly 
if a TD system or solid-phase micro extraction (SPME) is used. Usually, the concentration 
of the substances of interest is too low for the direct measurement of an air sample and 
therefore enrichment on suitable adsorbents is necessary. In thermal desorption, the 
concentrated volatile components are desorbed by rapid heating of the adsorption tube, 
injected and stored in a cold trap, and subsequently, these are transferred to the GC 
column by rapidly heating the cold trap. This two-step desorption might have a crucial 
impact on the volatiles detected, i.e., competitive binding and desorption, not to mention 
thermal-lability of the VOCs. 
 
The findings shown in this thesis indicated that most of the reactions result in multiple 
products ions and the abundance and stability of these ions strongly depends on the E/N 
ratio used.  
 
Product ions and branching ratios were determined under specific working conditions and 
subsequently quantitative determination of VOC concentrations evaluated. Calibration 
curves determined using SIFT-MS, PTR-MS and TD-GC-MS are given within the range 
101-103 ppbv.    
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This study demonstrates the potential way for standardising trace gas analysis of breath 
constituents given that different laboratories use different sampling and analytical 
techniques. In this work, the findings give slightly different results, but the approach 
taken of using standard headspaces enables a proper comparison to be made between 
three analytical techniques (SIFT-MS, PTR-MS and TD GC-MS) and enables these 
techniques to be tested for their accuracy and reproducibility.  
 
In addition, this study demonstrates that using some techniques, such as GC-MS, VOCs 
with low molecular weight can be difficult to accurately quantify and some compounds 
are separated better than others, therefore this technique is only semi-quantitative.   
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Chapter 5 
 
A longitudinal study of the VOC profile 
emitted by the faecal headspace of two 
different mouse models of diabetes  
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This chapter discusses the potential use of VOCs as a potential non-invasive method for 
monitoring the progress of diabetes. Mouse models of diabetes were used to identify 
potential indicators in VOCs emitted from faeces related to changes in blood glucose in 
type 2 diabetes (T2D). The results shown here were from studying two different mouse 
models of diabetes, namely, the Cushing´s syndrome mouse model of type 2 diabetes and 
single Afmid knockout mice exhibiting impaired glucose tolerance, and these were 
compared to their wild-type (WT) littermates respectively.    
This animal work is under preparation for publication.  
 
5. 1 A longitudinal study of the VOC profile emitted by the faecal headspace of Cushing´s 
syndrome mouse model of type 2 diabetes 
 
As discussed in chapter 1, Cushing´s mice are prone to developing type 2 diabetes, i.e. 
hyperglycaemia and insulin resistance (Bentley et al., 2014). In the present study the 
disease was tracked across the four time points (8, 12, 16 and 20 weeks of age) for the 
mutant (het) Cushing’s mice and the wild-type (WT) littermates. A cohort of 65 mice (21 
males and 44 females) was used of whom 30 were genotyped as mutants and 35 WT 
littermates. 
The body weight of the animals is normally distributed, therefore a T-test was used to 
compare the mean score of weights between mutants (het) and WT littermates. The 
mutation had statistically significant effects on body weight (Figure 5.1). The mutant (het) 
animals were significantly heavier (p <0.05) than the WT littermates.  
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Figure 5. 1 – Body weights along the age of Cushing´s mice (het) compared with WT littermates on a B6-C3PDE 
background. Data analysed using T- test (p < 0.05). 
 
 
One-way repeated measures ANOVA with Bonferroni post-hoc test was conducted to 
compare the animal’s weight along the age. The results indicated that the body weight of 
the animals significantly change over the four months of study. Thus, there was a 
statistically significant effect across the four periods of age, Wilk’s Lambda = 0.155, p < 
0.05.  
Female mutant (het) mice were significantly heavier from 16 weeks of age on a B6-C3PDE 
background (Figure 5.2).  
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Figure 5. 2 – Body weights along the age of male and female Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background. Data analysed using one-way repeated measures ANOVA with Bonferroni post-test.  
 
Blood glucose was taken for unfasted animals with the blood being sampled at the same 
period of the day using an AlphaTRAK2 blood glucose meter. The performance and 
accuracy of the AlphaTRAK2 blood glucose meter was previously evaluated and the 
average coefficient of variation (mouse) determined is 5.9% (AlphaTRAK2). The mutation 
had statistically significant effects on blood glucose (Figure 5.3). The data indicate that 
male and female mutant mice had hyperglycaemia (blood glucose > 11 mmol L-1) by the 
age of 16 weeks (Figure 5.3). In addition, the mutant male mice developed significant 
increased concentrations of blood glucose (p < 0.05) from 16 weeks of age compared to 
the WT littermates (Figure 5.4). Blood glucose sampling in mice induces stress in the 
animals and blood glucose variability might arise from that fact. In addition, some mice 
are more susceptible to obesity and diabetes than others, and insulin resistance 
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manifested at different time points. The estrous cycle in females significantly inserts some 
variability into the data.       
 
 
Figure 5. 3 – Blood glucose concentrations along the age in Cushing´s mice (het) compared with WT littermates on a B6-
C3PDE background. Data analysed using T- test (p < 0.05). 
 
Figure 5. 4 – Blood glucose concentrations along the age of male and female Cushing´s mice (het) compared with WT 
littermates on a B6-C3PDE background. Data analysed using Mann Whitney’s test (p < 0.05). 
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Blood collection was undertaken after terminal anaesthesia of the animals for further 
analysis of insulin plasma concentrations. Therefore, the plasma insulin concentrations 
indicated in Figure 5.5 do not correspond to 20 weeks of age but a later stage once the 
animals were culled, i.e. animals born in April and May were culled at 28 weeks of age, 
and animals born in June were culled at 24 weeks of age. The insulin concentration of 
three animals are above the upper limit for the ELISA assay thus a value of 15 mmol L-1 
was assigned for these animals.  
Mutant animals (het) had statistically significant elevated plasma insulin concentrations 
(median = 1.2 × 101, n = 30) after 20 weeks of age once compared to WT littermates 
(median = 2.3, n = 35), p < 0.05 (Figure 5.5). Insulin secretion is triggered by elevated 
glucose concentration in the blood, supporting the hypothesis that Cushing’s mice 
develop a diabetic phenotype. There is no significant difference between insulin levels of 
males and females. 
 
 
Figure 5. 5 – Plasma insulin concentrations of Cushing´s mice (het) compared with WT littermates on a B6-C3PDE 
background. Plasma insulin concentrations were taken once the animals were culled just after 20 weeks of age. Data 
analysed using Mann Whitney’s test (p < 0.05) 
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5.1.1 Univariate Analysis using SIFT-MS data 
The faecal headspace profile of Cushing´s mice was acquired using SIFT-MS at The Open 
University, in the form of m/z versus counts per second. The Kolmogorov-Smirnov 
statistic and Shapiro-Wilk statistic assessed the normality of the distribution of scores 
along the data set. Results indicated that the data are not normally distributed for H3O
+, 
NO+ and O2
+ precursor ions.  Accordingly, a non-parametric statistic technique, Mann-
Whitney U Test, was applied to test the differences between the two independent groups 
of variables, i.e. mutant (het) mice and WT littermates, and the same test was applied at 
each time point. The Mann-Whitney U test revealed significant differences in the VOCs 
levels of heterozygous mutant (het) animals and WT littermates for H3O
+, NO+ and O2
+ 
precursor ions.  
 
 
SIFT-MS H3O
+ data were obtained from the headspace of faecal samples from a cohort of 
65 mice (21 males and 44 females) of whom 30 were genotyped as mutants and 35 WT 
littermates. Using H3O
+ as the precursor ion, statistically significant differences in the VOC 
levels of faecal headspace from mutant (het) mice and WT littermates were identified and 
given in Table 5.1. 
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Figure 5.6 shows an illustrative mass spectrum zoomed in of one faecal headspace sample 
from a mutant (het) Cushing´s mouse. Data were acquired by SIFT-MS H3O
+, m/z range 
10-140, acquisition time of 5 seconds and six iterations.  
 
 
 
Figure 5. 6 – Illustrative mass spectrum of a faecal headspace sample from a mutant (het) Cushing´s mouse (animal ID 
4.1h). Data acquired by SIFT-MS H3O
+
, m/z range 10-140, acquisition time of 5 seconds and six iterations.  
 
 
 
Table 5.1 indicates the median values for statistically significant m/z values tested over 
the age (8, 12, 16 and 20 weeks of age), considering the full cohort of WT littermates and 
mutants respectively (n = 35, n = 30). The data were analysed using Mann Whitney´s test. 
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Table 5. 1 – Median values for statistically significant m/z values tested over the age (8, 12, 16 and 20 weeks old) of 
Cushing´s mice faecal headspace and its significance levels acquired using H3O
+
 precursor ion. Data were analysed using 
Mann Whitney´s test (p < 0.05). 
 
Ion 
 Median 
Significance level (p) 
 Possible compound (s) wt 
n = 35 
het 
n = 30 
 m/z 57 Propanoic acid 1.1 × 10
2
 3.4 × 10
2
 0.014 
 m/z 61 Acetic acid 
a
 1.7 × 10
3
 5.7 × 10
3
 0.047 
 m/z 65 Ethanol 1.3 × 10
3
 2.0 × 10
3
 0.042 
8 weeks m/z 77 Acetone 3.3 × 10
2
 5.7 × 10
2
 0.023 
 m/z 79 Acetic acid 9.8 × 10
2
 2.5 × 10
3
 0.001 
 m/z 93 Propanoic acid 5.5 × 10
1
 5.4 × 10
2
 0.031 
 m/z 97 Acetic acid 0.0 5.1 × 10
2
 0.003 
 m/z 107 Butanoic acid 9.3 × 10
1
 4.3 × 10
2
 0.030 
12 weeks m/z 83 Ethanol 8.9 × 10
2
 2.7 × 10
2
 0.017 
 m/z 33 Methanol 4.8 × 10
3
 3.2 × 10
3
 0.035 
16 weeks m/z 38 Unknown 2.9 × 10
2
 3.1 × 10
1
 0.007 
 m/z 89 Butanoic acid 3.3 × 10
3
 1.1 × 10
3
 0.043 
 m/z 43 Propanol 3.8 × 10
2
 9.5 × 10
2
 0.008 
 m/z 45 Acetaldehyde 6.8 × 10
2
 1.7 × 10
2
 0.009 
 m/z 47 Ethanol 9.3 × 10
2
 2.2 × 10
3
 0.001 
 m/z 57 Propanoic acid 2.1 × 10
2
 5.5 × 10
2
 0.008 
 m/z 61 Acetic acid 2.6 × 10
3
 7.6 × 10
3
 0.029 
20 weeks m/z 65 Ethanol 2.1 × 10
3
 6.5 × 10
3
 0.000 
 m/z 77 Acetone 3.1 × 10
2
 1.8 × 10
3
 0.004 
 m/z 79 Acetic acid 2.0 × 10
3
 4.3 × 10
3
 0.010 
 m/z 83 Ethanol 1.2 × 10
3
 2.5 × 10
3
 0.028 
 m/z 93 Propanoic acid 8.1 4.5 × 10
2
 0.002 
 m/z 97 Acetic acid 0.0 1.0 × 10
3
 0.001 
a 
It is best to use NO
+
 m/z 90 for acetic acid identification and m/z 43 for propanol identification 
 
The m/z values 57 and m/z 93 are likely to be propanoic acid and these are shown to be 
statistically significant at 8 and 20 weeks of age. Although butanol might overlap at m/z 
57 and m/z 93 potentially arising from the butyrate metabolism within the gut, i.e. 
reduction of butanoic acid to 1-butanol (Dash et al., 2014, Garner et al., 2007). Boxplots 
are indicated in Figure 5.7.  
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Figure 5. 7 – Boxplots of m/z 57 (a), m/z 93 (b); Cushing´s mice (het) compared with WT littermates on a B6-C3PDE 
background along the age. Data acquired by SIFT-MS H3O
+
 and analysed using Mann Whitney’s test (p < 0.05). 
 
 
(a) 
(b) 
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For H3O
+ data set, m/z values 61, m/z 79 and m/z 97 revealed significant increased counts 
per second for mutant (het) mice compared to WT littermates, statistically significant at 8 
and 20 weeks of age. These m/z values may be attributed to acetic acid because the NO+ 
data set revealed m/z 90 to be statistically significant (as discussed in the section below). 
Boxplots are given in Figure 5.8.  
 
 
The m/z values 47, m/z 65 and m/z 83 are likely attributed to ethanol and these were 
significantly higher at 20 weeks of age in the faecal headspace of the mutant (het) mice. 
Ethanol might result from the butyrate metabolism within the gut, converting acetic acid 
to acetaldehyde which in turn is converted to ethanol (Dash et al., 2014). At 8 weeks of 
age only m/z 65 was statistically significant; and m/z 83 significant at 12 weeks of age in 
which WT littermates had significantly higher levels of ethanol. Boxplots are indicated in 
Figure 5.9. 
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Figure 5. 8 – Boxplots of m/z 61 (a), m/z 79 (b), m/z 97 (c) are likely to be acetic acid; Cushing´s mice (het) compared 
with WT littermates on a B6-C3PDE background along the age. Data acquired by SIFT-MS H3O
+
 and analysed using Mann 
Whitney’s test (p < 0.05). 
(a) 
(b) 
(c) 
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Figure 5. 9 – Boxplots of m/z 47 (a), m/z 65 (b), m/z 83 (c) are likely to be ethanol; Cushing´s mice (het) compared with 
WT littermates on a B6-C3PDE background along the age. Data acquired by SIFT-MS H3O
+
 and analysed using Mann 
Whitney’s test (p < 0.05). 
 
(a) 
(b) 
(c) 
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Statistically significant higher counts per second of m/z 77 were also observed in mutant 
(het) mice faecal headspace at 8 and 20 weeks of age, which is most likely acetone 
(Figure 5.10). 
 
 
 
 
Figure 5. 10 – Boxplots of m/z 77; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS H3O
+
 and analysed using Mann Whitney’s test 
(p < 0.05). 
 
 
 
 
 
 
For m/z 89 and m/z 107, which is tentatively identified as butanoic acid (although it could 
be many other compounds, i.e. pentanol, benzaldehyde and ethyl acetate) was detected 
in significant higher levels in mutant (het) mice at 8 weeks of age (Figure 5.11).  
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Figure 5. 11 – Boxplots of m/z 89 (a), m/z 107 (b); Faecal headspace of Cushing´s mice (het) compared with WT 
littermates on a B6-C3PDE background along the age. Data acquired by SIFT-MS H3O
+
 and analysed using Mann 
Whitney’s test (p < 0.05). 
 
 
(a) 
(b) 
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m/z 43, tentatively identified as propanol (which also produces ions at m/z 61 and 
m/z 79) and m/z 43 ion was detected in significant higher levels of faecal headspace of 
mutant (het) mice at 20 weeks of age (Figure 5.12).  
 
 
 
 
 
 
Figure 5. 12 – Boxplots of m/z 43; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS H3O
+
 and analysed using Mann Whitney’s test 
(p < 0.05). 
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Correlations and age effect in faecal headspace profile 
The relationship between counts of m/z values and blood glucose levels was investigated 
using the non-parametric Spearman's rho correlation coefficient. Outliers have not been 
removed throughout this study. Three medium correlations (0.30 ≤ r ≤ 0.49) were found 
between specific m/z values and blood glucose levels respectively. Thus, medium 
correlation (0.30 ≤ r ≤ 0.49) for m/z 38 at 20 weeks of age (r = 0.338, n = 65, p = 0.006); 
m/z 93 at 16 weeks of age (r = 0.298, n = 65, p = 0.016); and m/z 59 at 16 weeks of age (r 
= 0.251, n = 65, p = 0.044). 
 
Friedman test (repeated measures) suggest that are significant differences in m/z 61 
(likely acetic acid according to NO+ results) across the age (p < 0.001). A Wilcoxon Signed 
Rank Test using a Bonferroni adjusted p value established that there is a statistically 
significant increase of acetic acid with age, i.e. from 8 to 12 weeks (z = -4.048, p < 0.001). 
In addition, a medium correlation was found between m/z 97 (acetic acid) and blood 
glucose levels at 20 weeks of age (r = 0.300, n = 65, p = 0.015). 
 
A Wilcoxon Signed Rank Test using a Bonferroni adjusted p value established that there is 
a statistically significant increase in m/z 65 (possibly ethanol) between 8 to 12 weeks of 
age (z = -4.153, p = 0.000); and between 8 to 20 weeks of age (z = -3.728, p = 0.000). 
In addition, a negative correlation (r = -0.302, n = 65, p = 0.014) was found between m/z 
83 and blood glucose levels at 8 weeks of age; small correlation for m/z 83 at 16 weeks of 
age (r = 0.278, n = 65, p = 0.025); and small correlation for m/z 83 at 20 weeks of age (r = 
0.244, n = 65, p = 0.050). 
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SIFT-MS NO+ data set: the Mann-Whitney U test revealed statistically significant 
differences in the VOCs levels of mutant (het) mice and WT littermates, were identified 
and given in Table 5.2.  
 
Table 5. 2 – Median values for statistically significant m/z values tested over the age (8, 12, 16 and 20 weeks old) of 
Cushing´s mice faecal headspace and its significance levels acquired using NO
+
 precursor ion. Data analysed using Mann 
Whitney´s test (p < 0.05). 
 
Ion 
 Median 
Significance level (p) 
 Possible compound (s) wt 
n = 35 
het 
n = 30 
8 weeks m/z 71 Butanoic acid 0.0 1.2 × 10
2
 0.036 
 m/z 77 Propanol 0.0 3.1 × 10
2
 0.005 
 m/z 90 Acetic acid 2.4 × 10
2
 6.8 × 10
2
 0.017 
 m/z 104 Propanoic acid 0.0 2.2 × 10
2
 0.000 
12 weeks 
Ion Possible compound (s) wt 
n = 23 
het 
n = 24 
Significance level (p) 
m/z 104 Propanoic acid 0.0 3.1 × 10
2
 0.014 
16 weeks 
Ion Possible compound (s) wt 
n = 35 
het 
n = 30 
Significance level (p) 
 --- --- --- --- ---- 
 Ion Possible compound (s) wt 
n = 35 
het 
n = 30 
Significance level (p) 
20 weeks m/z 77 Propanol 0.0 1.9 × 10
2
 0.011 
 m/z 88 Acetone 3.1 × 10
2
 1.1 × 10
3
 0.013 
 m/z 104 Propanoic acid 0.0 4.5 × 10
2
 0.003 
 
 
In SIFT-MS NO+ data set revealed that m/z values 71, 88, 90, and 104 are statistically 
significant, supporting the idea that these ions are in fact butanoic acid, acetone, acetic 
acid and propanoic acid respectively. Boxplots are represented below in Figures 5.13, 
5.14, 5.15 and 5.16.  
In addition, a medium correlation (r = 0.319, n = 47, p = 0.029) was found between m/z 90 
at 16 weeks of age and blood glucose levels.   
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Figure 5. 13 – Boxplots of m/z 71; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS NO
+
 and analysed using Mann Whitney’s test (p < 0.05). 
 
 
 
 
 
Figure 5. 14 – Boxplots of m/z 88; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS NO
+
 and analysed using Mann Whitney’s test (p < 0.05). 
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Figure 5. 15 – Boxplots of m/z 90; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS NO
+
 and analysed using Mann Whitney’s test (p < 0.05). 
 
 
 
 
Figure 5. 16 – Boxplots of m/z 104; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS NO
+
 and analysed using Mann Whitney’s test (p < 0.05). 
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m/z 77 was shown to be statistically significant at 8 and 20 weeks of age, and this could 
be propanol which yields m/z 59 through hydride transfer and m/z 77 with association of 
one water molecule (Figure 5.17).  
 
 
 
Figure 5. 17 – Boxplots of m/z 77; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS NO
+
 and analysed using Mann Whitney’s test (p < 0.05). 
 
 
Correlations and age effect in faecal headspace profile 
Positive medium correlations were found between m/z counts and blood glucose levels: 
Correlation for m/z 45 (ethanol) at 20 weeks of age (r = 0.301, n = 47, p = 0.040) 
Correlation for m/z 47 (unknown) at 8 weeks of age (r = 0.338, n = 47, p = 0.020) 
Correlation for m/z 48 (NO+(H2O)) at 20 weeks of age (r = 0.310, n = 47, p = 0.034) 
 
A Friedman test (repeated measures) suggest that are significant differences in m/z 48 
(NO+(H2O) across the age (p < 0.001). Wilcoxon Signed Rank Test using a Bonferroni 
adjusted p value established that there is a significant difference between 8 to 12 weeks 
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of age (z = -2.868, p = 0.004); 12 to 16 weeks of age (z = -2.836, p = 0.005); and 8 to 20 
weeks of age (z = -2.0656, p = 0.08). 
 
SIFT-MS O2
+ data set: the Mann-Whitney U test revealed statistically significant 
differences in the VOCs levels of mutant (het) mice and WT littermates, these were 
identified and are presented in Table 5.3.  
 
Table 5. 3 – Median values for statistically significant m/z values tested over the age (8, 12, 16 and 20 weeks old) of 
faecal headspace in Cushing´s mice and its significance levels acquired using O2
+
 precursor ion. Data analysed using 
Mann Whitney´s test (p < 0.05). 
 
Ion 
 Median 
Significance level (p) 
 Possible compound (s) wt 
n = 35 
het 
n = 30 
 m/z 43 Acetone, acetaldehyde,  
2-butanone, 2-pentanone, 
acetic acid 
1.5 × 10
3
 2.4 × 10
3
 0.023 
 m/z 60 Unknown 1.8 × 10
2
 6.4 × 10
2
 0.006 
8 weeks m/z 74 Unknown 0.0 2.3 × 10
2
 0.002 
 m/z 78 Benzene 0.0 4.6 × 102 0.008 
 m/z 92 Toluene  0.0 2.2 × 10
2
 0.019 
 Ion Possible compound (s) wt 
n = 23 
het 
n = 24 
Significance level (p) 
 m/z 43 Acetone, acetaldehyde,  
2-butanone, 2-pentanone, 
acetic acid 
2.4 × 10
3
 4.4 × 10
3
 0.010 
12 weeks m/z 60 Unknown 7.1 × 10
2
 3.0 × 10
3
 0.005 
 m/z 61 Unknown 4.4 × 10
1
 3.1 × 10
2
 0.012 
 m/z 78 Benzene 0.00 7.4 × 10
2
 0.032 
16 weeks 
Ion Possible compound (s) wt 
n = 34 
het 
n = 30 
Significance level (p) 
m/z 105 Benzaldehyde 0.0 0.0 0.030 
 Ion Possible compound (s) wt 
n = 35 
het 
n = 30 
Significance level (p) 
 m/z 31 Isopropylamine 4.1 × 10
3
 7.2 × 10
3
 0.040 
20 weeks m/z 74 Unknown 0.0 1.7 × 10
2
 0.037 
 m/z 92 Toluene 87.60 3.9 × 10
2
 0.044 
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SIFT-MS O2
+ data set confirms the presence of significant greater levels of acetone (m/z 
43) and acetic acid (m/z 43) in faecal headspace of mutant (het) mice. A graphical 
representation is given below.  
  
Figure 5. 18 – Boxplots of m/z 43; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS O2
+
 and analysed using Mann Whitney’s test (p < 0.05). 
 
 
 
Figure 5. 19 – Boxplots of m/z 60; Cushing´s mice (het) compared with WT littermates on a B6-C3PDE background along 
the age. Data acquired by SIFT-MS O2
+
 and analysed using Mann Whitney’s test (p < 0.05). 
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Figure 5. 20 – Boxplots of m/z 74; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS O2
+
 and analysed using Mann Whitney’s test (p < 0.05). 
 
 
 
 
 
 
 
 
Figure 5. 21 – Boxplots of m/z 78; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS O2
+
 and analysed using Mann Whitney’s test (p < 0.05). 
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Figure 5. 22 – Boxplots of m/z 61; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS O2
+
 and analysed using Mann Whitney’s test (p < 0.05). 
 
 
            
 
Figure 5. 23 – Boxplots of m/z 92; Faecal headspace of Cushing´s mice (het) compared with WT littermates on a 
B6-C3PDE background along the age. Data acquired by SIFT-MS O2
+
 and analysed using Mann Whitney’s test (p < 0.05). 
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A weak but positive correlation (r = 0.303, n = 46, p = 0.041) was found between m/z 60 
(which is currently unassigned compound) and blood glucose levels at 20 weeks of age, 
using the non-parametric Spearman's rho correlation coefficient. In addition to a 
significant change of VOC over the age (p < 0.001), where Wilcoxon Signed Rank Test using 
a Bonferroni adjusted p value revealed a significant difference between 8 to 12 weeks of 
age (z = -4.540, p = 0.000).   
 
5.1.2 Multivariate Statistics using SIFT-MS data 
A discriminant analysis was conducted for each data set individually using a single 
precursor ion at different time points (8, 12, 16 and 20 weeks of age); by combining all 
data sets at different time points for each precursor ion; and by combining data sets using 
H3O
+, NO+ and O2
+ to predict whether an animal was within the wild-type (WT) group or 
mutant (het) group. The cross-validated classification is presented in Table 5.4 and the 
corresponding test sensitivity and specificity was determined.  
Table 5. 4 – Cross-validated classification using Linear Discriminant Analysis and the corresponding test sensitivity and 
test specificity given for faecal headspace of Cushing´s mice data set using SIFT-MS. The best classification results are 
highlighted in bold. 
Precursor ion Age (weeks) Cross-validated classification (%) Sensitivity (%) Specificity (%) 
H3O
+
 
8 89.2 87 91 
12 81.5 77 86 
16 75.4 67 83 
20 86.2 83 89 
all 71.9 68 76 
NO
+
 
8 83.1 77 89 
12 80.9 79 83 
16 73.8 50 94 
20 70.8 70 71 
all 75.2 65 84 
O2
+
 
8 81.5 73 89 
12 85.1 83 87 
16 92.2 90 94 
20 72.3 57 86 
all 73.0 68 78 
H3O
+ 
+ NO
+
 + O2
+
 all 65.9 58 73 
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Discriminant analysis was carried out to predict whether an animal was within the mutant 
(het) group or WT group. The best classification results are highlighted in bold in Table 
5.4. The cross-validated classification showed that overall 89.2% were correctly classified 
using H3O
+ data set at 8 weeks old and 86.2% were correctly classified using H3O
+ data set 
at 20 weeks. Sensitivities and specificities are given respectively. The analytical method 
used showed a 83.1% correct classification using NO+ data set at 8 weeks old and 80.9% 
were correctly classified using NO+ data set at 12 weeks old. The best classification results 
are given for using O2
+ data set at 12 and 16 weeks old, where the cross-validated 
classification showed an overall 85.1% and 92.2% correct classification respectively. 
Combining data sets (H3O
+ + NO+ + O2
+) to discriminate between the groups (wt/het) 
showed that overall 65.9% were correctly classified, with a sensitivity of 58% and 
specificity of 73%. 
According to the previous findings, the best set of predictors that discriminate between 
the groups are indicated in the following Tables 5.5, 5.6 and 5.7. Wilks´ Lambda indicates 
the significance of the discriminant function, thus all predictors are significant (p < 0.000). 
 
Table 5. 5 – Best set of predictors discriminating between WT littermates and mutant (het) Cushing´s mice using SIFT-MS 
H3O
+
 data set. 
Precursor ion/ Age Variables Possible  
compound (s) (m/z) 
 
H3O
+
 (8 weeks) 
 
 
54 ammonia 
57 Propanoic acid, butanol 
71 Butanoic acid, pentanol 
79 Acetic acid, propanol 
122 Unknown  
H3O
+
 (20 weeks) 
 
38 Unknown 
60 Isopropylamine, 
methylethylamine, 1-propylamine 
63 Acetaldehyde 
65 Ethanol 
97 Acetic acid, propanol 
100 Unknown  
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Table 5. 6 – Best set of predictors discriminating between WT littermates and mutant (het) Cushing´s mice using SIFT-MS 
NO
+
 data set. 
Precursor ion/ Age Variables Possible  
compound (s) m/z 
 
NO
+
 (8 weeks) 
 
32 Artefact of O2
+
 
43 Acetaldehyde 
62 Dimethyl sulphide, methanol 
104 Propanoic acid 
 118 Butanoic acid 
NO
+
 (12 weeks) 
 
47 Unknown 
66 Unknown 
69 Unknown 
89 Unknown 
104 Propanoic acid 
 
Table 5. 7 – Best set of predictors discriminating between WT littermates and mutant (het) Cushing´s mice using SIFT-MS 
O2
+
 data set, and combining SIFT-MS H3O
+
 + NO
+ 
+ O2
+.  
Precursor ion/ Age Variables Possible  
compound (s) m/z 
O2
+ 
(12 weeks) 
43 Acetic acid, acetone, 2-butanone, 
2-pentanone, acetaldehyde 
46 Formic acid 
60 Unknown 
72 2-butanone, butanal, hexanal 
104 Unknown 
O2
+ 
(16 weeks) 
69 Pentanal 
77 Unknown 
81 Unknown 
108 Methyl phenol 
120 Unknown 
 
5.1.3 Univariate Analysis using GC-MS data 
Quantification using GC-MS was performed using an internal standard d8-toluene loaded 
onto each sample tube. Although quantification using this method is only 
semi-quantitative, GC-MS results might validate and support the SIFT-MS findings 
discussed above.    
A cohort of 65 mice (21 males and 44 females) was used of whom 30 were genotyped as 
mutants and 35 WT littermates. Deconvolution and identification of the top ten 
compounds present in the faecal headspace of Cushing´s mice is given in Table 5.8 and 
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the retention time in the column respectively. Highlighted in bold are the three most 
abundant VOCs in faecal headspace of Cushing´s mice at each time period. 
 
Table 5. 8 – Quantification of top 10 abundant compounds in faecal headspace of Cushing´s mice (8, 12, 16 and 20 
weeks of age). Data acquired by GC-MS using internal standard addition of d8-toluene. Retention time (RT) is given in 
minutes. Highlighted in bold is given the three most abundant VOCs in faecal headspace of Cushing´s mice.  
 
CAS 
RT 
[min] 
Compound 
Mean 
concentration 
8 weeks 
(ng L
-1
) 
Mean 
concentration 
12 weeks 
(ng L
-1
) 
Mean 
concentration 
16 weeks 
(ng L
-1
) 
Mean 
concentration 
20 weeks 
(ng L
-1
) 
64197 11.13 Acetic acid 6.8 × 10
2
 7.0 × 10
2
 9.3 × 10
2
 8.8 × 10
2
 
107926 14.30 Butanoic acid 3.2 × 10
2
 2.5 × 10
2
 4.4 × 10
2
 4.0 × 10
2
 
513860 12.80 Acetoin 3.0 × 10
2
 2.1 × 10
2
 3.7 × 10
2
 3.5 × 10
2
 
79312 14.54 Propanoic acid, 
2-methyl- 
1.9 × 10
2
 1.6 × 10
2
 1.8 × 10
2
 3.0 × 10
2
 
79094 13.05 Propanoic acid 2.0 × 10
2
 2.0 × 10
2
 3.0 × 10
2
 2.4 × 10
2
 
503742 14.92 Butanoic acid, 
3-methyl- 
9.0 × 10
1
 1.0 × 10
2
 1.1 × 10
2
 1.1 × 10
2
 
116530 15.04 Butanoic acid, 
2-methyl- 
8.6 × 10
1
 1.1 × 10
2
 1.2 × 10
2
 1.1 × 10
2
 
431038 9.43 2,3-
butanedione 
8.8 × 10
1
 7.2 × 10
1
 1.1 × 10
2
 1.1 × 10
2
 
71363 11.58 1-Butanol 7.7 × 10
1
 9.4 × 10
1
 1.4 × 10
2
 1.0 × 10
2
 
109524 15.43 Pentanoic acid 9.0 × 10
1
 8.3 × 10
1
 1.4 × 10
2
 1.0 × 10
2
 
 
 
Overall, acetic acid, butanoic acid and acetoin are present in faecal headspace in greater 
concentration than other compounds (Table 5.8). In Figure 5.24 present an illustrative 
chromatogram of a mutant animal at 8 weeks of age (a) and showing the increase in VOC 
across the age (8 and 20 weeks) (b).   
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Figure 5. 24 – Illustrative chromatogram of a mutant (het) animal at 8 weeks of age (a); zoom in overlapping 
chromatograms at 8 weeks and 20 weeks of age highlighted in blue, the same animal ID showing the increase in VOC 
across the age (b). 
 
(a) 
(b) 
Ethanol 
Acetone 
2,3-Butanedione 
Acetoin 
Acetic acid 
Butanoic acid 
Propanoic acid 
Butanoic acid, 3-methyl- 
Butanoic acid, 2-methyl- 
Pentanoic acid 
Ethanol 
Acetone 
1-propanol 
2,3-Butanedione 
2-Butanone 
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Table 5. 9 – Median concentrations expressed in ng L
-1
 for statistically significant VOCs tested over the age (8, 12, 16 and 
20 weeks of age) of Cushing´s mice. Highlighted in bold is given the compounds that are statistically significant for all 
time points. Data acquired by GC-MS and analysed using Mann Whitney´s test (p < 0.05). 
      
Age 
(weeks) 
CAS 
RT 
[min] 
Compound 
Median 
concentration 
wt  
n = 35 
het  
n = 30 
8 
64197 11.13 Acetic acid 3.0 × 10
2
 8.7 × 10
2
 
431038 9.43 2,3-butanedione 8.2 × 10
1
 6.5 × 10
1
  
79094 13.05 Propanoic acid 8.9 × 10
1
 2.2 × 10
2
 
71363 11.58 1-butanol 3.0 × 10
1
 4.7 × 10
1
 
116530 15.04 Butanoic acid, 2-methyl- 3.3 × 10
1
 5.8 × 10
1
 
12 
64197 11.13 Acetic acid 3.7 × 10
2
 8.4 × 10
2
 
79094 13.05 Propanoic acid 1.2 × 10
2
 1.7 × 10
2
 
79312 14.54 Propanoic acid, 2-methyl- 5.5 × 10
1
 7.6 × 10
1
 
71363 11.58 1-butanol 3.3 × 10
1
 7.2 × 10
1
 
109524 15.43 Pentanoic acid 3.9 × 10
1
 5.9 × 10
1
 
503742 14.92 Butanoic acid, 3-methyl- 5.2 × 10
1
 7.3 × 10
1
 
16 
64197 11.13 Acetic acid 6.3 × 10
2
 1.0 × 10
3
 
431038 9.43 2,3-butanedione 9.6 × 10
1
 5.7 × 10
2
 
79094 13.05 Propanoic acid 1.6 × 10
2
 2.7 × 10
2
 
79312 14.54 Propanoic acid, 2-methyl- 5.8 × 10
1
 1.1 × 10
2
 
71363 11.58 1-butanol 6.0 × 10
1
 1.3 × 10
2
 
20 
64197 11.13 Acetic acid 5.3 × 10
2
 1.1 × 10
3
 
79094 13.05 Propanoic acid 1.3 × 10
2
 2.5 × 10
2
 
109524 15.43 Pentanoic acid 6.7 × 10
1
 1.2 × 10
2
 
116530 15.04 Butanoic acid, 2-methyl- 6.8 × 10
1
 1.0 × 10
2
 
 
The chromatographic data do not follow a normal distribution, therefore the 
non-parametric Mann Whitney U test was used at each time point and revealed 
statistically significant differences (p < 0.05) in VOC concentration in faecal headspace of 
mutant (het) Cushing´s mice and WT littermates and these are indicated in Table 5.9. 
Remarkably, differences in acetic acid and propanoic acid concentration are statistically 
significant at each time point, and these occur in significantly increased levels in mutant 
mice, which is in agreement with previous findings discussed earlier using univariate 
analysis and multivariate statistics via SIFT-MS (Figure 5.25). However, the results of the 
Friedman test (repeated measures) suggest that are no significant differences in acetic 
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acid and propanoic acid levels across the age range nor are there any significant 
differences in the VOC profile concentration between males and females. 
 
 
Figure 5. 25 – Acetic acid (a) and propanoic acid (b) faecal headspace concentration of Cushing´s mice (het) compared 
with WT littermates on a B6-C3PDE background along the age. Data acquired by GC-MS and analysed using Mann 
Whitney’s test (p < 0.05). 
(b) 
(a) 
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Figure 5.26 present a graphical representation of statistically significant 2,3-butanedione 
(a), propanoic acid, 2-methyl- (b), 1-butanol (c), pentanoic acid (d), butanoic acid, 3-
methyl- (e), and butanoic acid, 2-methyl- (f) of Cushing´s mice (het) compared with WT 
littermates on a B6 C3PDE background. Mutant animals had significantly increased 
concentrations of butanoic acid, 3-methyl- at 12 weeks of age. Significantly greater 
concentrations of 1-butanol were found in mutant animals at 8, 12 and 16 weeks of age. 
Mutant animals had significantly increased concentrations of butanoic acid, 2-methyl- at 
8 and 20 weeks of age; pentanoic acid at 12 and 20 weeks of age; and propanoic acid, 2-
methyl- at 12 and 16 weeks of age. Interestingly, the volatile 2,3-butanedione was found 
to exist in significantly higher levels in WT littermates than mutant mice at 8 and 16 
weeks of age. 
 
Although not statistically significant at any time point, a Friedman test (repeated 
measures) suggests that are differences in acetoin levels across the age (p < 0.001). A 
Wilcoxon Signed Rank Test using a Bonferroni adjusted p value established that there is a 
statistically significant fluctuation of acetoin with age increase, i.e. from 8 to 12 weeks (z = 
-3.73, p < 0.001); and from 12 to 16 weeks (z = -4.60, p < 0.001). The last time point (16 to 
20 weeks) is not significant. 
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Figure 5. 26 – Faecal headspace concentration of 2,3-butanedione (a), propanoic acid, 2-methyl- (b), 1-butanol (c), 
pentanoic acid (d), butanoic acid, 3-methyl- (e), and butanoic acid, 2-methyl- (f) of Cushing´s mice (het) compared with 
WT littermates on a B6-C3PDE background along the age. Data analysed using Mann Whitney’s test (p < 0.05). 
 
(a) (b) 
(c) (d) 
(e) (f) 
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The relationship between VOC concentration and blood glucose levels was investigated 
using the non-parametric Spearman's rho correlation coefficient. Outliers have not been 
removed throughout this study. A small correlation (r = 0.236, n = 65, p = 0.059) was 
found between acetic acid concentration and blood glucose levels at 20 weeks of age.   
 
 
5. 2 A longitudinal study of the VOC profile emitted by the faecal headspace of single 
Afmid knockout mice exhibiting impaired glucose tolerance 
 
As discussed earlier in chapter 1, Afmid mice are prone to develop impaired glucose 
intolerance (IGT) which is a pre-diabetic state of hyperglycaemia. People with IGT have 
blood glucose levels that are higher than normal but not high enough to say they have 
diabetes. As discussed in chapter 1, people with IGT have plasma levels that are between 
7.8 to 11.0 mmol L-1 glucose.  
The disease was tracked across the three time points (8, 12 and 16 weeks of age) for the 
mutant (hom) Afmid mice and the WT littermates. The body weight of the animals is not 
normally distributed therefore a Mann Whitney U test was used to compare the mean 
score of weights. The mutation had no significant effects on body weight (Figure 5.27).  
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Figure 5. 27 – Body weights along the age of Afmid mice (hom) compared with WT littermates on a C57BL6/NTac 
background. Data analysed using Mann Whitney’s test. 
 
 
The non-parametric Friedman test (repeated measures) combined with individual post-
hoc tests, i.e. Wilcoxon Signed Rank Test using a Bonferroni adjusted p value (p < 0.01), 
was used to compare the animal’s weight along the age and to establish the statistically 
significant difference among the three time points. The results indicated that the body 
weight of the animals significantly change over the age (p < 0.001) and across the three 
time points, although there is no significant difference in the weight between mutants 
(hom) and WT littermates according to Mann Whitney’s test (Figure 5.28). Males [8 weeks 
(median = 2.4 × 101, p < 0.05); 12 weeks (median = 2.7 × 101, p < 0.05); 16 weeks (median 
= 2.9 × 101, p < 0.05)] are significantly heavier than females [8 weeks (median = 2.0 × 101, 
p < 0.05); 12 weeks (median = 2.2 × 101, p < 0.05); 16 weeks (median = 2.3 × 101, p < 0.05)] 
over the three periods of time. 
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Figure 5. 28 – Body weights along the age of male and female Afmid mice (hom) compared with WT littermates on a 
C57BL6/NTac background. Data analysed using non-parametric Friedman test (p < 0.001) together with Wilcoxon Signed 
Rank Test using a Bonferroni adjusted p value (p < 0.01). 
 
 
 
The variable blood glucose is not normally distributed therefore, individual Mann 
Whitney U tests were conducted to compare the mean scores per each time point. There 
is a significant difference in blood glucose levels of homozygous (hom) mice and WT 
littermates at 8, 12 and 16 weeks of age. Mutant (hom) mice developed significant 
increased concentrations of blood glucose (Figure 5.29). 
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Figure 5. 29 – Blood glucose concentrations along the age in Afmid mice (hom) compared with WT littermates on a 
C57BL6/NTac background. Data analysed using Mann Whitney’s test (p < 0.05). 
 
 
 
 
Blood glucose was taken for unfasted animals with the blood being sampled at the same 
period of the day, between 2 pm and 4 pm. 
The mutant (hom) male mice developed significant increased concentrations of blood 
glucose (p < 0.05) at the three time points compared to the WT littermates (Figure 5.30), 
although the increase of blood glucose levels with age are not statistically significant. 
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Figure 5. 30 – Blood glucose concentrations along the age of male and female Afmid (hom) compared with WT 
littermates on a C57BL6/NTac background. Data analysed using Mann Whitney’s test (p < 0.05).  
 
 
 
The plasma insulin concentrations indicated in Figure 5.31 do not correspond to 16 weeks 
of age but a later stage once the animals were culled, i.e. animals born in March were 
culled at 32 weeks of age, and animals born in May were culled at 28 weeks of age. Mann 
Whitney U test revealed no significant difference in plasma insulin concentration of 
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mutant (hom) mice and WT littermates (Figure 5.31) which is in agreement with previous 
findings (Hugill et al., 2015). As discussed earlier in chapter 1, these mice show impaired 
glucose tolerance, although their insulin sensitivity is unchanged when compared to 
wild-type animals (Hugill et al., 2015).  
 
 
 
 
Figure 5. 31 – Plasma insulin concentrations of Afmid (hom) compared with WT littermates on a C57BL6/NTac 
background.  
 
 
5.2.1 Univariate Analysis using SIFT-MS data 
The faecal volatile profile of Afmid mice was acquired using SIFT-MS at The Open 
University and the univariate analysis is given in this chapter. 
The SIFT-MS data set do not follow normal distribution either for H3O
+, NO+ and O2
+ 
precursor ions. According to the previous findings, a non-parametric statistic technique, 
Mann-Whitney U Test, was applied to test the differences between the two independent 
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groups of variables, i.e. mutant (hom) mice and WT littermates, and the same test was 
applied at each time point. The Mann-Whitney U test revealed significant differences in 
the VOCs levels of mutants (hom) animals and WT littermates, either for H3O
+, NO+ or O2
+ 
precursor ions.  
 
 
SIFT-MS H3O
+ data set was obtained using a cohort of 48 mice (24 males and 24 females) 
of whom 30 were genotyped as mutants and 18 WT littermates. Using H3O
+ as the 
precursor ion, statistically significant differences in the VOCs levels of mutant (hom) mice 
and WT littermates, were identified and given in Table 5.10. 
 
Below is shown an illustrative mass spectrum (Figure 5.32) zoomed in of one sample from 
a mutant (hom) mouse. Data acquired by SIFT-MS H3O
+, m/z range 10-140, acquisition 
time of 5  seconds and recorded for six iterations.  
 
 
Figure 5. 32 – Illustrative mass spectrum of a faecal headspace sample from a mutant (hom) Afmid mouse (animal ID 
51.1c). Data acquired by SIFT-MS H3O
+
, m/z range 10-140, acquisition time of 5 seconds and six iterations.  
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Table 5. 10 – Median values for statistically significant m/z values tested over the age (8 and 16 weeks of age) of faecal 
headspace Afmid mice and its significance levels acquired using H3O
+
 precursor ion. Data analysed using Mann 
Whitney´s test (p < 0.05). 
 
 
Ion 
 Median 
Significance level (p) 
 Possible compound (s) wt 
n = 18 
hom 
n = 30 
8 weeks m/z 59 Acetone, propanal 7.1 × 10
2
 1.1 × 10
2
 0.029 
16 weeks m/z 60 Acetonitrile 0.0 1.1 × 10
2
 0.043 
 
 
The ion m/z 59 is likely to be acetone and probably arise from-fatty acid and carbohydrate 
metabolism. The ion m/z 60 might not be an endogenous VOC. Boxplots are indicated in 
Figure 5.33. 
No significant differences were found for 12 weeks of age.  
 
 
 
Figure 5. 33 – Boxplots of m/z 59; Faecal headspace of Afmid mice (hom) compared with WT littermates on a 
C57BL6/NTac background along the age. Data acquired by SIFT-MS H3O
+
 and analysed using Mann Whitney’s test 
(p < 0.05). 
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Figure 5. 34 – Boxplots of m/z 77; Faecal headspace of Afmid mice (hom) compared with WT littermates on a 
C57BL6/NTac background along the age. Data acquired by SIFT-MS H3O
+
 and analysed using Mann Whitney’s test 
(p < 0.05). 
 
 
Correlations and age effect in faecal headspace profile 
The non-parametric Friedman test (repeated measures) followed with individual post-hoc 
tests, i.e. Wilcoxon Signed Rank Test using a Bonferroni adjusted p value (p < 0.01), was 
conducted and the results indicated that the ion m/z 59 (most likely acetone) significantly 
change over the age (p < 0.001) and specifically between 8 to 12 weeks of age. 
Additionally, a two medium correlations (r = 0.304, n = 48, p = 0.036) and (r = 0.295, n = 
48, p = 0.042) were found between m/z 59 at 16 weeks and corresponding blood glucose 
levels, and m/z 77 at 16 weeks and corresponding blood glucose levels, respectively.  
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Although not statistically significant between mutant (hom) animals and WT littermates, 
the ion m/z 61 (potentially acetic acid or propanol) significantly changes over the age, 
particularly between 8 to 12 weeks and 8 to 16 weeks of age (Figure 5.35).  
 
 
 
Figure 5. 35 – Boxplots of m/z 61; Faecal headspace of Afmid mice (hom) compared with WT littermates on a 
C57BL6/NTac background along the age. Data acquired by SIFT-MS H3O
+
 and analysed using Mann Whitney’s test 
(p < 0.05). 
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SIFT-MS NO+ data set: the Mann-Whitney U test revealed statistically significant 
differences in the VOCs levels of mutant (hom) mice and WT littermates, were identified 
and presented in Table 5.11.  
 
Table 5. 11 – Median values for statistically significant m/z values tested over the age (8, 12 and 16 weeks of age) of 
faecal headspace of Afmid mice and its significance levels acquired using NO
+
 precursor ion. Data analysed using Mann 
Whitney´s test (p < 0.05). 
 
Ion 
 Median 
Significance level (p) 8 weeks 
Possible compound (s) wt 
n = 18 
hom 
n = 30 
m/z 66 Unknown 0.0 3.3 × 10
2
 0.026 
12 weeks 
m/z 66 Unknown  0.0 4.5 × 10
2
 0.013 
m/z 118 Butanoic acid 9.9 × 10
2
 4.5 × 10
2
 0.059 
16 weeks m/z 43 Acetaldehyde  0.0 3.4 × 10
1
 0.054 
 
The unknown ion m/z 66 was found in significantly greater levels in mutant (hom) mice 
(p < 0.05), Figure 5.36. This is probably an artefact NO+(H2O)2. 
  
 
Figure 5. 36 – Boxplots of m/z 66; Faecal headspace of Afmid mice (hom) compared with WT littermates on a 
C57BL6/NTac background along the age. Data acquired by SIFT-MS NO
+
 and analysed using Mann Whitney’s test 
(p < 0.05). 
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SIFT-MS O2
+ data set: Statistically significant differences were detected for m/z values 
indicated in Table 5.12, by means of using a Mann-Whitney U test. Median values for 
each VOC within the mutant (hom) and WT groups are indicated and its significance 
levels.   
 
Table 5. 12 – Median values for statistically significant m/z values tested for 8 weeks of age of faecal headspace of 
Afmid mice and its significance levels acquired using O2
+
 precursor ion. Data analysed using Mann Whitney´s test 
(p < 0.05). 
 
Ion 
 Median 
Significance level (p) 
8 weeks 
Possible compound (s) wt 
n = 18 
hom 
n = 30 
--- ---   --- 
m/z 56 Hexanal, propenal 0.0 1.6 × 102 0.039 
m/z 89 Unknown 0.0 5.4 × 10
1
 0.029 
 
No significant differences were found at 12 and 16 weeks of age via SIFT-MS O2
+. 
Significant differences were detected for m/z 56 at 8 weeks of age. 
 
 
 
Figure 5. 37 – Boxplots of m/z 56; Faecal headspace of Afmid mice (hom) compared with WT littermates on a 
C57BL6/NTac background at 8 weeks of age. Data acquired by SIFT-MS O2
+
 and analysed using Mann Whitney’s test 
(p < 0.05). 
197 
 
5.2.2 Multivariate Statistics using SIFT-MS data 
A discriminant analysis was conducted for each Afmid data set individually using a single 
precursor ion at different time points (8, 12 and 16 weeks); by combining all data sets at 
different time points for each precursor ion; and by combining data sets using H3O
+, NO+ 
and O2
+ to predict whether an animal was within the WT group or mutant (hom) group.  
The cross-validated classification for all the precursor ions, and sensitivity and specificity 
are given in Table 5.13, where discriminant analysis was carried out to predict whether an 
animal was within the mutant (hom) group or WT group for each age point. 
 
Table 5. 13 – Cross-validated classification using Linear Discriminant Analysis and the corresponding test sensitivity and 
test specificity given for faecal headspace of Afmid mice data set using SIFT-MS. The best classification results are 
highlighted in bold. 
Precursor ion Age (weeks) Cross-validated classification (%) Sensitivity (%) Specificity (%) 
H3O
+
 
8 75.0 80 67 
12 72.9 87 50 
16 77.1 97 44 
all 71.5 96 31 
NO
+
 
8 77.1 83 67 
12 95.8 97 94 
16 77.1 97 45 
all 69.4 87 41 
O2
+
 
8 75.0 87 56 
12 72.9 87 50 
16 91.7 93 89 
all 78.5 91 57 
H3O
+ 
+ NO
+
 + O2
+
 all 68.3 92.6 27.8 
 
The best classification results are highlighted in bold in Table 5.13. The cross-validated 
classification showed that overall 75.0% were correctly classified using H3O
+ data set at 
8 weeks of age. Sensitivities and specificities are given respectively. The analytical method 
used showed a 95.8% correct classification using NO+ data set at 12 weeks of age. The 
best classification results are given for using O2
+ data set at 16 weeks, where the 
cross-validated classification showed an overall 91.7% correct classification.  
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According to the previous findings, the best set of predictors that discriminate between 
the groups are indicated in the following Tables 5.14, 5.15 and 5.16. Wilks´ Lambda 
indicates the significance of the discriminant function, thus all predictors are significant (p 
< 0.000). 
 
Table 5. 14 – Best set of predictors discriminating between WT littermates and mutant (hom) Afmid mice using SIFT-MS 
H3O
+
 data set. 
Precursor ion/ Age Variables Possible  
compound (s) m/z 
 
H3O
+
 (8 weeks) 
 
30 Unknown 
39 Unknown 
50 Unknown 
71 Butanoic acid, pentanol 
 80 Pyridine 
 
Table 5. 15 – Best set of predictors discriminating between WT littermates and mutant (hom) Afmid mice using SIFT-MS 
NO
+
 data set. 
Precursor ion/ Age Variables Possible  
compound (s) m/z 
 
NO
+
 (12 weeks) 
 
28 Unknown 
36 Unknown 
72 1-Butylamine 
78 Benzene 
 134 Unknown 
 
Table 5. 16 – Best set of predictors discriminating between WT littermates and mutant (hom) Afmid mice using SIFT-MS 
O2
+
 data set. 
Precursor ion/ Age Variables Possible  
compound (s) m/z 
 
O2
+
 (16 weeks) 
 
34 Unknown 
38 Unknown 
59 Methylethylamine 
79 Pyridine 
 99 Unknown 
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5.2.3 Univariate Analysis using GC-MS data 
As the same manner, quantification using GC-MS was done by means of using an internal 
standard d8-toluene loaded onto each sample tube.  
A cohort of 48 mice (24 males and 24 females) were bred of whom 30 were genotyped as 
mutants (hom) and 18 WT littermates. Four animals have been removed from the data 
set, thus, in this study was used a group of 44 mice (22 males and 22 females) whom 28 
were genotyped as mutants (hom) and 16 WT littermates.  Deconvolution and 
identification of the top ten compounds present in the faecal headspace of Afmid mice is 
given in Table 5.17. The three most abundant VOCs in faecal headspace of Afmid mice at 
each time period are highlighted in bold.  
 
Table 5. 17 – Quantification of top 10 abundant compounds in faecal headspace of Afmid mice (8, 12 and 16 weeks of 
age). Data acquired by GC-MS using internal standard addition of d8-toluene. Retention time (RT) is given in minutes. 
Highlighted in bold is given the three most abundant VOCs in faecal headspace of Afmid mice. 
 
CAS 
RT 
[min] 
Compound 
Mean 
concentration 
8 weeks 
(ng L
-1
) 
Mean 
concentration 
12 weeks 
(ng L
-1
) 
Mean 
concentration 
16 weeks 
(ng L
-1
) 
64197 11.13 Acetic acid 1.8 × 10
3
 5.7 × 10
2
 1.2 × 10
3
 
513860 12.80 Acetoin 2.0 × 10
3
 2.6 × 10
2
 6.2 × 10
2
 
107926 14.30 Butanoic acid 1.1 × 10
3
 2.6 × 10
2
 5.8 × 10
2
 
431038 9.43 2,3-butanedione 4.7 × 10
2
 8.6 × 10
1
 1.6 × 10
2
 
79094 13.05 Propanoic acid 2.3 × 10
2
 1.4 × 10
2
 2.6× 10
2
 
79312 14.54 Propanoic acid, 2-methyl- 1.1 × 10
2
 9.1 × 10
1
 1.8 × 10
2
 
71363 11.58 1-Butanol 9.1 × 10
1
 7.4 × 10
1
 2.0 × 10
2
 
109524 15.43 Pentanoic acid 7.7 × 10
1
 7.9 × 10
1
 1.4 × 10
2
 
116530 15.04 Butanoic acid, 2-methyl- 8.8 × 10
1
 8.4 × 10
1
 1.5 × 10
2
 
503742 14.92 Butanoic acid, 3-methyl- 6.9 × 10
1
 7.9 × 10
1
 1.2 × 10
2
 
 
Overall, acetic acid, acetoin and butanoic acid are present in faecal headspace in greater 
concentration than other compounds. In Figure 5.38 is represented an illustrative 
chromatogram of a mutant (hom) mouse at 8 weeks of age (a) and showing the increase 
in VOC across the age (8 and 16 weeks) (b).   
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Figure 5. 38 – Illustrative chromatogram of a faecal headspace sample of a mutant (hom) animal at 8 weeks of age (a); 
zoom in overlapping chromatograms at 8 weeks and 16 weeks of age highlighted in blue, same animal ID showing the 
increase in VOC across the age (b). 
 
(a) 
(b) 
Ethanol 
2,3-Butanedione 
Acetic acid Acetoin 
Butanoic acid 
Ethanol 
Acetone 
2,3-Butanedione 
2-Butanone 
1-propanol 
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The chromatographic data do not follow a normal distribution, therefore the 
non-parametric Mann Whitney U test was used at each time point (Table 5.18).  Mann 
Whitney U test revealed no significant differences in VOC concentration in faecal 
headspace of mutant (hom) Afmid mice and WT littermates at 8 weeks of age. At 12 
weeks of age, mutant (hom) animals had statistically significant elevated VOC 
concentrations in faecal headspace of acetic acid (median = 6.2 × 102, n = 28), propanoic 
acid (median = 1.6 × 102, n = 28) and 1-butanol (median = 8.3 × 101, n = 28) once 
compared to WT littermates respectively, acetic acid (median = 4.1 × 102, n = 16), 
propanoic acid (median = 1.0 × 102, n = 16), 1-butanol (median = 6.6 × 101, n = 16), p < 
0.05 (Figure 5.39). At 16 weeks of age, acetoin was found in significant increased levels in 
faecal headspace of mutant (hom) mice (median = 5.4 × 102, n = 28), WT littermates 
(median = 4.0 × 102, n = 16), p < 0.05.  
There is no significant differences in the VOC concentration between males and females.   
 
Table 5. 18 – Median concentrations expressed in ng L-1 for statistically significant VOCs tested over the age (8, 12 and 
16 weeks of age) of faecal headspace of Afmid mice. Data acquired by GC-MS and analysed using Mann Whitney´s test 
(p < 0.05). 
      
Age 
(weeks) 
CAS 
RT 
[min] 
Compound 
Median 
concentration 
wt  
n = 16 
hom  
n = 28  
8 -- -- none -- -- 
12 
64197 11.13 Acetic acid 4.1 × 10
2
 6.2 × 10
2
 
79094 13.05 Propanoic acid 1.0 × 10
2
 1.6 × 10
2
 
71363 11.58 1-butanol 6.6 × 10
1
 8.3 × 10
1
 
16 513860 12.80 Acetoin 4.0 × 10
2
 5.4 × 10
2
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(a) 
(b) 
(c) 
(d) 
(e) 
(f) 
(g) 
Figure 5. 39 – Faecal headspace concentration of acetic 
acid (a), propanoic acid (b), acetoin (c) along the age; and 
acetic acid at 12 weeks (d), propanoic acid at 12 weeks 
(e), acetoin at 16 weeks (f) and 1-butanol at 12 weeks (g) 
of Afmid mice (hom) compared with WT littermates on a 
C57BL6/NTac background. Data analysed using Mann 
Whitney’s test (p < 0.05). 
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Friedman test (repeated measures) suggests that are significant differences in acetoin 
and 1-butanol levels across the age (p < 0.001). A Wilcoxon Signed Rank Test using a 
Bonferroni adjusted p value established that there is a statistically significant fluctuation 
of acetoin with age increase, i.e. from 8 to 12 weeks (z = -4.68, p < 0.001; median (hom, 8 
weeks) = 1.1 × 103/ median (wt, 8 weeks) = 8.1 × 102; median (hom, 12 weeks) = 2.4 × 102/ 
median (wt, 12 weeks) = 1.7 × 102), and from 12 to 16 weeks (z = -4.94, p < 0.001; median 
(hom, 16 weeks) = 5.4 × 102/ median (wt, 16 weeks) = 4.0 × 102). 
A Wilcoxon Signed Rank Test using a Bonferroni adjusted p value established that there is 
a statistically significant increase of 1-butanol with age increase, specifically between 12 
to 16 weeks of age (z = -3.33, p < 0.001; median (hom, 12 weeks) = 8.3 × 101/ median (wt, 
12 weeks) = 6.6 × 101; median (hom, 16 weeks) = 1.5 × 102/ median (wt, 16 weeks) = 
8.9 × 101). 
 
 
 
The relationship between VOC headspace concentration and blood glucose levels was 
investigated using the non-parametric Spearman's rho correlation coefficient. Outliers 
have not been removed throughout this study. Two medium correlations indicated by a 
correlation coefficient between 0.30 to 0.49 (r = 0.361, n = 44, p = 0.016 and r = 0.357, n = 
44, p = 0.017) were found between acetoin concentration and blood glucose levels at 12 
and 16 weeks of age respectively.   
 
 
Concluding remarks 
 
Cushing´s mice developed obesity and insulin resistance, whereas Afmid mice did not 
developed obesity and these showed impaired glucose tolerance, although their insulin 
sensitivity is unchanged once compared to WT littermates.  
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Univariate analysis and multivariate statistics was performed for the SIFT-MS data, and 
merely univariate analysis for GC-MS data, since multivariate statistics would require 
further alignment of the peaks areas prior to statistical analysis. Univariate analysis have 
identified statistically significant individual m/z values, whereas multivariate statistics 
detected VOC patterns rather promising in separating the groups according to the 
phenotype.    
Overall, faecal headspace analysis by SIFT-MS and GC-MS indicated the presence of 
several compounds at statistically significant levels such as, short-chain fatty acids 
(SCFAs), ketones (acetone, 2,3-butanedione, acetoin), alcohols (methanol, ethanol, 
propanol, 1 butanol) and aldehydes (acetaldehyde). 
Significantly increased levels of acetic acid, propanoic acid, butanoic acid and acetone 
were found for diabetic (het) Cushing´s mice using SIFT-MS, and these findings were 
validated using GC-MS. Similarly to Cushing´s mice, acetic acid, acetoin and butanoic acid 
were found to be present in Afmid faecal headspace in greater concentration than other 
compounds by means of using GC-MS. In GC-MS data set, statistically significant elevated 
VOC concentrations in faecal headspace of acetic acid, propanoic acid, 1-butanol and 
acetoin were found in mutant (hom) Afmid mice, although SIFT-MS results did not 
confirmed this.   
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Chapter 6 
 
Analysis of the volatile faecal metabolome 
in screening for colorectal cancer 
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6. 1 Introductory notes 
There are many potential uses of VOC analysis in medical diagnostics, as discussed in 
chapter 1. This chapter discusses the potential use of the analysis of the volatile faecal 
metabolome as a potential screening technique for colorectal cancer.  
This work was carried out by a group of colleagues plus myself and published with data 
analysis carried out by a bioinformatics expert, Dr Michael Cauchi (Batty et al., 2015). The 
published work may be find in Appendix C.   
SIFT-MS measurements were taken and data analysis and statistics displayed in this thesis 
was carried out by me alone and is shown below. Statistical analysis presented here was 
performed using the software IBM SPSS Statistics 21.0, in contrast to the multivariate 
statistical techniques used by Cauchi (Batty et al., 2015) which was performed using a 
higher power computer, which allowed the setup of bootstrapping and testing the 
stability and reliability of the models, which is able to produce a much more rigorous 
assessment of statistical significance (Brereton R.G., 2009). 
 
6. 2 Univariate Analysis 
The data displayed in this chapter were acquired using the SIFT-MS instrument at The 
Open University. The normality of the data was assessed. The Kolmogorov-Smirnov 
statistic and Shapiro-Wilk statistic assessed the normality of the distribution of scores 
along the data set. Significant results (p < 0.05) indicated that the data do not follow 
normal distribution.   
A non-parametric statistic technique, Mann-Whitney U Test, was therefore applied to test 
the differences between the two independent groups of variables (Low Risk/ High Risk), 
where Low Risk stands for the ‘normal’ population and High Risk indicates the group 
within the class 5 and 6 (high grade adenoma and adenocarcinoma).  
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The Mann-Whitney U test revealed significant differences in the VOCs levels of low risk 
and high risk groups, either for H3O
+, NO+ and O2
+ precursor ions. Using H3O
+ as the 
precursor ion, statistically significant differences were detected for m/z 35, low risk 
(median = 188.7, n = 30) and high risk (median = 540.8, n = 31), p = 0.021; and m/z 90 
where, low risk (median = 0.0, n = 30) and high risk (median = 85.8, n = 31), p = 0.007.  
Figure 6.1 presents the boxplots for m/z = 35 (H3O
+) and m/z = 90 (H3O
+). The boxplots 
also provide information on outliers represented with a circle and extreme points are 
indicated with an asterisk. 
(a)   
(b)  
 
Figure 6. 1 – Boxplots for m/z values showing statistical significance, m/z 35 (a) and m/z 90 (b) using H3O
+
 precursor ion. 
Data analysed using Mann-Whitney´s test (p < 0.05). 
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A likely identification of m/z 35 [H3S
+] indicates that this VOC might be hydrogen sulphide 
(Španěl and Smith, 2000b). The potential existence of other overlapping ions at low 
molecular weight is reduced, thus there is a reasonable probability that in fact this ion is 
indeed H2S. Hydrogen sulphide has been identified as a product of microbiota 
fermentation within the gut (Moore et al., 1987). Sulphate reducing bacteria and 
existence of hydrogen sulphide in the gut and faeces have been shown to be present in 
patients with ulcerative colitis and colorectal cancer (Cai et al., 2010, Jia et al., 2012). The 
unknown variable m/z 90 also shown to be statistically significant. The ion m/z 90 might 
possibly be identified as 3-aminopropanoic acid (C3H7NO2), commonly known as -
alanine. In literature, this metabolite was found in colon carcinoma tissues with very high 
statistical significance using GC-TOF (Denkert et al., 2008).  
 
Using NO+ as precursor ion, the Mann-Whitney U test revealed statistically significant 
differences for m/z 96 [(CH3)2S2
+] (Figure 6.2) which may be identified as dimethyl 
disulphide (C2H6S2) (Španěl and Smith, 1998b). Where, low risk (median = 0.0, n = 30) and 
high risk (median = 58.3, n = 31), p = 0.026. Although the larger isotope 32S have not 
shown to be statistically significant at m/z 94, the O2
+ data set revealed that m/z 94 was 
statistically significant between the groups and thus, confirms this m/z as dimethyl 
disulphide. 
The presence of sulphides in the gut are controlled by the levels of sulphate reducing 
bacteria in the gut and these have been shown to be present in patients with colorectal 
cancer (Gibson et al., 1993, Cai et al., 2010).   
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Figure 6. 2 – Boxplots for m/z 96 showing statistical significance, using NO
+
 precursor ion. Data analysed using 
Mann-Whitney´s test (p < 0.05). 
 
 
Using O2
+ as precursor ion, statistically significant differences were detected for m/z 48, 
m/z 62, m/z 66 and m/z 94 using Mann-Whitney U test. Median values for each VOC 
within the Low and High Risk groups are indicated in Table 6.1 with their significance 
levels.   
 
Table 6. 1 – Median values of Low and High Risk groups for m/z 48, m/z 62, m/z 66 and m/z 94 and its significance levels 
acquired using O2
+
 precursor ion. Data analysed using Mann Whitney´s test (p < 0.05).  
 
Ion 
Median 
Significance level (p) 
Low Risk High Risk 
m/z 48 1533.5 3299.3 0.041 
m/z 62 325.6 546.7 0.036 
m/z 66 0.0 98.7 0.036 
m/z 94 197.2 431.0 0.024 
 
In Figure 6.3 are indicated the boxplots for m/z 48, m/z 62, m/z 66 and m/z 94 
respectively, acquired using O2
+ precursor ion. 
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(a) 
 
(b) 
 
(c) 
 
(d) 
Figure 6. 3 – Boxplots for m/z values showing statistical significance, m/z 48 (a),  m/z 62 (b), m/z 66 (c), and m/z 94 (d) 
using O2
+
 precursor ion. Data analysed using Mann-Whitney´s test (p < 0.05). 
 
The ions m/z 62 and m/z 94 were tentatively identified as dimethyl sulphide [(CH3)2S
+] 
and dimethyl disulphide [(CH3)2S2
+] (Španěl and Smith, 1998b) respectively, supporting 
the hypothesis that increased production of sulphides is more predominant in the high 
risk group. The unknown variables m/z 48 and m/z 66 are also shown to be statistically 
significant.  
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6. 3 Multivariate Statistics 
A discriminant analysis was conducted for each data set individually using a single 
precursor ion, and by combining data sets using H3O
+, NO+ and O2
+ to predict whether a 
subject was within the Low Risk group or High Risk group.  
The cross-validated classification showed an overall good classification for all the 
precursor ions, and sensitivity and specificity are given (Table 6.2). 
 
Table 6. 2 – Cross-validated classification using Linear Discriminant Analysis and the corresponding test sensitivity and 
test specificity  
Precursor ion Cross-validated classification (%) Sensitivity (%) Specificity (%) 
H3O
+
 77.0 68 87 
NO
+
 68.9 71 67 
O2
+
 93.4 90 97 
H3O
+ 
+ NO
+
 + O2
+
 68.9 67 71 
 
In a national screening programme, although it is highly desirable to detect cancers, it is 
also very important to minimise the number of false positives obtained in any test. This 
will reduce the number of unnecessary invasive, unpleasant and expensive diagnostic 
tests (e.g. colonoscopies). For this reason, it is desirable to have a high specificity in any 
screening test, in other words to limit the number of false positives. Taking into account 
this particular requirement, therefore, the best results were achieved using the data sets 
H3O
+, O2
+ and by combining data sets (H3O
+ + NO+ + O2
+). The cross-validated classification 
showed that overall 77.0% were correctly classified using H3O
+ data set, which had a 
specificity of 87% and sensitivity of 68%. Although the O2
+ classification results seem 
promising, these would need to be further validated with other statistical models. 
Using the data set for H3O
+, the best set of predictors that discriminate between the 
groups are indicated in Table 6.3. Wilks´ Lambda indicates the significance of the 
discriminant function, thus all predictors are significant (p < 0.000). 
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Table 6. 3 – Best set of predictors discriminating between Low Risk group and High Risk group using the data set H3O
+
 
Variables  
(m/z) 
Wilks' Lambda  
(p < 0.000) 
Possible compound (s) 
35 0.000 Hydrogen sulphide 
42 0.000 Acetonitrile  
77 0.000 Acetone, Carbon disulphide 
 
The metabolic profile given through the multivariate analysis is in agreement with the 
results assessed using univariate analysis, in which m/z 35 was found to be responsible 
for separating the groups. This leads to the conclusion that m/z 35 might be used as 
clinically relevant biomarker for colorectal cancer. The variable m/z 42 is possibly 
acetonitrile, which has been known to be an exogenous compound. Acetonitrile 
concentrations were commonly found in the breath and urine of smokers (Abbott et al., 
2003). The ion m/z 77 might be acetone or carbon disulphide, or a mixture of both.  
Significant higher abundances of Proteobacteria were found in patients with colorectal 
adenomas and a significant lower abundance of Bacteroidetes (Shen et al., 2010). Thus 
there is evidence of changes in the gut flora in patients with colorectal cancer. 
Adenomatous polyps are a precursor form of colorectal cancer, i.e. polyps are not usually 
cancerous, although it might eventually turn into cancer if left untreated (Leslie et al., 
2002). A recent study indicated changes in faecal microbiota associated with 
adenomatous polyps (Hale et al., 2017).    
The results shown in this thesis may indicate a change in the gut microbiota and the 
existing of sulphate reducing bacteria in the gut which process available hydrogen (Gibson 
et al., 1993), or in fact that the sulphate reducing bacteria are present in a greater 
amount in the bowel of the high risk group. Sulphide compounds, including hydrogen 
sulphide appear to offer potential as biomarkers for screening of colorectal cancer.  
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Chapter 7 
 
Conclusions and future work 
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7. 1 Conclusions 
 
This thesis aimed to investigate the use of VOCs in disease diagnosis and monitoring, 
through the faecal headspace analysis of mouse models of type 2 diabetes, and human 
studies analysing faecal headspace from patients with colorectal cancer. Faecal 
headspace studies using mouse models of type 2 diabetes (T2D) have never been 
performed before. Fundamental chemistry studies have been performed due to the need 
of having standardised data, and thus investigates a potential method for standardising 
the analysis of breath gas VOCs. 
 
Chapter 4 discussed a potential method for standardising the analysis of breath gas VOCs 
using different analytical techniques, in order to get consistent results amongst such 
techniques.  
The results of the present study of the reactions of H3O
+ with six VOCs biologically 
significant, comprising several alcohols, one ketone and one aldehyde, indicates that 
most of the reactions result in multiple products ions, and the abundance and stability of 
these ions strongly depends on the E/N ratio used. It is critical that the reaction rate 
coefficients for the reactions between H3O
+ and VOC be determined under the actual 
conditions in order to obtain reliable quantification.  
 
In contrast to SIFT-MS, in PTR-MS the underlying ion chemistry is often not known, 
specifically, the kinetics of the ion-molecule reactions and reaction time are not well 
established and can be very sensitive to changes in E/N (Warneke et al., 1996). Thus, 
careful calibration of the instrument is usually carried out for each VOC and is presently 
the preferred method to ensure accurate quantification (Beauchamp et al., 2013). 
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Nevertheless, quantification of VOC concentrations may be accomplished if proton 
transfer reaction rate coefficients are known (Cappellin et al., 2012).  
Product ions and branching ratios were determined at specific working conditions, and 
subsequently, quantitative determination of VOC concentrations evaluated. Calibration 
curves determined using SIFT-MS, PTR-MS and TD-GC-MS are given within the range 
101-103 ppbv.    
 
This study demonstrates the potential for overcoming inherent difficulties in the 
standardisation procedure required for the trace gas analysis of breath constituents. In 
this work, the findings give slightly different results, but the approach taken of using 
standard headspaces enables a proper comparison to be made between the three 
analytical techniques (SIFT-MS, PTR-MS and TD-GC-MS) and enables these techniques to 
be tested for their accuracy and reproducibility. Additionally this study provides an 
estimate of how accurately rate coefficients can be determined in SIFT-MS and PTR-MS. 
This may be one way of standardising methods given that different laboratories use 
different sampling and analytical techniques. In identifying biomarkers with techniques, 
such as GC-MS, some compounds cannot be accurately quantified, particularly across a 
wide range of size and volatility or even polarity. For instance, this study has shown that 
while SIFT-MS and PTR-MS may be able to detect ethanol and acetaldehyde simply and 
accurately, a typical TD-GC-MS technique used in VOC biomarker identification is poor at 
quantification of smaller compounds due to the need to carefully pick sorbents to cover 
the range.   
 
This work has demonstrated that VOCs may be measured at trace concentrations via 
different analytical techniques, and the measured levels depend upon several factors, i.e. 
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collection, storage and analysis. The lack of standardization between analytical 
techniques is still an issue to deal with, which in turn promotes the existence of 
inconsistent published results. Testing standards calibrated for the gas phase according to 
Henry´s law may be an easy option to overcome those difficulties.   
 
Chapter 5 discusses the potential use of VOCs as a potential non-invasive method for 
monitoring the progress of diabetes. Mice have the potential to provide large data sets 
for metabolic profiling at controlled conditions. The results shown here were from 
studying two different mouse models of diabetes, namely, the Cushing´s syndrome 
mouse model of type 2 diabetes, and single Afmid knockout mice exhibiting impaired 
glucose tolerance. 
   
Type 2 Diabetes (T2D) is a metabolic disease and it has been attributed to changes in diet, 
poor physical activity, life-style, genetic predisposition, while more recently some studies 
suggest that there is a link between metabolic diseases and bacterial populations in the 
gut. Alterations in the gut microbiota have been linked to obesity (Ley et al., 2006), insulin 
resistance and T2D (Rabot et al., 2010). However, whether gut microbiota plays a causal 
role in the pathogenesis of metabolic diseases, and the mechanism by which 
modifications to the gut microbiota might lead to these conditions in humans is unknown. 
There is evidence of changes in the gut microbiota of type-2 diabetic patients when 
compared to non-diabetic subjects (Larsen et al., 2010). In this study the composition of 
faecal microbiota in adults with T2D was compared to non-diabetic controls and the 
relative abundance of bacterial species Firmicutes was significantly lower, while the 
proportion of Bacteroidetes and Proteobacteria was somewhat higher in diabetics 
compared to non-diabetic controls. Accordingly, the ratios of Bacteroidetes to Firmicutes 
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are found to be positively correlated with reduced glucose tolerance. Two other studies 
indicated that patients with type-2 diabetes had less butyrate-producing bacteria than 
controls (Qin et al., 2012, Karisson et al., 2013). However, it is important to note that 
studies’ discrepancies may be due to ethnic factors, dietary differences, and intake of 
medication to treat T2D which greatly influences bacterial composition in the gut (Shin et 
al., 2014). 
 
Gut microbiota are thought to influence glucose and energy metabolism through the 
production of SCFAs (short-chain fatty acids). These volatile  SCFAs include butyric acid 
also known as butanoic acid, acetic acid, propionic acid also known as propanoic acid, 
formic acid, isobutyric acid, valeric acid, isovaleric acid, and caproic acids (Bergman, 
1990), although acetate, propionate and butyrate resemble 90 to 95% of SCFAs within the 
gut. These SCFAs are produced through fermentation of undigested dietary 
carbohydrates by gut bacteria, particularly by Bacteroides (Bäckhed et al., 2005), along 
with the production of CO2, H2, and CH4. The faecal SCFAs concentration in healthy 
humans has been studied earlier (McOrist et al., 2008) and these concentrations strongly 
depend on the dietary regime, medication, age, and genetic background.   
 
Alterations in the gut microbiota, and consequently in SCFAs composition have been 
assumed to be associated with the development of obesity, insulin resistance and 
diabetes. Mice studies indicated that germ-free mice developed enhanced insulin 
sensitivity with improved glucose tolerance when fed a high-fat diet (HFD) (Rabot et al., 
2010).  It was suggested that SCFAs may regulate gut hormones via their endogenous 
receptors Free fatty acid receptors 2 (FFAR2) and 3 (FFAR3), but direct evidence is lacking. 
In earlier studies, SCFAs were administrated in mice, and the findings suggested that 
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butyrate, propionate and acetate protect against diet-induced obesity and insulin 
resistance (Lin et al., 2012, Gao et al., 2009). Butyrate and propionate, but not acetate, 
induce gut hormones and reduce food intake (Lin et al., 2012). A hypothetical model for 
propionic acid effects in humans was also reported (Al-Lahham et al., 2010) suggesting 
that propionic acid reduces food intake, reduces inflammation and consequently insulin 
resistance.  
Headspace of faecal samples have not been investigated before and the fact that the 
acids spotted in this thesis are statistically significant may hint at different mechanisms 
occurring in the gut of Afmid and Cushing´s mice.   
 
Importantly, the composition of the gut microbiota are not constant over the age. Thus, 
the faecal flora in humans of different ages, ranging from 3 to 89 years old, was studied 
and results indicated that there are significant differences between elderly people and 
younger adults and children, although the major SCFAs (acetate, propionate and 
butyrate) within the gut did not suffered alterations across the ageing process (Andrieux 
et al., 2002). 
In the animal work reported in this thesis, Cushing´s mice faecal headspace suffered 
alterations over the age. Using H3O
+ data set, significant differences in m/z 61 (likely 
acetic acid according to NO+ results) across the age (p < 0.001) were found, i.e. from 8 to 
12 weeks (z = -4.048, p < 0.001), in Cushing´s mice. In addition, there was a statistically 
significant increase in m/z 65 (possibly ethanol) between 8 to 12 weeks of age, and 
between 8 to 20 weeks of age. For Afmid mice, the faecal headspace suffered alterations 
over the age, this means that the ion m/z 59 (most likely acetone) significantly changed 
over the age (p < 0.001) and specifically between 8 to 12 weeks of age.  
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Both increases (Li et al., 2014, Rahat-Rozenbloom et al., 2014) and decreases (Murphy et 
al., 2010) in plasma and faecal SCFAs concentrations were associated with overfeeding, 
obesity and the metabolic syndrome. A recent and detailed study (Perry et al., 2016) 
reported changes to gut microbiota, and altered faecal SCFAs concentrations, and these 
have been associated with obesity, insulin resistance and the metabolic syndrome. 
Increased production of acetate by an altered gut microbiota in rodents on a high-fat diet 
(HFD) led to activation of the parasympathetic nervous system –  the part of the nervous 
system that controls 'subconscious' operations such as heart rate and digestion – which in 
turn, promoted increased glucose output and stimulated the secretion of insulin in 
rodents, increased ghrelin (hormone produced in the gastrointestinal tract with a 
significant role in regulating appetite) secretion, abnormally increased appetite, and 
obesity. They also observed that injections of acetate into rats fed a normal diet 
stimulated insulin secretion by beta-cells in the pancreas, indicating that acetate was 
responsible for this effect, however the mechanism is unknown. The relationship 
between the gut microbiota and increased insulin was studied after transferring faecal 
matter from chow- or HFD-fed donor rats to chow- or HFD-fed recipients, they reported 
similar changes in the gut microbiota, acetate levels, and insulin, except for chow-fed 
donors into chow-fed recipients in which the microbiota did not changed or metabolic 
phenotypes. Thus, plasma and faecal acetate concentrations were significantly increased 
in insulin-resistant rats after 3 days or 4 weeks on a HFD diet, which in turn leads to 
increased food intake, and drives obesity and insulin resistance. These results support the 
findings presented in this thesis, in which greater concentrations of acetic acid were 
found for diabetic (het) mice, either by SIFT-MS and GC-MS. The mutant Cushing´s mice 
developed obesity and showed significantly higher blood glucose concentrations and 
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plasma insulin concentrations, supporting the hypothesis that Cushing’s mice develop a 
diabetic phenotype related to a gut microbiota interaction.  
 
No significant differences in body weight were detected between Afmid mice and WT 
littermates, thus Afmid mice do not develop obesity. Afmid mice show impaired glucose 
tolerance, although their insulin sensitivity is unchanged when compared to WT 
littermates. Greater concentrations of acetic acid were found for mutant (hom) Afmid 
mice by GC-MS, although SIFT-MS results did not confirm this.  
 
All the animals were fed ad libitum on a commercial diet (5.3% fat [corn oil], 21.2% 
protein, 57.4% carbohydrate, 4.6% fibre; Rat and Mouse Diet No. 3 (RM3). All the animals 
(het, hom and WT littermates) were placed under the same diet, however we do not 
know whether diabetic animals ate the same amount as WT littermates.  
 
In this work, the ketones (acetone, 2,3-butanedione, acetoin), alcohols (methanol, 
ethanol, propanol, 1-butanol) and aldehydes (acetaldehyde) were also found to be 
statistically significant in the measured samples. Ketones bodies were found to be 
produced by the liver during fatty-acid and carbohydrate metabolism and related to 
glucose metabolism in humans (Kalapos, 2003, Decombaz et al., 1983). Interestingly, in 
this work acetoin (3-hydroxy-2-butanone) was found in higher levels in diabetic mice (het 
and hom) and there is evidence that acetoin is a product of fermentation in bacteria (Xiao 
and Xu, 2007, Lopez et al., 1975). Bacillus subtilis, Bacillus amyloliquefaciens, Enterobacter 
cloacae, Serratia marcescens, and Paenibacillus polymyxa, can produce acetoin from 
pyruvate via α-acetolactate by two enzymatic steps catalysed by α-acetolactate synthase 
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and α-acetolactate decarboxylase (Xiao and Xu, 2007). Acetoin can be further converted 
to 2,3-butanediol (Bae et al., 2016). 
 
Bacteria present in the gut produce alcohols, including methanol, ethanol, propanol and 
butanol (Ewen et al., 2005). Long-chain alcohols may be made by reduction of the 
corresponding acid, therefore butanoic acid may be reduced to 1-butanol (Garner et al., 
2007). Acetaldehyde is a toxic intermediate breakdown product of ethanol metabolism by 
the liver and small amounts of acetaldehyde are produced naturally through gut microbial 
fermentation and high acetaldehyde levels indicating to promote carcinogenesis in rats 
(Seitz et al., 1990). 
 
Finger-prick blood tests for monitoring T2D are painful and patients tend to avoid them, 
either due to the discomfort or phobia. VOC analysis of breath or body fluids may provide 
non-invasive alternative method for monitoring the disease, however a lot of research is 
still required.  As VOC trials are expensive and difficult in human volunteers, initial studies 
using mouse models are useful to provide insight about the disease at controlled 
conditions. The gut microbiota of diabetic mice seem to have a different composition 
once compared to WT littermates, and fermentation products within the gut seem to 
appear in different concentrations, including short-chain fatty acids (SCFAs), alcohols, 
ketones and aldehydes.  
 
Chapter 6 discussed the use of VOCs as a screening tool of colorectal cancer. It has been 
suggested that colorectal cancer risk is determined by the interaction between diet and 
microbial metabolism within the gut (O'Keefe et al., 2007). Colorectal cancer risk has 
been attributed to a diet regime high in red meat and fat leading to protein fermentation 
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metabolites potentially carcinogenic and likely linked to colon cancer (Hughes et al., 2000, 
Larsson and Wolk, 2006). Sulphur compounds are generally assimilated in the human diet 
through protein (Carbonero et al., 2012), thus, sulphate reducing bacteria use these 
sulphur residues from meat. The results shown in this thesis may indicate a change in the 
gut microbiota and the existing of sulphate reducing bacteria in the gut which process 
available hydrogen (Gibson et al., 1993), or in fact that the sulphate reducing bacteria are 
present in a greater amount in the bowel of the high risk group.  
The association between colorectal cancer and gut microbiota has been studied for many 
years using conventional culture methods and the majority of the VOC-based studies are 
relatively small. In a recent study the total bacterial counts, in particular anaerobic 
bacteria, was found to be significantly lower (10.3 ± 0.7 vs. 10.8± 0.3 log10 cells/g of 
faeces; p < 0.001) in patients with colorectal cancer than in healthy individuals (Ohigashi 
et al., 2013). The concentrations of short-chain fatty acids (SCFAs) produced by 
microbiota carbohydrate fermentation, such as acetic acid, propionic acid, and butyric 
acid, were significantly decreased in the diseased group. Significant higher abundances of 
Proteobacteria were found in patients with colorectal adenomas and a significant lower 
abundance of Bacteroidetes (Shen et al., 2010). Thus there is evidence of changes in the 
gut flora in patients with colorectal cancer. In addition there is increasing evidence that 
the development of colorectal cancer is promoted when the gastrointestinal/faecal pH is 
alkaline, which is directly related to the concentrations of organic acids produced by 
bacteria (Ohigashi et al., 2013, Pye et al., 1990). However, our findings do not provide 
evidence of increased acid levels. 
 
Following the multivariate analysis on the SIFT-MS data, the analytical method used 
showed a 77.0% correct classification using H3O
+ data set. Along with a specificity of 87% 
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and sensitivity of 68%, meaning that overall this method shows promise as a replacement 
for the faecal occult blood test (FOBT). Remarkably, through the use of the volatile faecal 
profile, this study was able to discriminate the groups better than the FOBT in which all 
the subjects have tested positive for FOBT initially.  In order to replace FOBT as a 
screening test, any replacement would need to be better than FOBT in at least one 
respect and at least as good in all other respects.  It must also be a similar cost, be easy to 
use and quick to perform, and potentially of greater accuracy. While the present method 
shows potential it will have to be validated using a much greater number of patients, 
however, including those with pre-cancerous polyps. 
Sulphide compounds, including hydrogen sulphide appear to offer potential as 
biomarkers for screening of colorectal cancer, although further studies will be required to 
confirm this.    
The published literature in faecal headspace analysis in disease diagnosis is scarce. VOC 
analysis shows promise for the screening of CRC, non-invasively and painlessly.  
 
7. 2 Future work  
Future work comprises the standardization of additional VOCs using different analytical 
techniques, through the use of standards calibrated for the gas-phase at physiologically 
representative concentrations. 
Additional CRC studies comprising a larger group of patients in order to validate the pilot 
study presented here as a screening test of CRC; follow-up of the statistically significant 
compounds (sulphide compounds) identified here, using Multiple Ion Mode (MIM) of 
SIFT-MS and Selective Ion Monitoring (SIM) mode of GC-MS.  
The animal work presented here should be further investigated. Human studies are 
essential, with testing the breath and urine headspace of many patients at a range of 
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blood glucose concentrations at many time points.  Without this basic research, it is very 
unlikely that a VOC substitute for direct blood glucose testing will ever be realised. 
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Appendix A 
ELISA assay 
Test Name: INSULIN MILLIPORE 
ID2: Cat #: EZRMI-13K 
ID3: Lot #: 2430979 
 
Basic settings   
  
Measurement type: Absorbance 
Microplate name: NUNC 96 
 
 
 
 
Optic settings 
No. Excitation Emission 
1 450 Empty 
2 590 Empty 
 
General settings: Bottom optic used    
    
Positioning delay [s]: 0.5   
Reading direction: bidirectional, horizontal left to right, top to bottom   
Target temperature [°C]: 25  
 
  
Absorbance (values are displayed as OD)  
Y = Bottom + (Top-Bottom) / (1+(EC50/x)^Slope) 
Wavelength:  
Top 4.354407201 
240 
 
Slope 1.574396683 
EC50 10.81707518 
log(EC50) 1.034109848 
Bottom -0.011845421 
r = 0.999963023 
r² = 0.999926047 
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